Varian Medical Systems, Inc.. (VAR) NEW YORK STOCK EXCHANGE, INC.
$177.07 - (-)
Market Cap: $16.26B
As of 04/14/21 12:00 AM EDT. Market closed.
Varian Medical Systems, Inc.. (VAR)
NEW YORK STOCK EXCHANGE, INC.
$177.07
- (-)
Market Cap: $16.26B
As of 04/14/21 12:00 AM EDT. Market closed.
Add to Portfolio
COMPANY PROFILE
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
CEO Compensation (Base)
$1M
CEO Compensation (Total)
$10.28M
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
CEO
Dow Wilson
CEO Compensation (Base)
$1M
CEO Compensation (Total)
$10.28M
URL
Address
3100 Hansen Way Bldg 4A, California, Palo Alto, 94304-1038.
PRICE CHART FOR VARIAN MEDICAL SYSTEMS, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$177.07
Previous Close
$177.07
Days Range
$177.03 - $177.20
52 week range
$103.67 - $177.38
Volume
0
Avg. Volume (30 days)
762,697
Market Cap
$16.26B
Dividend Yield
-
P/E
58.60
Shares Outstanding
91,838,813
Open
$177.07
Previous Close
$177.07
Days Range
$177.03 - $177.20
52 week range
$103.67 - $177.38
Volume
0
Avg. Volume (30 days)
762,697
Market Cap
$16.26B
Dividend Yield
-
P/E
58.60
Shares Outstanding
91,838,813
FINANCIAL STATEMENTS FOR VARIAN MEDICAL SYSTEMS, INC.
LOADING...
INSIDER TRANSACTIONS FOR VARIAN MEDICAL SYSTEMS, INC.
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Bruff Jesse Michael | SVP Finance, CFO | Mar 01, 2021 | Sale | $175.81 | 6,499 | 1,142,563 | 823 | Mar 03, 2021, 06:27 PM |
Bruff Jesse Michael | SVP Finance, CFO | Feb 16, 2021 | Option Exercise | $176.15 | 476 | 83,847 | 7,322 | Feb 17, 2021, 07:20 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Feb 16, 2021 | Option Exercise | $176.15 | 1,118 | 196,936 | 29,256 | Feb 17, 2021, 07:19 PM |
BUTEL JEAN LUC | Director | Feb 16, 2021 | Option Exercise | $176.15 | 367 | 64,647 | 4,048 | Feb 17, 2021, 07:13 PM |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | Feb 16, 2021 | Option Exercise | $176.15 | 342 | 60,243 | 621 | Feb 17, 2021, 07:01 PM |
Toth Christopher A. | SVP and Pres. Oncology Systems | Feb 16, 2021 | Option Exercise | $176.15 | 848 | 149,375 | 15,230 | Feb 17, 2021, 06:59 PM |
O'Reilly Kevin | SVP, President of Oncology Sys | Feb 16, 2021 | Option Exercise | $176.15 | 848 | 149,375 | 1,482 | Feb 17, 2021, 06:57 PM |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | Dec 10, 2020 | Option Exercise | $81.97 | 4,473 | 366,652 | 4,549 | Dec 14, 2020, 12:48 PM |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | Dec 10, 2020 | Sale | $174.95 | 4,473 | 782,551 | 76 | Dec 14, 2020, 12:48 PM |
WILSON DOW R | President and CEO | Dec 08, 2020 | Option Exercise | $109.03 | 159,198 | 17,357,358 | 280,643 | Dec 10, 2020, 08:24 PM |
WILSON DOW R | President and CEO | Dec 08, 2020 | Sale | $174.40 | 159,198 | 27,764,769 | 121,445 | Dec 10, 2020, 08:24 PM |
WILSON DOW R | President and CEO | Dec 07, 2020 | Option Exercise | $81.34 | 186,845 | 15,197,911 | 203,945 | Dec 09, 2020, 08:53 PM |
WILSON DOW R | President and CEO | Dec 07, 2020 | Sale | $174.35 | 157,515 | 27,463,047 | 121,445 | Dec 09, 2020, 08:53 PM |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | Dec 04, 2020 | Option Exercise | $74.78 | 14,330 | 1,071,602 | 9,921 | Dec 08, 2020, 05:33 PM |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | Dec 04, 2020 | Sale | $174.47 | 15,909 | 2,775,625 | 1,655 | Dec 08, 2020, 05:33 PM |
Toth Christopher A. | SVP and Pres. Oncology Systems | Dec 01, 2020 | Option Exercise | $174.19 | 36,403 | 6,341,039 | 13,702 | Dec 03, 2020, 03:19 PM |
Toth Christopher A. | SVP and Pres. Oncology Systems | Dec 01, 2020 | Option Exercise | $125.86 | 35,640 | 4,485,512 | 20,244 | Dec 03, 2020, 03:19 PM |
Bruff Jesse Michael | SVP Finance, CFO | Dec 01, 2020 | Option Exercise | $174.19 | 26,531 | 4,621,435 | 6,499 | Dec 03, 2020, 03:18 PM |
Bruff Jesse Michael | SVP Finance, CFO | Dec 01, 2020 | Option Exercise | $123.89 | 31,053 | 3,847,176 | 15,790 | Dec 03, 2020, 03:18 PM |
Hutchinson Michael Damon | SVP,Chief Legal Officer, Secy | Dec 01, 2020 | Option Exercise | $174.19 | 5,425 | 944,981 | 5,589 | Dec 03, 2020, 03:16 PM |
O'Reilly Kevin | SVP, President of Oncology Sys | Nov 23, 2020 | Option Exercise | $173.50 | 410 | 71,135 | 802 | Nov 25, 2020, 07:15 PM |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | Nov 23, 2020 | Option Exercise | $173.50 | 297 | 51,530 | 1,655 | Nov 25, 2020, 07:10 PM |
Toth Christopher A. | SVP and Pres. Oncology Systems | Nov 23, 2020 | Option Exercise | $173.50 | 667 | 115,725 | 2,871 | Nov 25, 2020, 07:08 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Nov 23, 2020 | Option Exercise | $173.50 | 4,225 | 733,038 | 31,406 | Nov 25, 2020, 07:07 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Nov 24, 2020 | Sale | $174.15 | 4,288 | 746,759 | 27,118 | Nov 25, 2020, 07:07 PM |
WILSON DOW R | President and CEO | Nov 23, 2020 | Option Exercise | $173.50 | 9,401 | 1,631,074 | 92,115 | Nov 25, 2020, 07:05 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Nov 16, 2020 | Option Exercise | $131.77 | 400 | 52,708 | 27,518 | Nov 18, 2020, 01:03 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Nov 16, 2020 | Sale | $173.70 | 400 | 69,481 | 27,118 | Nov 18, 2020, 01:03 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Nov 09, 2020 | Option Exercise | $112.82 | 543 | 61,261 | 27,661 | Nov 10, 2020, 04:44 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Nov 09, 2020 | Sale | $173.79 | 543 | 94,370 | 27,118 | Nov 10, 2020, 04:44 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Oct 14, 2020 | Option Exercise | $131.77 | 400 | 52,708 | 27,518 | Oct 16, 2020, 01:46 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Oct 14, 2020 | Sale | $172.01 | 400 | 68,805 | 27,118 | Oct 16, 2020, 01:46 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Oct 08, 2020 | Option Exercise | $112.82 | 543 | 61,261 | 27,661 | Oct 09, 2020, 08:14 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Oct 08, 2020 | Sale | $171.91 | 543 | 93,347 | 27,118 | Oct 09, 2020, 08:14 PM |
WILSON DOW R | President and CEO | Sep 21, 2020 | Option Exercise | $67.12 | 38,907 | 2,611,438 | 121,471 | Sep 23, 2020, 01:15 PM |
WILSON DOW R | President and CEO | Sep 21, 2020 | Sale | $172.43 | 38,907 | 6,708,734 | 82,564 | Sep 23, 2020, 01:15 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Sep 14, 2020 | Option Exercise | $131.77 | 400 | 52,708 | 27,518 | Sep 16, 2020, 06:55 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Sep 14, 2020 | Sale | $173.48 | 400 | 69,392 | 27,118 | Sep 16, 2020, 06:55 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Sep 08, 2020 | Option Exercise | $112.82 | 543 | 61,261 | 27,661 | Sep 10, 2020, 05:13 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Sep 08, 2020 | Sale | $173.60 | 543 | 94,266 | 27,118 | Sep 10, 2020, 05:13 PM |
WILSON DOW R | President and CEO | Aug 21, 2020 | Option Exercise | $67.12 | 38,907 | 2,611,438 | 121,471 | Aug 24, 2020, 11:52 AM |
WILSON DOW R | President and CEO | Aug 21, 2020 | Sale | $172.63 | 38,907 | 6,716,321 | 82,564 | Aug 24, 2020, 11:52 AM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Aug 14, 2020 | Option Exercise | $131.77 | 400 | 52,708 | 27,518 | Aug 19, 2020, 11:19 AM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Aug 14, 2020 | Sale | $173.18 | 400 | 69,271 | 27,118 | Aug 19, 2020, 11:19 AM |
Bruff Jesse Michael | SVP Finance, CFO | Aug 10, 2020 | Option Exercise | $173.33 | 558 | 96,718 | 1,977 | Aug 12, 2020, 07:34 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Aug 10, 2020 | Option Exercise | $130.37 | 7,344 | 957,429 | 34,462 | Aug 12, 2020, 07:33 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Aug 10, 2020 | Sale | $173.31 | 7,344 | 1,272,769 | 27,661 | Aug 12, 2020, 07:33 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Jul 29, 2020 | Option Exercise | $112.82 | 2,716 | 306,419 | 29,834 | Jul 31, 2020, 04:33 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Jul 29, 2020 | Sale | $135.00 | 2,716 | 366,660 | 27,118 | Jul 31, 2020, 04:33 PM |
Bruff Jesse Michael | SVP Finance, CFO | May 07, 2020 | Sale | $117.22 | 205 | 24,031 | 919 | May 11, 2020, 04:00 PM |
Toth Christopher A. | SVP and Pres. Oncology Systems | Apr 13, 2020 | Sale | $109.74 | 1,625 | 178,325 | 2,253 | Apr 15, 2020, 01:07 PM |
WILSON DOW R | President and CEO | Mar 17, 2020 | Option Exercise | $67.12 | 38,909 | 2,611,572 | 121,267 | Mar 18, 2020, 03:39 PM |
WILSON DOW R | President and CEO | Mar 17, 2020 | Sale | $110.00 | 38,909 | 4,279,990 | 82,358 | Mar 18, 2020, 03:39 PM |
BUTEL JEAN LUC | Director | Mar 02, 2020 | Option Exercise | $126.55 | 561 | 70,995 | 3,190 | Mar 04, 2020, 08:43 PM |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | Feb 19, 2020 | Sale | $147.19 | 1,090 | 160,439 | 1,717 | Feb 21, 2020, 03:10 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Feb 19, 2020 | Sale | $147.19 | 2,653 | 390,503 | 29,152 | Feb 21, 2020, 03:07 PM |
Bruff Jesse Michael | SVP Finance, CFO | Feb 18, 2020 | Option Exercise | $145.90 | 249 | 36,329 | 919 | Feb 20, 2020, 07:49 PM |
WILSON DOW R | President and CEO | Feb 18, 2020 | Option Exercise | $145.90 | 1,619 | 236,212 | 82,358 | Feb 20, 2020, 07:47 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Feb 18, 2020 | Option Exercise | $145.90 | 1,334 | 194,631 | 29,771 | Feb 20, 2020, 07:45 PM |
Toth Christopher A. | SVP and Pres. Oncology Systems | Feb 18, 2020 | Option Exercise | $145.90 | 873 | 127,371 | 3,249 | Feb 20, 2020, 07:42 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Feb 18, 2020 | Option Exercise | $145.90 | 891 | 129,997 | 40,269 | Feb 20, 2020, 07:40 PM |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | Feb 18, 2020 | Option Exercise | $145.90 | 638 | 93,084 | 1,987 | Feb 20, 2020, 07:37 PM |
BUTEL JEAN LUC | Director | Feb 13, 2020 | Option Exercise | $146.91 | 372 | 54,651 | 1,880 | Feb 18, 2020, 07:28 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Feb 10, 2020 | Option Exercise | $94.56 | 1,243 | 117,541 | 28,361 | Feb 12, 2020, 05:06 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Feb 10, 2020 | Sale | $141.68 | 1,243 | 176,111 | 28,074 | Feb 12, 2020, 05:06 PM |
ECKERT R ANDREW | Director | Feb 04, 2020 | Option Exercise | $61.98 | 5,651 | 350,249 | 15,566 | Feb 04, 2020, 07:25 PM |
ECKERT R ANDREW | Director | Feb 04, 2020 | Sale | $142.41 | 5,651 | 804,759 | 9,915 | Feb 04, 2020, 07:25 PM |
ILLINGWORTH DAVID J | Director | Feb 03, 2020 | Option Exercise | $61.98 | 5,651 | 350,249 | 16,562 | Feb 04, 2020, 07:24 PM |
ILLINGWORTH DAVID J | Director | Feb 03, 2020 | Sale | $141.23 | 5,651 | 798,091 | 10,911 | Feb 04, 2020, 07:24 PM |
WILSON DOW R | President and CEO | Jan 10, 2020 | Option Exercise | $146.62 | 2,955 | 433,262 | 76,250 | Jan 13, 2020, 06:24 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Jan 10, 2020 | Option Exercise | $80.40 | 699 | 56,200 | 27,118 | Jan 10, 2020, 06:40 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Jan 08, 2020 | Option Exercise | $112.82 | 543 | 61,261 | 27,661 | Jan 10, 2020, 06:40 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Jan 08, 2020 | Sale | $146.71 | 1,242 | 182,214 | 27,118 | Jan 10, 2020, 06:40 PM |
Toth Christopher A. | SVP and Pres. Oncology Systems | Jan 03, 2020 | Option Exercise | $112.82 | 1,597 | 180,174 | 3,282 | Jan 07, 2020, 06:57 PM |
Toth Christopher A. | SVP and Pres. Oncology Systems | Jan 03, 2020 | Sale | $145.00 | 1,597 | 231,565 | 1,685 | Jan 07, 2020, 06:57 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Jan 02, 2020 | Option Exercise | $94.59 | 1,243 | 117,574 | 33,224 | Jan 06, 2020, 07:55 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Jan 02, 2020 | Sale | $143.28 | 6,106 | 874,869 | 31,981 | Jan 06, 2020, 07:55 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Dec 16, 2019 | Option Exercise | $94.30 | 814 | 76,760 | 39,373 | Dec 18, 2019, 07:33 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Dec 16, 2019 | Sale | $141.97 | 814 | 115,566 | 39,024 | Dec 18, 2019, 07:33 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Dec 12, 2019 | Option Exercise | $112.82 | 2,443 | 275,619 | 41,002 | Dec 16, 2019, 06:09 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Dec 12, 2019 | Sale | $142.00 | 2,443 | 346,906 | 38,559 | Dec 16, 2019, 06:09 PM |
Toth Christopher A. | SVP and Pres. Oncology Systems | Dec 06, 2019 | Sale | $138.95 | 564 | 78,366 | 1,830 | Dec 10, 2019, 06:22 PM |
WILSON DOW R | President and CEO | Nov 21, 2019 | Option Exercise | $129.97 | 14,251 | 1,852,202 | 79,205 | Nov 25, 2019, 05:05 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Nov 21, 2019 | Option Exercise | $129.97 | 2,957 | 384,321 | 38,559 | Nov 25, 2019, 05:04 PM |
Toth Christopher A. | SVP and Pres. Oncology Systems | Nov 21, 2019 | Option Exercise | $129.97 | 719 | 93,448 | 2,249 | Nov 25, 2019, 05:02 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Nov 21, 2019 | Option Exercise | $129.97 | 4,781 | 621,387 | 31,981 | Nov 25, 2019, 05:01 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Nov 15, 2019 | Option Exercise | $94.57 | 4,969 | 469,924 | 32,087 | Nov 20, 2019, 07:52 AM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Nov 15, 2019 | Sale | $128.00 | 4,969 | 636,032 | 27,118 | Nov 20, 2019, 07:52 AM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Nov 15, 2019 | Option Exercise | $80.40 | 465 | 37,386 | 35,568 | Nov 19, 2019, 09:57 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Nov 15, 2019 | Sale | $128.02 | 465 | 59,531 | 35,523 | Nov 19, 2019, 09:57 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Oct 15, 2019 | Option Exercise | $80.40 | 465 | 37,386 | 35,566 | Oct 17, 2019, 06:00 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Oct 15, 2019 | Sale | $113.83 | 465 | 52,932 | 35,101 | Oct 17, 2019, 06:00 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Sep 16, 2019 | Option Exercise | $80.40 | 465 | 37,386 | 35,411 | Sep 18, 2019, 07:52 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Sep 16, 2019 | Sale | $116.30 | 465 | 54,080 | 35,101 | Sep 18, 2019, 07:52 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Aug 19, 2019 | Option Exercise | $80.40 | 465 | 37,386 | 35,566 | Aug 20, 2019, 08:13 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Aug 19, 2019 | Sale | $110.49 | 465 | 51,378 | 35,101 | Aug 20, 2019, 08:13 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jul 15, 2019 | Option Exercise | $80.40 | 465 | 37,386 | 35,566 | Jul 17, 2019, 07:56 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jul 15, 2019 | Sale | $135.22 | 465 | 62,879 | 35,101 | Jul 17, 2019, 07:56 PM |
GUERTIN TIMOTHY E | Director | Jul 15, 2019 | Option Exercise | $61.98 | 5,651 | 350,249 | 13,589 | Jul 17, 2019, 07:54 PM |
GUERTIN TIMOTHY E | Director | Jul 15, 2019 | Sale | $135.21 | 7,000 | 946,456 | 32,125 | Jul 17, 2019, 07:54 PM |
GUERTIN TIMOTHY E | Director | Jul 15, 2019 | Sale | $135.22 | 5,651 | 764,117 | 7,938 | Jul 17, 2019, 07:54 PM |
BISCHOPING GARY E JR | SVP, Finance & CFO | Jul 11, 2019 | Option Exercise | $96.55 | 56,232 | 5,429,104 | 27,393 | Jul 15, 2019, 02:42 PM |
BISCHOPING GARY E JR | SVP, Finance & CFO | Jul 11, 2019 | Sale | $132.56 | 56,232 | 7,454,176 | 22,623 | Jul 15, 2019, 02:42 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Jul 10, 2019 | Option Exercise | $80.40 | 699 | 56,200 | 27,789 | Jul 10, 2019, 06:30 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Jul 08, 2019 | Option Exercise | $112.82 | 543 | 61,261 | 27,633 | Jul 10, 2019, 06:30 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Jul 10, 2019 | Sale | $138.29 | 699 | 96,662 | 27,393 | Jul 10, 2019, 06:30 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Jul 08, 2019 | Sale | $137.61 | 543 | 74,722 | 27,139 | Jul 10, 2019, 06:30 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jun 17, 2019 | Option Exercise | $80.40 | 465 | 37,386 | 35,566 | Jun 19, 2019, 07:31 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jun 17, 2019 | Sale | $131.40 | 465 | 61,103 | 35,101 | Jun 19, 2019, 07:31 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Jun 10, 2019 | Option Exercise | $94.57 | 1,242 | 117,461 | 27,789 | Jun 12, 2019, 06:54 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Jun 10, 2019 | Sale | $131.51 | 1,242 | 163,332 | 27,090 | Jun 12, 2019, 06:54 PM |
BISCHOPING GARY E JR | SVP, Finance & CFO | May 22, 2019 | Sale | $127.94 | 845 | 108,109 | 2,283 | May 24, 2019, 06:25 PM |
BISCHOPING GARY E JR | SVP, Finance & CFO | May 18, 2019 | Option Exercise | $130.51 | 974 | 127,117 | 3,128 | May 22, 2019, 07:45 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | May 15, 2019 | Option Exercise | $80.40 | 465 | 37,386 | 35,566 | May 17, 2019, 07:07 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | May 15, 2019 | Sale | $130.11 | 465 | 60,502 | 35,466 | May 17, 2019, 07:07 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | May 10, 2019 | Option Exercise | $80.40 | 699 | 56,200 | 27,789 | May 14, 2019, 07:31 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | May 10, 2019 | Sale | $132.88 | 699 | 92,880 | 27,589 | May 14, 2019, 07:31 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | May 08, 2019 | Option Exercise | $112.82 | 544 | 61,374 | 27,634 | May 10, 2019, 06:24 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | May 08, 2019 | Sale | $134.49 | 544 | 73,164 | 27,190 | May 10, 2019, 06:24 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Apr 16, 2019 | Option Exercise | $112.82 | 4,888 | 551,464 | 39,763 | Apr 17, 2019, 07:51 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Apr 15, 2019 | Option Exercise | $75.37 | 6,390 | 481,642 | 39,448 | Apr 17, 2019, 07:51 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Apr 15, 2019 | Sale | $140.88 | 8,371 | 1,179,291 | 36,956 | Apr 17, 2019, 07:51 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Apr 16, 2019 | Sale | $142.00 | 4,888 | 694,096 | 34,875 | Apr 17, 2019, 07:51 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Apr 10, 2019 | Option Exercise | $80.40 | 699 | 56,200 | 27,597 | Apr 10, 2019, 07:16 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Apr 08, 2019 | Option Exercise | $112.82 | 543 | 61,261 | 27,441 | Apr 10, 2019, 07:16 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Apr 10, 2019 | Sale | $140.90 | 699 | 98,492 | 26,898 | Apr 10, 2019, 07:16 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Apr 08, 2019 | Sale | $140.98 | 543 | 76,552 | 27,041 | Apr 10, 2019, 07:16 PM |
WILSON DOW R | President and CEO | Mar 29, 2019 | Option Exercise | $74.06 | 45,050 | 3,336,403 | 109,533 | Apr 02, 2019, 07:30 PM |
WILSON DOW R | President and CEO | Mar 29, 2019 | Sale | $141.58 | 45,050 | 6,378,211 | 97,534 | Apr 02, 2019, 07:30 PM |
Toth Christopher A. | SVP and Pres. Oncology Systems | Apr 01, 2019 | Option Exercise | $112.82 | 1,400 | 157,948 | 2,521 | Apr 02, 2019, 07:29 PM |
Toth Christopher A. | SVP and Pres. Oncology Systems | Apr 01, 2019 | Sale | $142.50 | 1,400 | 199,500 | 1,121 | Apr 02, 2019, 07:29 PM |
Toth Christopher A. | SVP and Pres. Oncology Systems | Mar 21, 2019 | Option Exercise | $80.40 | 1,211 | 97,364 | 2,332 | Mar 25, 2019, 07:48 PM |
Toth Christopher A. | SVP and Pres. Oncology Systems | Mar 22, 2019 | Option Exercise | $112.82 | 1,400 | 157,948 | 2,521 | Mar 25, 2019, 07:48 PM |
Toth Christopher A. | SVP and Pres. Oncology Systems | Mar 21, 2019 | Sale | $137.50 | 1,211 | 166,513 | 1,121 | Mar 25, 2019, 07:48 PM |
Toth Christopher A. | SVP and Pres. Oncology Systems | Mar 22, 2019 | Sale | $140.00 | 1,400 | 196,000 | 1,121 | Mar 25, 2019, 07:48 PM |
Toth Christopher A. | SVP and Pres. Oncology Systems | Mar 18, 2019 | Option Exercise | $71.68 | 3,498 | 250,722 | 3,144 | Mar 20, 2019, 05:02 PM |
Toth Christopher A. | SVP and Pres. Oncology Systems | Mar 18, 2019 | Sale | $135.17 | 4,621 | 624,633 | 2,244 | Mar 20, 2019, 05:02 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Mar 08, 2019 | Option Exercise | $112.82 | 543 | 61,261 | 27,441 | Mar 12, 2019, 09:11 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Mar 11, 2019 | Option Exercise | $80.40 | 700 | 56,280 | 27,598 | Mar 12, 2019, 09:11 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Mar 08, 2019 | Sale | $131.69 | 543 | 71,508 | 26,898 | Mar 12, 2019, 09:11 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Mar 11, 2019 | Sale | $133.94 | 700 | 93,761 | 26,898 | Mar 12, 2019, 09:11 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Feb 15, 2019 | Option Exercise | $132.74 | 1,002 | 133,005 | 36,856 | Feb 20, 2019, 07:14 PM |
BISCHOPING GARY E JR | SVP, Finance & CFO | Feb 15, 2019 | Option Exercise | $132.74 | 333 | 44,202 | 1,583 | Feb 20, 2019, 07:09 PM |
BISCHOPING GARY E JR | SVP, Finance & CFO | Feb 15, 2019 | Sale | $131.69 | 300 | 39,508 | 1,383 | Feb 20, 2019, 07:09 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Feb 15, 2019 | Option Exercise | $132.74 | 2,044 | 271,321 | 29,123 | Feb 20, 2019, 06:59 PM |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | Feb 19, 2019 | Sale | $131.60 | 2,225 | 292,810 | 27,198 | Feb 20, 2019, 06:59 PM |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | Feb 15, 2019 | Option Exercise | $132.74 | 758 | 100,617 | 2,127 | Feb 20, 2019, 06:51 PM |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | Feb 19, 2019 | Sale | $131.56 | 1,446 | 190,237 | 1,093 | Feb 20, 2019, 06:51 PM |
WILSON DOW R | President and CEO | Feb 15, 2019 | Option Exercise | $132.74 | 3,131 | 415,609 | 84,483 | Feb 20, 2019, 06:49 PM |
Toth Christopher A. | SVP and Pres. Oncology Systems | Feb 15, 2019 | Option Exercise | $132.74 | 1,216 | 161,412 | 2,244 | Feb 20, 2019, 06:46 PM |
BUTEL JEAN LUC | Director | Feb 11, 2019 | Option Exercise | $131.09 | 432 | 56,631 | 1,009 | Feb 14, 2019, 08:34 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Feb 12, 2019 | Option Exercise | $67.12 | 1,088 | 73,027 | 27,567 | Feb 14, 2019, 07:12 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Feb 12, 2019 | Sale | $132.57 | 1,088 | 144,233 | 26,898 | Feb 14, 2019, 07:12 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Feb 11, 2019 | Option Exercise | $80.40 | 699 | 56,200 | 27,597 | Feb 13, 2019, 07:58 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Feb 11, 2019 | Sale | $131.45 | 699 | 91,886 | 26,898 | Feb 13, 2019, 07:58 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Feb 08, 2019 | Option Exercise | $112.82 | 6,517 | 735,248 | 32,986 | Feb 12, 2019, 04:41 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Feb 08, 2019 | Sale | $130.10 | 6,517 | 847,848 | 26,898 | Feb 12, 2019, 04:41 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Jan 28, 2019 | Option Exercise | $71.62 | 19,580 | 1,402,325 | 34,798 | Jan 30, 2019, 08:00 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Jan 28, 2019 | Sale | $130.48 | 19,580 | 2,554,738 | 26,898 | Jan 30, 2019, 08:00 PM |
ECKERT R ANDREW | Director | Jan 28, 2019 | Option Exercise | $57.27 | 5,651 | 323,633 | 15,127 | Jan 30, 2019, 07:58 PM |
ECKERT R ANDREW | Director | Jan 28, 2019 | Sale | $130.15 | 5,651 | 735,478 | 9,476 | Jan 30, 2019, 07:58 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Jan 11, 2019 | Sale | $125.00 | 6,462 | 807,750 | 26,898 | Jan 15, 2019, 04:51 PM |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | Jan 03, 2019 | Option Exercise | $74.06 | 2,800 | 207,368 | 3,281 | Jan 07, 2019, 04:02 PM |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | Jan 03, 2019 | Sale | $110.17 | 2,800 | 308,465 | 681 | Jan 07, 2019, 04:02 PM |
WILSON DOW R | President and CEO | Nov 16, 2018 | Option Exercise | $118.76 | 17,691 | 2,100,983 | 93,590 | Nov 20, 2018, 02:40 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Nov 16, 2018 | Option Exercise | $118.76 | 5,510 | 654,368 | 33,360 | Nov 20, 2018, 02:39 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Nov 16, 2018 | Option Exercise | $118.76 | 4,707 | 559,003 | 34,875 | Nov 20, 2018, 02:37 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Nov 15, 2018 | Option Exercise | $71.75 | 1,324 | 95,002 | 30,648 | Nov 16, 2018, 06:12 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Nov 15, 2018 | Sale | $115.50 | 1,324 | 152,923 | 30,086 | Nov 16, 2018, 06:12 PM |
BISCHOPING GARY E JR | SVP, Finance & CFO | Oct 31, 2018 | Sale | $120.24 | 845 | 101,603 | 1,000 | Nov 01, 2018, 06:52 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Oct 29, 2018 | Option Exercise | $80.40 | 465 | 37,386 | 30,551 | Oct 31, 2018, 03:18 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Oct 29, 2018 | Sale | $111.99 | 465 | 52,073 | 30,086 | Oct 31, 2018, 03:18 PM |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | Oct 29, 2018 | Option Exercise | $68.42 | 2,700 | 184,747 | 2,224 | Oct 31, 2018, 03:16 PM |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | Oct 29, 2018 | Sale | $111.72 | 2,700 | 301,639 | 838 | Oct 31, 2018, 03:16 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Oct 15, 2018 | Option Exercise | $67.12 | 862 | 57,857 | 30,686 | Oct 17, 2018, 02:22 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Oct 15, 2018 | Sale | $105.26 | 862 | 90,737 | 30,086 | Oct 17, 2018, 02:22 PM |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | Oct 04, 2018 | Option Exercise | $60.91 | 100 | 6,091 | 724 | Oct 05, 2018, 05:55 PM |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | Oct 04, 2018 | Sale | $110.21 | 100 | 11,021 | 624 | Oct 05, 2018, 05:55 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Sep 17, 2018 | Option Exercise | $71.77 | 1,327 | 95,243 | 30,948 | Sep 19, 2018, 06:43 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Sep 17, 2018 | Sale | $110.90 | 1,327 | 147,167 | 30,086 | Sep 19, 2018, 06:43 PM |
GUERTIN TIMOTHY E | Director | Sep 05, 2018 | Sale | $110.84 | 10,000 | 1,108,360 | 55,800 | Sep 06, 2018, 02:09 PM |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | Sep 04, 2018 | Option Exercise | $60.91 | 2,800 | 170,548 | 3,424 | Sep 06, 2018, 02:02 PM |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | Sep 04, 2018 | Sale | $111.68 | 2,800 | 312,696 | 624 | Sep 06, 2018, 02:02 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Aug 16, 2018 | Option Exercise | $80.40 | 365 | 29,346 | 30,451 | Aug 20, 2018, 12:56 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Aug 16, 2018 | Sale | $110.00 | 365 | 40,150 | 30,086 | Aug 20, 2018, 12:56 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Aug 15, 2018 | Option Exercise | $68.50 | 962 | 65,897 | 30,948 | Aug 17, 2018, 12:18 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Aug 15, 2018 | Sale | $108.84 | 962 | 104,707 | 30,186 | Aug 17, 2018, 12:18 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jul 16, 2018 | Option Exercise | $71.77 | 1,327 | 95,243 | 30,948 | Jul 18, 2018, 11:40 AM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jul 16, 2018 | Sale | $115.28 | 1,327 | 152,974 | 30,486 | Jul 18, 2018, 11:40 AM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jun 15, 2018 | Option Exercise | $71.77 | 1,329 | 95,378 | 30,950 | Jun 18, 2018, 05:57 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jun 15, 2018 | Sale | $122.55 | 1,329 | 162,871 | 30,086 | Jun 18, 2018, 05:57 PM |
BISCHOPING GARY E JR | SVP, Finance & CFO | May 18, 2018 | Option Exercise | $118.40 | 974 | 115,322 | 1,845 | May 21, 2018, 01:49 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | May 15, 2018 | Option Exercise | $71.77 | 1,327 | 95,243 | 30,948 | May 16, 2018, 01:30 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | May 15, 2018 | Sale | $117.15 | 1,327 | 155,460 | 30,086 | May 16, 2018, 01:30 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | May 10, 2018 | Option Exercise | $80.40 | 699 | 56,200 | 27,555 | May 11, 2018, 05:23 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | May 10, 2018 | Sale | $118.20 | 699 | 82,624 | 26,856 | May 11, 2018, 05:23 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Apr 16, 2018 | Option Exercise | $71.77 | 1,328 | 95,311 | 31,173 | Apr 17, 2018, 05:40 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Apr 16, 2018 | Sale | $121.94 | 1,328 | 161,935 | 30,310 | Apr 17, 2018, 05:40 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Apr 10, 2018 | Option Exercise | $80.40 | 699 | 56,200 | 27,361 | Apr 10, 2018, 06:54 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Apr 10, 2018 | Sale | $120.33 | 699 | 84,113 | 26,862 | Apr 10, 2018, 06:54 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Mar 15, 2018 | Option Exercise | $71.77 | 1,328 | 95,311 | 31,173 | Mar 15, 2018, 08:47 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Mar 15, 2018 | Sale | $125.51 | 1,328 | 166,672 | 30,710 | Mar 15, 2018, 08:47 PM |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | Mar 12, 2018 | Sale | $126.47 | 1,556 | 196,792 | 6,588 | Mar 12, 2018, 08:00 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Mar 12, 2018 | Option Exercise | $80.40 | 699 | 56,200 | 27,361 | Mar 12, 2018, 07:56 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Mar 12, 2018 | Sale | $126.47 | 699 | 88,400 | 26,662 | Mar 12, 2018, 07:56 PM |
ILLINGWORTH DAVID J | Director | Mar 06, 2018 | Option Exercise | $57.27 | 5,651 | 323,633 | 12,737 | Mar 07, 2018, 06:59 PM |
ILLINGWORTH DAVID J | Director | Mar 06, 2018 | Sale | $122.56 | 5,651 | 692,558 | 7,086 | Mar 07, 2018, 06:59 PM |
WILSON DOW R | President and CEO | Mar 01, 2018 | Option Exercise | $74.06 | 24,000 | 1,777,440 | 99,356 | Mar 02, 2018, 06:08 PM |
WILSON DOW R | President and CEO | Mar 01, 2018 | Sale | $118.03 | 24,000 | 2,832,803 | 93,813 | Mar 02, 2018, 06:08 PM |
BOSTROM SUSAN L | Director | Feb 22, 2018 | Sale | $120.60 | 1,952 | 235,413 | 3,809 | Feb 22, 2018, 07:22 PM |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | Feb 15, 2018 | Option Exercise | $121.87 | 874 | 106,514 | 8,144 | Feb 16, 2018, 07:17 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Feb 15, 2018 | Option Exercise | $121.87 | 1,463 | 178,296 | 29,845 | Feb 16, 2018, 07:14 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Feb 15, 2018 | Option Exercise | $78.62 | 6,442 | 506,476 | 32,940 | Feb 16, 2018, 07:14 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Feb 15, 2018 | Sale | $120.67 | 6,442 | 777,344 | 29,940 | Feb 16, 2018, 07:14 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Feb 15, 2018 | Option Exercise | $121.87 | 1,751 | 213,394 | 30,175 | Feb 16, 2018, 07:10 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Feb 16, 2018 | Sale | $121.16 | 3,513 | 425,621 | 26,662 | Feb 16, 2018, 07:10 PM |
WILSON DOW R | President and CEO | Feb 15, 2018 | Option Exercise | $121.87 | 7,899 | 962,651 | 75,356 | Feb 16, 2018, 07:01 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Feb 12, 2018 | Option Exercise | $80.40 | 8,390 | 674,556 | 35,052 | Feb 13, 2018, 06:47 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Feb 12, 2018 | Sale | $116.47 | 8,390 | 977,162 | 32,852 | Feb 13, 2018, 06:47 PM |
WILSON DOW R | President and CEO | Feb 01, 2018 | Option Exercise | $74.06 | 24,000 | 1,777,440 | 90,776 | Feb 02, 2018, 07:13 PM |
WILSON DOW R | President and CEO | Feb 01, 2018 | Sale | $126.73 | 24,000 | 3,041,464 | 75,222 | Feb 02, 2018, 07:13 PM |
LARET MARK R | Director | Feb 01, 2018 | Sale | $126.97 | 2,161 | 274,382 | 0 | Feb 02, 2018, 07:09 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jan 16, 2018 | Option Exercise | $67.12 | 863 | 57,925 | 28,224 | Jan 17, 2018, 07:05 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jan 16, 2018 | Sale | $108.43 | 863 | 93,575 | 27,461 | Jan 17, 2018, 07:05 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Jan 16, 2018 | Option Exercise | $81.97 | 933 | 76,478 | 27,595 | Jan 17, 2018, 06:58 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Jan 16, 2018 | Sale | $108.31 | 933 | 101,056 | 27,495 | Jan 17, 2018, 06:58 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Jan 12, 2018 | Option Exercise | $67.12 | 1,089 | 73,094 | 27,751 | Jan 16, 2018, 05:04 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Jan 12, 2018 | Sale | $108.19 | 1,089 | 117,823 | 27,651 | Jan 16, 2018, 05:04 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jan 08, 2018 | Option Exercise | $73.95 | 7,991 | 590,944 | 35,352 | Jan 10, 2018, 03:05 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jan 08, 2018 | Sale | $110.65 | 7,991 | 884,200 | 32,352 | Jan 10, 2018, 03:05 PM |
GUERTIN TIMOTHY E | Director | Jan 02, 2018 | Sale | $111.46 | 10,000 | 1,114,639 | 68,108 | Jan 03, 2018, 06:19 PM |
WILSON DOW R | President and CEO | Dec 18, 2017 | Option Exercise | $60.91 | 88,766 | 5,406,737 | 155,542 | Dec 18, 2017, 09:24 PM |
WILSON DOW R | President and CEO | Dec 18, 2017 | Sale | $111.00 | 88,766 | 9,852,915 | 76,052 | Dec 18, 2017, 09:24 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Dec 13, 2017 | Option Exercise | $81.97 | 931 | 76,314 | 27,593 | Dec 13, 2017, 08:41 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Dec 12, 2017 | Option Exercise | $67.12 | 1,087 | 72,959 | 27,749 | Dec 13, 2017, 08:41 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Dec 13, 2017 | Sale | $113.01 | 931 | 105,210 | 27,162 | Dec 13, 2017, 08:41 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Dec 12, 2017 | Sale | $111.09 | 1,087 | 120,755 | 27,549 | Dec 13, 2017, 08:41 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Nov 13, 2017 | Option Exercise | $73.98 | 2,021 | 149,505 | 27,750 | Nov 14, 2017, 06:08 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Nov 13, 2017 | Sale | $107.36 | 2,021 | 216,983 | 27,350 | Nov 14, 2017, 06:08 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Oct 18, 2017 | Option Exercise | $81.97 | 931 | 76,314 | 27,531 | Oct 19, 2017, 08:26 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Oct 18, 2017 | Sale | $105.00 | 931 | 97,755 | 26,600 | Oct 19, 2017, 08:26 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Oct 12, 2017 | Option Exercise | $67.12 | 1,088 | 73,027 | 27,688 | Oct 13, 2017, 03:23 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Oct 12, 2017 | Sale | $101.55 | 1,088 | 110,490 | 27,588 | Oct 13, 2017, 03:23 PM |
ECKERT R ANDREW | Director | Oct 06, 2017 | Option Exercise | $62.74 | 5,651 | 354,544 | 14,650 | Oct 06, 2017, 07:55 PM |
ECKERT R ANDREW | Director | Oct 06, 2017 | Sale | $102.39 | 5,651 | 578,595 | 8,999 | Oct 06, 2017, 07:55 PM |
WILSON DOW R | President and CEO | Oct 06, 2017 | Option Exercise | $51.23 | 15,059 | 771,473 | 81,835 | Oct 06, 2017, 07:46 PM |
WILSON DOW R | President and CEO | Oct 06, 2017 | Sale | $102.40 | 15,059 | 1,541,981 | 66,776 | Oct 06, 2017, 07:46 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Sep 13, 2017 | Option Exercise | $81.97 | 933 | 76,478 | 27,533 | Sep 19, 2017, 08:40 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Sep 12, 2017 | Option Exercise | $67.12 | 1,088 | 73,027 | 27,688 | Sep 19, 2017, 08:36 PM |
WILSON DOW R | President and CEO | Sep 07, 2017 | Option Exercise | $51.23 | 15,059 | 771,473 | 81,835 | Sep 19, 2017, 08:26 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Sep 13, 2017 | Sale | $107.29 | 933 | 100,100 | 26,600 | Sep 14, 2017, 11:36 AM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Sep 12, 2017 | Sale | $107.33 | 1,088 | 116,777 | 26,600 | Sep 13, 2017, 11:25 AM |
WILSON DOW R | President and CEO | Sep 07, 2017 | Sale | $105.41 | 15,059 | 1,587,372 | 71,254 | Sep 08, 2017, 03:05 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Aug 31, 2017 | Option Exercise | $81.97 | 931 | 76,314 | 27,531 | Sep 01, 2017, 03:48 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Aug 31, 2017 | Sale | $105.00 | 931 | 97,755 | 26,600 | Sep 01, 2017, 03:48 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Aug 14, 2017 | Option Exercise | $67.12 | 1,088 | 73,027 | 26,600 | Aug 15, 2017, 07:56 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Aug 14, 2017 | Sale | $97.91 | 1,088 | 106,525 | 26,600 | Aug 15, 2017, 07:56 PM |
WILSON DOW R | President and CEO | Aug 07, 2017 | Option Exercise | $51.23 | 15,059 | 771,473 | 81,835 | Aug 08, 2017, 08:08 PM |
WILSON DOW R | President and CEO | Aug 07, 2017 | Sale | $96.48 | 15,059 | 1,452,895 | 66,776 | Aug 08, 2017, 08:08 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jul 13, 2017 | Option Exercise | $81.97 | 734 | 60,166 | 27,361 | Jul 13, 2017, 08:08 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jul 12, 2017 | Option Exercise | $67.12 | 863 | 57,925 | 28,224 | Jul 13, 2017, 08:08 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jul 13, 2017 | Sale | $104.38 | 734 | 76,614 | 27,361 | Jul 13, 2017, 08:08 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jul 12, 2017 | Sale | $104.48 | 863 | 90,166 | 27,361 | Jul 13, 2017, 08:08 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Jul 13, 2017 | Option Exercise | $81.97 | 933 | 76,478 | 27,533 | Jul 13, 2017, 07:59 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Jul 12, 2017 | Option Exercise | $67.12 | 1,088 | 73,027 | 27,688 | Jul 13, 2017, 07:59 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Jul 13, 2017 | Sale | $105.00 | 933 | 97,965 | 26,600 | Jul 13, 2017, 07:59 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Jul 12, 2017 | Sale | $104.49 | 1,088 | 113,689 | 26,600 | Jul 13, 2017, 07:59 PM |
WILSON DOW R | President and CEO | Jul 10, 2017 | Option Exercise | $51.23 | 15,060 | 771,524 | 81,836 | Jul 11, 2017, 07:26 PM |
WILSON DOW R | President and CEO | Jul 10, 2017 | Sale | $103.37 | 15,060 | 1,556,698 | 67,776 | Jul 11, 2017, 07:26 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Jun 20, 2017 | Option Exercise | $81.97 | 26,092 | 2,138,761 | 52,692 | Jun 21, 2017, 04:49 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Jun 20, 2017 | Sale | $105.00 | 26,092 | 2,739,660 | 26,600 | Jun 21, 2017, 04:49 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jun 13, 2017 | Option Exercise | $81.97 | 734 | 60,166 | 28,095 | Jun 14, 2017, 07:07 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jun 13, 2017 | Sale | $101.91 | 734 | 74,800 | 27,361 | Jun 14, 2017, 07:07 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jun 12, 2017 | Option Exercise | $67.12 | 863 | 57,925 | 28,224 | Jun 13, 2017, 07:11 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jun 12, 2017 | Sale | $101.25 | 863 | 87,378 | 27,461 | Jun 13, 2017, 07:11 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Jun 12, 2017 | Option Exercise | $67.12 | 1,087 | 72,959 | 27,687 | Jun 13, 2017, 07:07 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Jun 12, 2017 | Sale | $101.20 | 1,087 | 110,000 | 26,700 | Jun 13, 2017, 07:07 PM |
GUERTIN TIMOTHY E | Director | Jun 09, 2017 | Sale | $103.22 | 16,000 | 1,651,544 | 89,400 | Jun 12, 2017, 07:48 PM |
LARET MARK R | Director | Jun 08, 2017 | Sale | $103.47 | 1,428 | 147,761 | 3,289 | Jun 09, 2017, 04:02 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Jun 01, 2017 | Option Exercise | $70.63 | 56,573 | 3,995,848 | 83,173 | Jun 02, 2017, 06:59 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Jun 01, 2017 | Sale | $99.76 | 56,573 | 5,643,894 | 74,068 | Jun 02, 2017, 06:59 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | May 31, 2017 | Option Exercise | $81.97 | 19,819 | 1,624,563 | 47,180 | Jun 01, 2017, 03:58 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | May 31, 2017 | Sale | $99.67 | 19,819 | 1,975,360 | 27,361 | Jun 01, 2017, 03:58 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | May 12, 2017 | Option Exercise | $67.12 | 862 | 57,857 | 28,223 | May 12, 2017, 06:48 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | May 12, 2017 | Sale | $96.39 | 862 | 83,084 | 27,361 | May 12, 2017, 06:48 PM |
BOSTROM SUSAN L | Director | May 02, 2017 | Sale | $91.08 | 3,589 | 326,902 | 3,809 | May 03, 2017, 06:29 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Apr 12, 2017 | Option Exercise | $67.12 | 864 | 57,992 | 27,914 | Apr 13, 2017, 07:04 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Apr 12, 2017 | Sale | $89.74 | 864 | 77,533 | 27,050 | Apr 13, 2017, 07:04 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Mar 17, 2017 | Option Exercise | $74.06 | 3,876 | 287,057 | 30,926 | Mar 20, 2017, 07:38 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Mar 17, 2017 | Sale | $91.75 | 3,876 | 355,623 | 27,050 | Mar 20, 2017, 07:38 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Mar 13, 2017 | Option Exercise | $67.12 | 862 | 57,857 | 27,912 | Mar 14, 2017, 08:34 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Mar 13, 2017 | Sale | $87.89 | 862 | 75,758 | 27,050 | Mar 14, 2017, 08:34 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Mar 01, 2017 | Option Exercise | $67.12 | 10,353 | 694,893 | 37,403 | Mar 02, 2017, 08:04 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Mar 01, 2017 | Sale | $84.81 | 10,353 | 878,038 | 27,050 | Mar 02, 2017, 08:04 PM |
LARET MARK R | Director | Feb 22, 2017 | Option Exercise | $60.01 | 11,302 | 678,177 | 14,891 | Feb 24, 2017, 05:10 PM |
LARET MARK R | Director | Feb 22, 2017 | Sale | $83.56 | 11,302 | 944,408 | 3,589 | Feb 24, 2017, 05:10 PM |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | Feb 15, 2017 | Option Exercise | $81.12 | 783 | 63,517 | 6,289 | Feb 16, 2017, 08:52 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Feb 15, 2017 | Option Exercise | $81.12 | 1,830 | 148,450 | 27,050 | Feb 16, 2017, 08:47 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Feb 15, 2017 | Option Exercise | $81.12 | 2,160 | 175,219 | 26,359 | Feb 16, 2017, 08:44 PM |
FINNEY ELISHA W | Exec VP and CFO | Feb 15, 2017 | Option Exercise | $81.12 | 2,002 | 162,402 | 10,260 | Feb 16, 2017, 08:40 PM |
WILSON DOW R | President and CEO | Feb 15, 2017 | Option Exercise | $81.12 | 9,168 | 743,708 | 66,465 | Feb 16, 2017, 08:36 PM |
WILSON DOW R | President and CEO | Jan 10, 2017 | Option Exercise | $89.99 | 6,871 | 618,321 | 57,420 | Jan 11, 2017, 06:55 PM |
WILSON DOW R | President and CEO | Jan 05, 2017 | Option Exercise | $52.83 | 13,334 | 704,435 | 77,625 | Jan 06, 2017, 05:14 PM |
WILSON DOW R | President and CEO | Jan 05, 2017 | Sale | $88.74 | 13,334 | 1,183,260 | 64,291 | Jan 06, 2017, 05:14 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Dec 08, 2016 | Sale | $90.33 | 1,267 | 114,451 | 24,027 | Dec 08, 2016, 08:32 PM |
WILSON DOW R | President and CEO | Dec 05, 2016 | Option Exercise | $52.83 | 10,000 | 528,300 | 74,291 | Dec 05, 2016, 09:18 PM |
WILSON DOW R | President and CEO | Dec 05, 2016 | Sale | $90.03 | 10,000 | 900,311 | 64,291 | Dec 05, 2016, 09:18 PM |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | Nov 21, 2016 | Option Exercise | $89.66 | 474 | 42,499 | 5,576 | Nov 22, 2016, 06:48 PM |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | Nov 18, 2016 | Option Exercise | $88.25 | 257 | 22,680 | 4,703 | Nov 21, 2016, 07:28 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Nov 18, 2016 | Option Exercise | $88.25 | 792 | 69,894 | 25,294 | Nov 21, 2016, 07:22 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Nov 18, 2016 | Option Exercise | $88.25 | 1,063 | 93,810 | 22,462 | Nov 21, 2016, 05:13 PM |
FINNEY ELISHA W | Exec VP and CFO | Nov 18, 2016 | Option Exercise | $88.25 | 1,432 | 126,374 | 6,636 | Nov 21, 2016, 05:06 PM |
WILSON DOW R | President and CEO | Nov 18, 2016 | Option Exercise | $88.25 | 4,029 | 355,559 | 64,291 | Nov 21, 2016, 05:03 PM |
WILSON DOW R | President and CEO | Nov 07, 2016 | Option Exercise | $52.83 | 10,000 | 528,300 | 70,598 | Nov 08, 2016, 06:38 PM |
WILSON DOW R | President and CEO | Nov 07, 2016 | Sale | $90.59 | 10,000 | 905,907 | 69,098 | Nov 08, 2016, 06:38 PM |
GUERTIN TIMOTHY E | Director | Oct 31, 2016 | Sale | $90.32 | 4,000 | 361,296 | 94,900 | Nov 01, 2016, 09:55 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Oct 20, 2016 | Option Exercise | $83.70 | 21,266 | 1,779,964 | 45,293 | Oct 20, 2016, 09:14 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Oct 20, 2016 | Sale | $103.70 | 21,266 | 2,205,284 | 24,027 | Oct 20, 2016, 09:14 PM |
WILSON DOW R | President and CEO | Oct 05, 2016 | Option Exercise | $52.83 | 10,000 | 528,300 | 70,598 | Oct 06, 2016, 06:33 PM |
WILSON DOW R | President and CEO | Oct 05, 2016 | Sale | $99.44 | 10,000 | 994,417 | 60,598 | Oct 06, 2016, 06:33 PM |
FINNEY ELISHA W | Exec VP and CFO | Oct 03, 2016 | Option Exercise | $68.84 | 4,668 | 321,345 | 9,863 | Oct 04, 2016, 05:19 PM |
FINNEY ELISHA W | Exec VP and CFO | Oct 03, 2016 | Sale | $98.87 | 4,668 | 461,537 | 6,553 | Oct 04, 2016, 05:19 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Sep 15, 2016 | Option Exercise | $68.84 | 4,073 | 280,385 | 28,100 | Sep 15, 2016, 06:42 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Sep 15, 2016 | Sale | $95.47 | 4,073 | 388,860 | 26,597 | Sep 15, 2016, 06:42 PM |
FINNEY ELISHA W | Exec VP and CFO | Sep 07, 2016 | Option Exercise | $68.84 | 9,000 | 619,560 | 14,195 | Sep 08, 2016, 07:04 PM |
FINNEY ELISHA W | Exec VP and CFO | Sep 07, 2016 | Sale | $96.95 | 9,000 | 872,550 | 5,195 | Sep 08, 2016, 07:04 PM |
WILSON DOW R | President and CEO | Sep 06, 2016 | Option Exercise | $52.83 | 10,000 | 528,300 | 70,598 | Sep 07, 2016, 07:52 PM |
WILSON DOW R | President and CEO | Sep 06, 2016 | Sale | $96.08 | 10,000 | 960,818 | 60,598 | Sep 07, 2016, 07:52 PM |
FINNEY ELISHA W | Exec VP and CFO | Sep 01, 2016 | Option Exercise | $68.84 | 2,000 | 137,680 | 7,195 | Sep 02, 2016, 04:52 PM |
FINNEY ELISHA W | Exec VP and CFO | Sep 01, 2016 | Sale | $95.82 | 2,000 | 191,646 | 5,195 | Sep 02, 2016, 04:52 PM |
THYAGARAJAN VENKATRAMAN | Director | Aug 22, 2016 | Option Exercise | $95.22 | 712 | 67,797 | 12,186 | Aug 23, 2016, 04:16 PM |
WILSON DOW R | President and CEO | Aug 05, 2016 | Option Exercise | $52.83 | 10,000 | 528,300 | 70,598 | Aug 08, 2016, 09:00 PM |
WILSON DOW R | President and CEO | Aug 05, 2016 | Sale | $95.14 | 10,000 | 951,425 | 60,598 | Aug 08, 2016, 09:00 PM |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | Aug 01, 2016 | Option Exercise | $50.52 | 7,500 | 378,900 | 11,116 | Aug 03, 2016, 05:45 PM |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | Aug 01, 2016 | Sale | $94.88 | 9,483 | 899,756 | 6,116 | Aug 03, 2016, 05:45 PM |
GUERTIN TIMOTHY E | Director | Aug 01, 2016 | Sale | $94.88 | 4,000 | 379,519 | 95,800 | Aug 03, 2016, 05:42 PM |
FINNEY ELISHA W | Exec VP and CFO | Aug 01, 2016 | Option Exercise | $63.95 | 25,334 | 1,619,999 | 12,529 | Aug 03, 2016, 05:39 PM |
FINNEY ELISHA W | Exec VP and CFO | Aug 01, 2016 | Sale | $94.90 | 25,334 | 2,404,095 | 5,195 | Aug 03, 2016, 05:39 PM |
WILSON DOW R | President and CEO | Jul 05, 2016 | Option Exercise | $52.83 | 10,000 | 528,300 | 70,598 | Jul 06, 2016, 05:43 PM |
WILSON DOW R | President and CEO | Jul 05, 2016 | Sale | $82.08 | 10,000 | 820,806 | 61,598 | Jul 06, 2016, 05:43 PM |
WILSON DOW R | President and CEO | Jun 27, 2016 | Option Exercise | $52.83 | 10,000 | 528,300 | 70,598 | Jun 28, 2016, 08:44 PM |
WILSON DOW R | President and CEO | Jun 27, 2016 | Sale | $78.27 | 10,000 | 782,741 | 62,261 | Jun 28, 2016, 08:44 PM |
NAUMANN-ETIENNE RUEDIGER | Director | Jun 08, 2016 | Sale | $84.83 | 1,000 | 84,831 | 0 | Jun 09, 2016, 02:59 PM |
LARET MARK R | Director | Jun 03, 2016 | Sale | $83.47 | 1,545 | 128,969 | 1,428 | Jun 06, 2016, 02:40 PM |
GUERTIN TIMOTHY E | Director | May 02, 2016 | Sale | $81.55 | 4,000 | 326,210 | 99,800 | May 03, 2016, 07:49 PM |
FINNEY ELISHA W | Exec VP and CFO | Apr 20, 2016 | Option Exercise | $57.90 | 4,000 | 231,600 | 9,011 | Apr 21, 2016, 07:17 PM |
FINNEY ELISHA W | Exec VP and CFO | Apr 20, 2016 | Sale | $85.95 | 4,000 | 343,800 | 5,011 | Apr 21, 2016, 07:17 PM |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | Apr 18, 2016 | Option Exercise | $50.52 | 2,500 | 126,300 | 8,445 | Apr 19, 2016, 04:47 PM |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | Apr 18, 2016 | Sale | $85.00 | 2,500 | 212,500 | 5,945 | Apr 19, 2016, 04:47 PM |
WILSON DOW R | President and CEO | Mar 23, 2016 | Option Exercise | $50.66 | 53,000 | 2,684,980 | 105,931 | Mar 24, 2016, 03:56 PM |
WILSON DOW R | President and CEO | Mar 23, 2016 | Sale | $78.86 | 45,650 | 3,599,968 | 60,281 | Mar 24, 2016, 03:56 PM |
NAUMANN-ETIENNE RUEDIGER | Director | Mar 10, 2016 | Sale | $77.99 | 428 | 33,378 | 1,000 | Mar 10, 2016, 07:13 PM |
GUERTIN TIMOTHY E | Director | Mar 07, 2016 | Sale | $79.47 | 4,000 | 317,894 | 105,463 | Mar 07, 2016, 07:42 PM |
SANYAL SUNNY | SVP and President, ICB | Feb 16, 2016 | Option Exercise | $78.03 | 1,197 | 93,402 | 4,198 | Feb 17, 2016, 06:38 PM |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | Feb 16, 2016 | Option Exercise | $78.03 | 453 | 35,348 | 5,945 | Feb 17, 2016, 06:35 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Feb 16, 2016 | Option Exercise | $78.03 | 1,281 | 99,956 | 23,710 | Feb 17, 2016, 06:31 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Feb 16, 2016 | Option Exercise | $78.03 | 1,505 | 117,435 | 20,309 | Feb 17, 2016, 06:29 PM |
FINNEY ELISHA W | Exec VP and CFO | Feb 16, 2016 | Option Exercise | $78.03 | 1,469 | 114,626 | 7,465 | Feb 17, 2016, 06:26 PM |
FINNEY ELISHA W | Exec VP and CFO | Feb 17, 2016 | Sale | $78.59 | 2,454 | 192,868 | 5,011 | Feb 17, 2016, 06:26 PM |
WILSON DOW R | President and CEO | Feb 16, 2016 | Option Exercise | $78.03 | 4,582 | 357,533 | 52,931 | Feb 17, 2016, 06:20 PM |
THYAGARAJAN VENKATRAMAN | Director | Feb 16, 2016 | Option Exercise | $78.03 | 267 | 20,834 | 7,150 | Feb 17, 2016, 03:13 PM |
REINHARDT ERICH R | Director | Feb 16, 2016 | Option Exercise | $78.03 | 228 | 17,791 | 1,200 | Feb 17, 2016, 03:11 PM |
WILSON DOW R | President and CEO | Dec 07, 2015 | Option Exercise | $50.66 | 9,000 | 455,940 | 53,943 | Dec 08, 2015, 05:55 PM |
WILSON DOW R | President and CEO | Dec 07, 2015 | Sale | $80.00 | 9,000 | 720,000 | 44,943 | Dec 08, 2015, 05:55 PM |
ECKERT R ANDREW | Director | Dec 02, 2015 | Option Exercise | $60.32 | 3,000 | 180,960 | 10,016 | Dec 03, 2015, 03:55 PM |
ECKERT R ANDREW | Director | Dec 02, 2015 | Sale | $81.67 | 3,000 | 245,010 | 7,016 | Dec 03, 2015, 03:55 PM |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | Nov 23, 2015 | Option Exercise | $80.81 | 716 | 57,860 | 5,268 | Nov 25, 2015, 03:09 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Nov 23, 2015 | Option Exercise | $80.81 | 727 | 58,749 | 21,640 | Nov 25, 2015, 03:06 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Nov 23, 2015 | Option Exercise | $80.81 | 970 | 78,386 | 17,646 | Nov 25, 2015, 03:03 PM |
FINNEY ELISHA W | Exec VP and CFO | Nov 23, 2015 | Option Exercise | $80.81 | 1,431 | 115,639 | 6,324 | Nov 25, 2015, 02:58 PM |
FINNEY ELISHA W | Exec VP and CFO | Nov 23, 2015 | Sale | $81.10 | 1,021 | 82,799 | 5,011 | Nov 25, 2015, 02:58 PM |
FINNEY ELISHA W | Exec VP and CFO | Nov 24, 2015 | Sale | $80.75 | 1,313 | 106,026 | 5,011 | Nov 25, 2015, 02:58 PM |
WILSON DOW R | President and CEO | Nov 23, 2015 | Option Exercise | $80.81 | 3,790 | 306,270 | 44,943 | Nov 25, 2015, 02:24 PM |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | Nov 20, 2015 | Option Exercise | $80.62 | 188 | 15,157 | 3,992 | Nov 23, 2015, 05:12 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Nov 20, 2015 | Option Exercise | $80.62 | 565 | 45,550 | 20,430 | Nov 23, 2015, 05:09 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Nov 20, 2015 | Option Exercise | $80.62 | 754 | 60,787 | 16,033 | Nov 23, 2015, 05:07 PM |
FINNEY ELISHA W | Exec VP and CFO | Nov 20, 2015 | Option Exercise | $80.62 | 1,113 | 89,730 | 6,032 | Nov 23, 2015, 05:05 PM |
WILSON DOW R | President and CEO | Nov 20, 2015 | Option Exercise | $80.62 | 2,948 | 237,668 | 41,469 | Nov 23, 2015, 05:03 PM |
WILSON DOW R | President and CEO | Nov 06, 2015 | Option Exercise | $50.66 | 9,000 | 455,940 | 47,767 | Nov 06, 2015, 06:49 PM |
WILSON DOW R | President and CEO | Nov 05, 2015 | Option Exercise | $50.66 | 9,000 | 455,940 | 47,767 | Nov 06, 2015, 06:49 PM |
WILSON DOW R | President and CEO | Nov 06, 2015 | Sale | $80.51 | 9,000 | 724,603 | 38,767 | Nov 06, 2015, 06:49 PM |
WILSON DOW R | President and CEO | Nov 05, 2015 | Sale | $80.00 | 9,000 | 720,000 | 38,767 | Nov 06, 2015, 06:49 PM |
WILSON DOW R | President and CEO | Sep 08, 2015 | Option Exercise | $50.66 | 9,000 | 455,940 | 47,767 | Sep 10, 2015, 02:56 PM |
WILSON DOW R | President and CEO | Sep 08, 2015 | Sale | $80.05 | 9,000 | 720,450 | 38,767 | Sep 10, 2015, 02:56 PM |
WILSON DOW R | President and CEO | Aug 06, 2015 | Option Exercise | $50.66 | 9,000 | 455,940 | 47,767 | Aug 07, 2015, 06:50 PM |
WILSON DOW R | President and CEO | Aug 06, 2015 | Sale | $86.67 | 9,000 | 780,013 | 40,067 | Aug 07, 2015, 06:50 PM |
FINNEY ELISHA W | Exec VP and CFO | Aug 03, 2015 | Option Exercise | $57.90 | 2,000 | 115,800 | 6,846 | Aug 04, 2015, 06:02 PM |
FINNEY ELISHA W | Exec VP and CFO | Aug 03, 2015 | Sale | $85.96 | 2,000 | 171,914 | 4,946 | Aug 04, 2015, 06:02 PM |
GUERTIN TIMOTHY E | Director | Aug 03, 2015 | Sale | $85.57 | 4,000 | 342,281 | 47,332 | Aug 04, 2015, 05:59 PM |
WILSON DOW R | President and CEO | Jul 06, 2015 | Option Exercise | $50.66 | 9,000 | 455,940 | 47,767 | Jul 07, 2015, 03:27 PM |
WILSON DOW R | President and CEO | Jul 06, 2015 | Sale | $85.80 | 9,000 | 772,227 | 47,667 | Jul 07, 2015, 03:27 PM |
FINNEY ELISHA W | Exec VP and CFO | Jul 02, 2015 | Option Exercise | $57.90 | 2,000 | 115,800 | 6,846 | Jul 07, 2015, 01:10 PM |
FINNEY ELISHA W | Exec VP and CFO | Jul 02, 2015 | Sale | $85.95 | 2,000 | 171,900 | 4,846 | Jul 07, 2015, 01:10 PM |
GUERTIN TIMOTHY E | Director | Jul 01, 2015 | Option Exercise | $57.90 | 25,000 | 1,447,500 | 84,040 | Jul 02, 2015, 02:14 PM |
GUERTIN TIMOTHY E | Director | Jul 01, 2015 | Sale | $84.20 | 25,000 | 2,104,946 | 60,040 | Jul 02, 2015, 02:14 PM |
WILSON DOW R | President and CEO | Jun 05, 2015 | Option Exercise | $50.66 | 9,000 | 455,940 | 67,767 | Jun 08, 2015, 06:54 PM |
WILSON DOW R | President and CEO | Jun 05, 2015 | Sale | $86.29 | 9,000 | 776,646 | 58,767 | Jun 08, 2015, 06:54 PM |
FINNEY ELISHA W | Exec VP and CFO | Jun 01, 2015 | Option Exercise | $57.90 | 2,000 | 115,800 | 6,846 | Jun 02, 2015, 08:42 PM |
FINNEY ELISHA W | Exec VP and CFO | Jun 01, 2015 | Sale | $85.99 | 2,000 | 171,986 | 4,846 | Jun 02, 2015, 08:42 PM |
GUERTIN TIMOTHY E | Director | Jun 01, 2015 | Option Exercise | $57.90 | 25,000 | 1,447,500 | 84,040 | Jun 02, 2015, 08:36 PM |
GUERTIN TIMOTHY E | Director | Jun 01, 2015 | Sale | $86.08 | 25,000 | 2,151,927 | 59,140 | Jun 02, 2015, 08:36 PM |
NAUMANN-ETIENNE RUEDIGER | Director | May 29, 2015 | Sale | $87.12 | 1,545 | 134,596 | 0 | Jun 02, 2015, 03:11 PM |
WILSON DOW R | President and CEO | May 06, 2015 | Option Exercise | $50.66 | 9,000 | 455,940 | 67,767 | May 07, 2015, 03:36 PM |
WILSON DOW R | President and CEO | May 06, 2015 | Sale | $86.64 | 9,000 | 779,756 | 58,767 | May 07, 2015, 03:36 PM |
FINNEY ELISHA W | Exec VP and CFO | May 04, 2015 | Option Exercise | $57.90 | 2,000 | 115,800 | 6,846 | May 06, 2015, 03:36 PM |
FINNEY ELISHA W | Exec VP and CFO | May 04, 2015 | Sale | $88.34 | 2,000 | 176,682 | 4,846 | May 06, 2015, 03:36 PM |
GUERTIN TIMOTHY E | Director | May 04, 2015 | Option Exercise | $57.90 | 25,000 | 1,447,500 | 84,040 | May 06, 2015, 03:32 PM |
GUERTIN TIMOTHY E | Director | May 04, 2015 | Sale | $88.33 | 25,000 | 2,208,355 | 59,140 | May 06, 2015, 03:32 PM |
GUERTIN TIMOTHY E | Director | May 04, 2015 | Sale | $88.34 | 4,000 | 353,364 | 51,332 | May 06, 2015, 03:32 PM |
WILSON DOW R | President and CEO | Apr 17, 2015 | Option Exercise | $49.88 | 18,760 | 935,749 | 77,223 | Apr 17, 2015, 07:09 PM |
WILSON DOW R | President and CEO | Apr 17, 2015 | Sale | $93.63 | 18,760 | 1,756,444 | 74,723 | Apr 17, 2015, 07:09 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Apr 16, 2015 | Option Exercise | $68.84 | 776 | 53,420 | 15,210 | Apr 17, 2015, 05:16 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Apr 16, 2015 | Sale | $95.00 | 649 | 61,655 | 14,561 | Apr 17, 2015, 05:16 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Apr 09, 2015 | Option Exercise | $68.84 | 581 | 39,996 | 19,766 | Apr 10, 2015, 04:40 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Apr 09, 2015 | Sale | $93.97 | 581 | 54,594 | 19,185 | Apr 10, 2015, 04:40 PM |
FINNEY ELISHA W | Exec VP and CFO | Apr 01, 2015 | Option Exercise | $57.90 | 5,000 | 289,500 | 9,671 | Apr 02, 2015, 07:00 PM |
FINNEY ELISHA W | Exec VP and CFO | Apr 01, 2015 | Sale | $92.76 | 5,000 | 463,780 | 4,871 | Apr 02, 2015, 07:00 PM |
GUERTIN TIMOTHY E | Director | Apr 01, 2015 | Option Exercise | $57.90 | 25,000 | 1,447,500 | 84,040 | Apr 02, 2015, 06:56 PM |
GUERTIN TIMOTHY E | Director | Apr 01, 2015 | Sale | $92.76 | 25,000 | 2,318,989 | 59,940 | Apr 02, 2015, 06:56 PM |
WILSON DOW R | President and CEO | Mar 20, 2015 | Option Exercise | $49.88 | 18,759 | 935,699 | 77,222 | Mar 23, 2015, 01:44 PM |
WILSON DOW R | President and CEO | Mar 20, 2015 | Sale | $94.44 | 18,759 | 1,771,577 | 58,463 | Mar 23, 2015, 01:44 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Mar 16, 2015 | Option Exercise | $68.84 | 2,327 | 160,191 | 16,406 | Mar 17, 2015, 08:34 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Mar 16, 2015 | Sale | $95.00 | 1,972 | 187,340 | 14,434 | Mar 17, 2015, 08:34 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Mar 09, 2015 | Option Exercise | $68.84 | 582 | 40,065 | 19,767 | Mar 10, 2015, 07:46 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Mar 09, 2015 | Sale | $93.66 | 582 | 54,509 | 19,185 | Mar 10, 2015, 07:46 PM |
GUERTIN TIMOTHY E | Director | Mar 06, 2015 | Sale | $93.50 | 4,000 | 374,012 | 55,332 | Mar 09, 2015, 06:22 PM |
FINNEY ELISHA W | Exec VP and CFO | Mar 02, 2015 | Option Exercise | $57.90 | 5,000 | 289,500 | 9,671 | Mar 03, 2015, 07:55 PM |
FINNEY ELISHA W | Exec VP and CFO | Mar 02, 2015 | Sale | $93.44 | 5,000 | 467,215 | 4,671 | Mar 03, 2015, 07:55 PM |
GUERTIN TIMOTHY E | Director | Mar 02, 2015 | Option Exercise | $52.83 | 50,000 | 2,641,500 | 109,040 | Mar 03, 2015, 07:51 PM |
GUERTIN TIMOTHY E | Director | Mar 02, 2015 | Sale | $93.48 | 50,000 | 4,674,140 | 59,040 | Mar 03, 2015, 07:51 PM |
FINNEY ELISHA W | Exec VP and CFO | Feb 23, 2015 | Sale | $92.97 | 1,326 | 123,279 | 4,671 | Feb 24, 2015, 07:44 PM |
SANYAL SUNNY | SVP and President, ICB | Feb 17, 2015 | Option Exercise | $92.86 | 645 | 59,895 | 1,600 | Feb 18, 2015, 07:02 PM |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | Feb 17, 2015 | Option Exercise | $92.86 | 816 | 75,774 | 14,079 | Feb 18, 2015, 06:56 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Feb 17, 2015 | Option Exercise | $92.86 | 672 | 62,402 | 19,185 | Feb 18, 2015, 06:50 PM |
FINNEY ELISHA W | Exec VP and CFO | Feb 17, 2015 | Option Exercise | $92.86 | 798 | 74,102 | 5,997 | Feb 18, 2015, 06:39 PM |
WILSON DOW R | President and CEO | Feb 17, 2015 | Option Exercise | $92.86 | 3,116 | 289,352 | 58,463 | Feb 18, 2015, 06:32 PM |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | Feb 17, 2015 | Option Exercise | $92.86 | 232 | 21,544 | 3,383 | Feb 18, 2015, 06:25 PM |
THYAGARAJAN VENKATRAMAN | Director | Feb 10, 2015 | Option Exercise | $92.53 | 298 | 27,574 | 5,989 | Feb 11, 2015, 08:27 PM |
LARET MARK R | Director | Feb 10, 2015 | Option Exercise | $42.38 | 10,000 | 423,750 | 10,000 | Feb 11, 2015, 08:18 PM |
LARET MARK R | Director | Feb 10, 2015 | Sale | $92.32 | 10,000 | 923,156 | 0 | Feb 11, 2015, 08:18 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Feb 09, 2015 | Option Exercise | $68.84 | 582 | 40,065 | 18,647 | Feb 10, 2015, 03:45 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Feb 09, 2015 | Sale | $92.80 | 582 | 54,008 | 18,065 | Feb 10, 2015, 03:45 PM |
THYAGARAJAN VENKATRAMAN | Director | Feb 03, 2015 | Option Exercise | $70.48 | 10,000 | 704,800 | 14,742 | Feb 04, 2015, 07:38 PM |
THYAGARAJAN VENKATRAMAN | Director | Feb 03, 2015 | Sale | $92.71 | 10,000 | 927,118 | 4,742 | Feb 04, 2015, 07:38 PM |
NAUMANN-ETIENNE RUEDIGER | Director | Feb 02, 2015 | Option Exercise | $70.48 | 10,000 | 704,800 | 10,000 | Feb 03, 2015, 08:48 PM |
NAUMANN-ETIENNE RUEDIGER | Director | Feb 02, 2015 | Sale | $91.87 | 10,000 | 918,734 | 0 | Feb 03, 2015, 08:48 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Feb 02, 2015 | Option Exercise | $68.84 | 3,490 | 240,252 | 21,555 | Feb 03, 2015, 08:45 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Feb 02, 2015 | Sale | $92.04 | 3,490 | 321,218 | 18,265 | Feb 03, 2015, 08:45 PM |
WILSON DOW R | President and CEO | Feb 02, 2015 | Option Exercise | $49.88 | 60,000 | 2,992,800 | 115,606 | Feb 03, 2015, 08:41 PM |
WILSON DOW R | President and CEO | Feb 02, 2015 | Sale | $91.78 | 60,000 | 5,506,736 | 60,006 | Feb 03, 2015, 08:41 PM |
GUERTIN TIMOTHY E | Director | Feb 02, 2015 | Option Exercise | $52.83 | 50,000 | 2,641,500 | 109,040 | Feb 03, 2015, 08:37 PM |
GUERTIN TIMOTHY E | Director | Feb 02, 2015 | Sale | $91.78 | 50,000 | 4,588,843 | 62,852 | Feb 03, 2015, 08:37 PM |
FINNEY ELISHA W | Exec VP and CFO | Feb 02, 2015 | Option Exercise | $52.83 | 6,667 | 352,218 | 11,338 | Feb 03, 2015, 08:34 PM |
FINNEY ELISHA W | Exec VP and CFO | Feb 02, 2015 | Sale | $91.79 | 6,667 | 611,963 | 4,971 | Feb 03, 2015, 08:34 PM |
WILSON DOW R | President and CEO | Jan 12, 2015 | Option Exercise | $87.71 | 6,099 | 534,913 | 55,606 | Jan 13, 2015, 05:23 PM |
GUERTIN TIMOTHY E | Director | Jan 05, 2015 | Option Exercise | $52.83 | 50,000 | 2,641,500 | 109,040 | Jan 06, 2015, 03:52 PM |
GUERTIN TIMOTHY E | Director | Jan 05, 2015 | Sale | $86.27 | 50,000 | 4,313,344 | 81,000 | Jan 06, 2015, 03:52 PM |
FINNEY ELISHA W | Exec VP and CFO | Jan 02, 2015 | Option Exercise | $52.83 | 15,000 | 792,450 | 19,671 | Jan 05, 2015, 06:07 PM |
FINNEY ELISHA W | Exec VP and CFO | Jan 02, 2015 | Sale | $87.05 | 15,000 | 1,305,823 | 17,970 | Jan 05, 2015, 06:07 PM |
GUERTIN TIMOTHY E | Director | Dec 11, 2014 | Option Exercise | $52.71 | 105,000 | 5,535,050 | 114,040 | Dec 12, 2014, 01:19 PM |
GUERTIN TIMOTHY E | Director | Dec 11, 2014 | Sale | $86.67 | 105,000 | 9,100,360 | 59,040 | Dec 12, 2014, 01:19 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Dec 09, 2014 | Option Exercise | $68.84 | 775 | 53,351 | 13,105 | Dec 10, 2014, 02:48 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Dec 09, 2014 | Sale | $88.01 | 725 | 63,807 | 12,705 | Dec 10, 2014, 02:48 PM |
FINNEY ELISHA W | Exec VP and CFO | Dec 01, 2014 | Option Exercise | $51.69 | 21,000 | 1,085,560 | 25,671 | Dec 02, 2014, 08:10 PM |
FINNEY ELISHA W | Exec VP and CFO | Dec 01, 2014 | Sale | $88.72 | 21,000 | 1,863,130 | 23,771 | Dec 02, 2014, 08:10 PM |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | Nov 21, 2014 | Option Exercise | $87.75 | 1,190 | 104,423 | 3,084 | Nov 24, 2014, 08:35 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Nov 21, 2014 | Option Exercise | $87.75 | 1,712 | 150,228 | 18,065 | Nov 24, 2014, 08:32 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Nov 21, 2014 | Option Exercise | $87.75 | 2,566 | 225,167 | 12,655 | Nov 24, 2014, 08:29 PM |
FINNEY ELISHA W | Exec VP and CFO | Nov 21, 2014 | Option Exercise | $87.75 | 3,194 | 280,274 | 7,601 | Nov 24, 2014, 08:21 PM |
FINNEY ELISHA W | Exec VP and CFO | Nov 24, 2014 | Sale | $88.24 | 2,930 | 258,532 | 4,671 | Nov 24, 2014, 08:21 PM |
WILSON DOW R | President and CEO | Nov 21, 2014 | Option Exercise | $87.75 | 6,608 | 579,852 | 61,705 | Nov 24, 2014, 08:09 PM |
GUERTIN TIMOTHY E | Director | Nov 21, 2014 | Option Exercise | $87.75 | 5,290 | 464,198 | 59,040 | Nov 24, 2014, 08:01 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Nov 14, 2014 | Option Exercise | $87.58 | 943 | 82,588 | 15,629 | Nov 18, 2014, 04:58 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Nov 14, 2014 | Option Exercise | $87.58 | 998 | 87,405 | 10,301 | Nov 18, 2014, 04:55 PM |
GUERTIN TIMOTHY E | Director | Nov 14, 2014 | Option Exercise | $87.58 | 6,010 | 526,356 | 54,191 | Nov 18, 2014, 04:50 PM |
FINNEY ELISHA W | Exec VP and CFO | Nov 14, 2014 | Option Exercise | $87.58 | 2,003 | 175,423 | 6,508 | Nov 18, 2014, 04:47 PM |
FINNEY ELISHA W | Exec VP and CFO | Nov 17, 2014 | Sale | $87.71 | 1,837 | 161,123 | 4,671 | Nov 18, 2014, 04:47 PM |
WILSON DOW R | President and CEO | Nov 14, 2014 | Option Exercise | $87.58 | 2,306 | 201,959 | 55,647 | Nov 18, 2014, 04:44 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Nov 11, 2014 | Option Exercise | $57.90 | 606 | 35,087 | 14,667 | Nov 12, 2014, 08:04 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Nov 11, 2014 | Sale | $86.63 | 606 | 52,499 | 14,567 | Nov 12, 2014, 08:04 PM |
NAUMANN-ETIENNE RUEDIGER | Director | Nov 10, 2014 | Option Exercise | $64.73 | 5,000 | 323,650 | 5,000 | Nov 12, 2014, 08:01 PM |
NAUMANN-ETIENNE RUEDIGER | Director | Nov 10, 2014 | Sale | $85.31 | 5,000 | 426,533 | 0 | Nov 12, 2014, 08:01 PM |
ECKERT R ANDREW | Director | Nov 10, 2014 | Option Exercise | $52.61 | 5,000 | 263,050 | 11,394 | Nov 12, 2014, 07:56 PM |
ECKERT R ANDREW | Director | Nov 10, 2014 | Sale | $85.11 | 5,000 | 425,529 | 6,394 | Nov 12, 2014, 07:56 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Nov 10, 2014 | Option Exercise | $68.84 | 776 | 53,420 | 9,244 | Nov 12, 2014, 07:44 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Nov 11, 2014 | Option Exercise | $57.90 | 641 | 37,114 | 9,176 | Nov 12, 2014, 07:44 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Nov 10, 2014 | Sale | $85.13 | 709 | 60,360 | 8,535 | Nov 12, 2014, 07:44 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Nov 11, 2014 | Sale | $86.67 | 533 | 46,193 | 9,076 | Nov 12, 2014, 07:44 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Apr 11, 2013 | Option Exercise | $57.90 | 640 | 37,056 | 11,359 | Nov 12, 2014, 07:34 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Apr 11, 2013 | Sale | $72.15 | 640 | 46,178 | 10,719 | Nov 12, 2014, 07:34 PM |
FINNEY ELISHA W | Exec VP and CFO | Nov 03, 2014 | Option Exercise | $51.53 | 25,000 | 1,288,200 | 19,671 | Nov 04, 2014, 07:28 PM |
FINNEY ELISHA W | Exec VP and CFO | Nov 03, 2014 | Sale | $83.82 | 25,000 | 2,095,404 | 6,071 | Nov 04, 2014, 07:28 PM |
GUERTIN TIMOTHY E | Director | Nov 03, 2014 | Option Exercise | $52.61 | 80,000 | 4,208,800 | 128,683 | Nov 04, 2014, 07:24 PM |
GUERTIN TIMOTHY E | Director | Nov 03, 2014 | Sale | $83.72 | 80,000 | 6,697,770 | 95,398 | Nov 04, 2014, 07:24 PM |
FINNEY ELISHA W | Exec VP and CFO | Oct 29, 2014 | Option Exercise | $52.83 | 10,000 | 528,300 | 14,671 | Oct 30, 2014, 08:56 PM |
FINNEY ELISHA W | Exec VP and CFO | Oct 29, 2014 | Sale | $83.95 | 10,000 | 839,500 | 4,671 | Oct 30, 2014, 08:56 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Oct 27, 2014 | Option Exercise | $63.89 | 1,415 | 90,407 | 9,176 | Oct 28, 2014, 09:33 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Oct 27, 2014 | Sale | $81.00 | 1,240 | 100,440 | 8,468 | Oct 28, 2014, 09:33 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Oct 13, 2014 | Option Exercise | $57.90 | 606 | 35,087 | 14,667 | Oct 14, 2014, 08:07 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Oct 13, 2014 | Sale | $79.64 | 606 | 48,263 | 14,061 | Oct 14, 2014, 08:07 PM |
FINNEY ELISHA W | Exec VP and CFO | Oct 01, 2014 | Option Exercise | $50.66 | 15,000 | 759,900 | 19,496 | Oct 02, 2014, 08:42 PM |
FINNEY ELISHA W | Exec VP and CFO | Oct 01, 2014 | Sale | $79.98 | 15,000 | 1,199,694 | 4,496 | Oct 02, 2014, 08:42 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Sep 11, 2014 | Option Exercise | $57.90 | 605 | 35,030 | 14,666 | Sep 12, 2014, 05:27 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Sep 11, 2014 | Sale | $85.82 | 605 | 51,923 | 14,061 | Sep 12, 2014, 05:27 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Sep 11, 2014 | Option Exercise | $57.90 | 641 | 37,114 | 8,293 | Sep 12, 2014, 05:25 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Sep 09, 2014 | Option Exercise | $68.84 | 776 | 53,420 | 7,652 | Sep 10, 2014, 08:20 PM |
FINNEY ELISHA W | Exec VP and CFO | Sep 02, 2014 | Option Exercise | $51.20 | 20,000 | 1,024,050 | 24,496 | Sep 03, 2014, 08:46 PM |
FINNEY ELISHA W | Exec VP and CFO | Sep 02, 2014 | Sale | $85.18 | 20,000 | 1,703,604 | 4,496 | Sep 03, 2014, 08:46 PM |
THYAGARAJAN VENKATRAMAN | Director | Aug 20, 2014 | Option Exercise | $64.73 | 5,000 | 323,650 | 9,742 | Aug 20, 2014, 07:31 PM |
THYAGARAJAN VENKATRAMAN | Director | Aug 20, 2014 | Sale | $84.25 | 5,000 | 421,250 | 4,742 | Aug 20, 2014, 07:31 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Aug 11, 2014 | Option Exercise | $63.90 | 1,416 | 90,476 | 7,012 | Aug 12, 2014, 04:06 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Aug 11, 2014 | Sale | $85.03 | 776 | 65,985 | 6,236 | Aug 12, 2014, 04:06 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Aug 11, 2014 | Option Exercise | $57.90 | 606 | 35,087 | 14,667 | Aug 12, 2014, 04:04 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Aug 11, 2014 | Sale | $85.07 | 606 | 51,550 | 14,061 | Aug 12, 2014, 04:04 PM |
FINNEY ELISHA W | Exec VP and CFO | Aug 07, 2014 | Option Exercise | $52.83 | 5,000 | 264,150 | 9,496 | Aug 07, 2014, 05:32 PM |
FINNEY ELISHA W | Exec VP and CFO | Aug 07, 2014 | Sale | $83.95 | 5,000 | 419,750 | 4,496 | Aug 07, 2014, 05:32 PM |
FINNEY ELISHA W | Exec VP and CFO | Aug 01, 2014 | Option Exercise | $50.66 | 15,000 | 759,900 | 19,496 | Aug 04, 2014, 03:09 PM |
FINNEY ELISHA W | Exec VP and CFO | Aug 01, 2014 | Sale | $81.66 | 15,000 | 1,224,890 | 14,496 | Aug 04, 2014, 03:09 PM |
GUERTIN TIMOTHY E | Director | Aug 01, 2014 | Option Exercise | $52.61 | 80,000 | 4,208,800 | 128,683 | Aug 04, 2014, 03:06 PM |
GUERTIN TIMOTHY E | Director | Aug 01, 2014 | Sale | $81.69 | 80,000 | 6,534,904 | 119,783 | Aug 04, 2014, 03:06 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Jul 14, 2014 | Option Exercise | $57.90 | 641 | 37,114 | 6,877 | Jul 14, 2014, 09:44 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Jul 14, 2014 | Sale | $85.12 | 641 | 54,565 | 6,236 | Jul 14, 2014, 09:44 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jul 11, 2014 | Option Exercise | $57.90 | 605 | 35,030 | 14,666 | Jul 14, 2014, 09:41 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jul 11, 2014 | Sale | $84.96 | 605 | 51,400 | 14,061 | Jul 14, 2014, 09:41 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jul 09, 2014 | Option Exercise | $68.84 | 582 | 40,065 | 14,643 | Jul 10, 2014, 08:15 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jul 09, 2014 | Sale | $85.00 | 582 | 49,470 | 14,061 | Jul 10, 2014, 08:15 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Jul 09, 2014 | Option Exercise | $68.84 | 775 | 53,351 | 7,011 | Jul 10, 2014, 08:11 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Jul 09, 2014 | Sale | $84.69 | 775 | 65,633 | 6,236 | Jul 10, 2014, 08:11 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Jun 16, 2014 | Option Exercise | $63.90 | 1,416 | 90,476 | 7,012 | Jul 10, 2014, 08:08 PM |
FINNEY ELISHA W | Exec VP and CFO | Jul 01, 2014 | Option Exercise | $51.20 | 20,000 | 1,024,050 | 24,496 | Jul 02, 2014, 03:38 PM |
FINNEY ELISHA W | Exec VP and CFO | Jul 01, 2014 | Sale | $83.86 | 20,000 | 1,677,222 | 19,496 | Jul 02, 2014, 03:38 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jun 23, 2014 | Option Exercise | $68.84 | 1,745 | 120,126 | 15,806 | Jun 24, 2014, 07:11 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jun 23, 2014 | Sale | $85.00 | 1,745 | 148,325 | 14,061 | Jun 24, 2014, 07:11 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Jun 16, 2014 | Sale | $82.42 | 1,416 | 116,704 | 6,236 | Jun 18, 2014, 03:07 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jun 11, 2014 | Option Exercise | $57.90 | 606 | 35,087 | 14,667 | Jun 11, 2014, 08:08 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jun 11, 2014 | Sale | $81.38 | 606 | 49,314 | 14,061 | Jun 11, 2014, 08:08 PM |
FINNEY ELISHA W | Exec VP and CFO | Jun 02, 2014 | Option Exercise | $50.66 | 10,000 | 506,600 | 14,496 | Jun 03, 2014, 07:56 PM |
FINNEY ELISHA W | Exec VP and CFO | Jun 02, 2014 | Sale | $82.35 | 10,000 | 823,495 | 4,496 | Jun 03, 2014, 07:56 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | May 12, 2014 | Option Exercise | $57.90 | 605 | 35,030 | 14,666 | May 12, 2014, 08:41 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | May 12, 2014 | Sale | $82.79 | 605 | 50,087 | 14,566 | May 12, 2014, 08:41 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | May 12, 2014 | Option Exercise | $57.90 | 641 | 37,114 | 6,877 | May 12, 2014, 08:36 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | May 09, 2014 | Option Exercise | $68.84 | 776 | 53,420 | 7,012 | May 12, 2014, 08:36 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | May 09, 2014 | Sale | $81.26 | 776 | 63,056 | 6,236 | May 12, 2014, 08:36 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | May 12, 2014 | Sale | $82.82 | 641 | 53,085 | 6,777 | May 12, 2014, 08:36 PM |
FINNEY ELISHA W | Exec VP and CFO | May 01, 2014 | Option Exercise | $51.83 | 10,000 | 518,300 | 14,496 | May 02, 2014, 05:48 PM |
FINNEY ELISHA W | Exec VP and CFO | May 01, 2014 | Sale | $78.99 | 10,000 | 789,871 | 4,496 | May 02, 2014, 05:48 PM |
GUERTIN TIMOTHY E | Director | May 01, 2014 | Option Exercise | $47.04 | 80,000 | 3,763,500 | 128,683 | May 02, 2014, 05:44 PM |
GUERTIN TIMOTHY E | Director | May 01, 2014 | Sale | $78.98 | 80,000 | 6,318,672 | 48,683 | May 02, 2014, 05:44 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Apr 11, 2014 | Option Exercise | $57.90 | 606 | 35,087 | 14,326 | Apr 15, 2014, 04:30 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Apr 11, 2014 | Sale | $80.77 | 606 | 48,944 | 13,720 | Apr 15, 2014, 04:30 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Apr 11, 2014 | Option Exercise | $57.90 | 640 | 37,056 | 6,876 | Apr 15, 2014, 04:28 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Apr 11, 2014 | Sale | $80.90 | 640 | 51,775 | 6,236 | Apr 15, 2014, 04:28 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Apr 09, 2014 | Option Exercise | $68.84 | 775 | 53,351 | 7,011 | Apr 10, 2014, 08:41 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Apr 09, 2014 | Sale | $83.56 | 775 | 64,762 | 6,236 | Apr 10, 2014, 08:41 PM |
FINNEY ELISHA W | Exec VP and CFO | Apr 01, 2014 | Option Exercise | $52.61 | 10,000 | 526,100 | 14,308 | Apr 02, 2014, 06:20 PM |
FINNEY ELISHA W | Exec VP and CFO | Apr 01, 2014 | Sale | $83.97 | 10,000 | 839,731 | 4,308 | Apr 02, 2014, 06:20 PM |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | Mar 17, 2014 | Sale | $84.70 | 1,140 | 96,562 | 768 | Mar 17, 2014, 08:33 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Mar 11, 2014 | Option Exercise | $68.17 | 9,913 | 675,781 | 23,633 | Mar 12, 2014, 05:07 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Mar 11, 2014 | Sale | $84.98 | 9,913 | 842,447 | 23,533 | Mar 12, 2014, 05:07 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Mar 11, 2014 | Option Exercise | $57.90 | 641 | 37,114 | 6,877 | Mar 11, 2014, 07:12 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Mar 10, 2014 | Option Exercise | $68.84 | 776 | 53,420 | 7,012 | Mar 11, 2014, 07:12 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Mar 11, 2014 | Sale | $84.80 | 641 | 54,356 | 6,777 | Mar 11, 2014, 07:12 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Mar 10, 2014 | Sale | $84.06 | 776 | 65,229 | 6,236 | Mar 11, 2014, 07:12 PM |
GUERTIN TIMOTHY E | Director | Mar 10, 2014 | Option Exercise | $37.17 | 80,000 | 2,973,600 | 128,683 | Mar 11, 2014, 07:09 PM |
GUERTIN TIMOTHY E | Director | Mar 10, 2014 | Sale | $84.05 | 80,000 | 6,723,835 | 126,683 | Mar 11, 2014, 07:09 PM |
FINNEY ELISHA W | Exec VP and CFO | Mar 03, 2014 | Option Exercise | $52.61 | 10,000 | 526,100 | 14,308 | Mar 04, 2014, 05:26 PM |
FINNEY ELISHA W | Exec VP and CFO | Mar 03, 2014 | Sale | $83.41 | 10,000 | 834,066 | 4,308 | Mar 04, 2014, 05:26 PM |
NAUMANN-ETIENNE RUEDIGER | Director | Feb 21, 2014 | Option Exercise | $60.32 | 3,000 | 180,960 | 4,411 | Feb 24, 2014, 06:16 PM |
NAUMANN-ETIENNE RUEDIGER | Director | Feb 21, 2014 | Sale | $83.99 | 4,411 | 370,468 | 1,411 | Feb 24, 2014, 06:16 PM |
LARET MARK R | Director | Feb 21, 2014 | Sale | $84.06 | 1,411 | 118,609 | 0 | Feb 24, 2014, 06:13 PM |
THYAGARAJAN VENKATRAMAN | Director | Feb 18, 2014 | Option Exercise | $82.86 | 263 | 21,792 | 4,742 | Feb 19, 2014, 08:29 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Feb 11, 2014 | Option Exercise | $57.90 | 605 | 35,030 | 14,325 | Feb 11, 2014, 08:41 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Feb 11, 2014 | Sale | $80.62 | 605 | 48,776 | 13,720 | Feb 11, 2014, 08:41 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Feb 11, 2014 | Option Exercise | $57.90 | 640 | 37,056 | 6,876 | Feb 11, 2014, 08:35 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Feb 10, 2014 | Option Exercise | $68.84 | 776 | 53,420 | 7,012 | Feb 11, 2014, 08:35 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Feb 11, 2014 | Sale | $80.67 | 640 | 51,632 | 6,236 | Feb 11, 2014, 08:35 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Feb 10, 2014 | Sale | $80.52 | 776 | 62,481 | 6,236 | Feb 11, 2014, 08:35 PM |
ECKERT R ANDREW | Director | Feb 10, 2014 | Option Exercise | $60.32 | 5,000 | 301,600 | 10,870 | Feb 11, 2014, 08:27 PM |
ECKERT R ANDREW | Director | Feb 10, 2014 | Sale | $80.52 | 5,887 | 474,007 | 5,870 | Feb 11, 2014, 08:27 PM |
GUERTIN TIMOTHY E | Director | Feb 03, 2014 | Option Exercise | $37.17 | 25,000 | 929,250 | 73,683 | Feb 05, 2014, 01:52 PM |
GUERTIN TIMOTHY E | Director | Feb 03, 2014 | Sale | $79.39 | 2,000 | 158,773 | 60,332 | Feb 05, 2014, 01:52 PM |
GUERTIN TIMOTHY E | Director | Feb 03, 2014 | Sale | $79.34 | 25,000 | 1,983,495 | 60,863 | Feb 05, 2014, 01:52 PM |
LEVY RICHARD M | Director | Feb 03, 2014 | Option Exercise | $39.85 | 20,000 | 797,000 | 20,000 | Feb 05, 2014, 01:33 PM |
LEVY RICHARD M | Director | Feb 03, 2014 | Sale | $79.35 | 20,000 | 1,586,916 | 10,032 | Feb 05, 2014, 01:33 PM |
FINNEY ELISHA W | Exec VP and CFO | Feb 03, 2014 | Option Exercise | $52.61 | 10,000 | 526,100 | 14,308 | Feb 05, 2014, 01:28 PM |
FINNEY ELISHA W | Exec VP and CFO | Feb 03, 2014 | Sale | $79.34 | 10,000 | 793,420 | 9,308 | Feb 05, 2014, 01:28 PM |
BOSTROM SUSAN L | Director | Jan 31, 2014 | Option Exercise | $68.56 | 15,000 | 1,028,450 | 19,753 | Feb 03, 2014, 09:37 PM |
BOSTROM SUSAN L | Director | Jan 31, 2014 | Sale | $81.50 | 18,900 | 1,540,350 | 853 | Feb 03, 2014, 09:37 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jan 13, 2014 | Option Exercise | $57.90 | 606 | 35,087 | 14,326 | Jan 15, 2014, 04:52 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jan 13, 2014 | Sale | $80.29 | 606 | 48,658 | 13,720 | Jan 15, 2014, 04:52 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Jan 13, 2014 | Option Exercise | $57.90 | 640 | 37,056 | 6,876 | Jan 15, 2014, 04:50 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Jan 13, 2014 | Sale | $80.29 | 640 | 51,384 | 6,636 | Jan 15, 2014, 04:50 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Jan 09, 2014 | Option Exercise | $68.84 | 775 | 53,351 | 7,011 | Jan 10, 2014, 06:05 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Jan 09, 2014 | Sale | $80.79 | 775 | 62,614 | 6,711 | Jan 10, 2014, 06:05 PM |
FINNEY ELISHA W | Exec VP and CFO | Jan 02, 2014 | Option Exercise | $52.61 | 20,000 | 1,052,200 | 28,629 | Jan 03, 2014, 04:19 PM |
FINNEY ELISHA W | Exec VP and CFO | Jan 02, 2014 | Sale | $77.69 | 24,321 | 1,889,455 | 4,308 | Jan 03, 2014, 04:19 PM |
LEVY RICHARD M | Director | Jan 02, 2014 | Option Exercise | $39.85 | 20,000 | 797,000 | 20,000 | Jan 03, 2014, 04:11 PM |
LEVY RICHARD M | Director | Jan 02, 2014 | Sale | $77.68 | 20,000 | 1,553,696 | 0 | Jan 03, 2014, 04:11 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Dec 30, 2013 | Option Exercise | $57.90 | 3,027 | 175,263 | 16,747 | Dec 31, 2013, 03:30 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Dec 30, 2013 | Sale | $77.08 | 3,027 | 233,330 | 13,720 | Dec 31, 2013, 03:30 PM |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | Dec 23, 2013 | Sale | $76.13 | 1,297 | 98,744 | 1,908 | Dec 24, 2013, 12:29 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Dec 11, 2013 | Option Exercise | $57.90 | 641 | 37,114 | 6,877 | Dec 12, 2013, 05:43 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Dec 11, 2013 | Sale | $77.70 | 641 | 49,804 | 6,336 | Dec 12, 2013, 05:43 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Dec 09, 2013 | Option Exercise | $68.84 | 776 | 53,420 | 7,012 | Dec 11, 2013, 04:26 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Dec 09, 2013 | Sale | $79.13 | 776 | 61,403 | 6,236 | Dec 11, 2013, 04:26 PM |
WILSON DOW R | President and CEO | Dec 09, 2013 | Option Exercise | $52.61 | 95,000 | 4,997,950 | 146,474 | Dec 11, 2013, 04:23 PM |
WILSON DOW R | President and CEO | Dec 09, 2013 | Sale | $79.09 | 95,000 | 7,513,616 | 51,474 | Dec 11, 2013, 04:23 PM |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | Dec 04, 2013 | Sale | $80.00 | 12,932 | 1,034,560 | 20,347 | Dec 05, 2013, 06:15 PM |
FINNEY ELISHA W | Exec VP and CFO | Dec 02, 2013 | Option Exercise | $52.61 | 10,000 | 526,100 | 18,629 | Dec 03, 2013, 07:26 PM |
FINNEY ELISHA W | Exec VP and CFO | Dec 02, 2013 | Sale | $79.04 | 10,000 | 790,354 | 18,329 | Dec 03, 2013, 07:26 PM |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | Dec 02, 2013 | Option Exercise | $68.84 | 9,889 | 680,759 | 43,168 | Dec 03, 2013, 07:22 PM |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | Dec 02, 2013 | Sale | $79.00 | 9,889 | 781,231 | 33,279 | Dec 03, 2013, 07:22 PM |
LEVY RICHARD M | Director | Dec 02, 2013 | Option Exercise | $39.85 | 20,000 | 797,000 | 20,000 | Dec 03, 2013, 07:19 PM |
LEVY RICHARD M | Director | Dec 02, 2013 | Sale | $79.04 | 20,000 | 1,580,780 | 19,400 | Dec 03, 2013, 07:19 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Nov 29, 2013 | Option Exercise | $68.84 | 9,307 | 640,694 | 15,543 | Dec 02, 2013, 08:53 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Nov 29, 2013 | Sale | $78.00 | 9,307 | 725,946 | 6,236 | Dec 02, 2013, 08:53 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Nov 25, 2013 | Sale | $75.49 | 2,972 | 224,360 | 7,696 | Nov 26, 2013, 03:30 PM |
WILSON DOW R | President and CEO | Nov 21, 2013 | Option Exercise | $75.20 | 5,448 | 409,690 | 51,474 | Nov 25, 2013, 05:35 PM |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | Nov 21, 2013 | Option Exercise | $75.20 | 2,966 | 223,043 | 33,279 | Nov 25, 2013, 05:20 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Nov 21, 2013 | Option Exercise | $75.20 | 1,848 | 138,970 | 9,308 | Nov 25, 2013, 05:10 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Nov 22, 2013 | Sale | $75.00 | 100 | 7,500 | 9,208 | Nov 25, 2013, 05:10 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Nov 21, 2013 | Option Exercise | $75.20 | 1,557 | 117,086 | 13,720 | Nov 25, 2013, 05:04 PM |
FINNEY ELISHA W | Exec VP and CFO | Nov 21, 2013 | Option Exercise | $75.20 | 3,194 | 240,189 | 10,246 | Nov 25, 2013, 05:00 PM |
FINNEY ELISHA W | Exec VP and CFO | Nov 22, 2013 | Sale | $74.83 | 1,617 | 120,998 | 8,629 | Nov 25, 2013, 05:00 PM |
GUERTIN TIMOTHY E | Director | Nov 21, 2013 | Option Exercise | $75.20 | 5,290 | 397,808 | 48,683 | Nov 25, 2013, 04:49 PM |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | Nov 21, 2013 | Option Exercise | $75.20 | 685 | 51,512 | 3,205 | Nov 25, 2013, 04:37 PM |
LARET MARK R | Director | Nov 20, 2013 | Option Exercise | $52.61 | 5,000 | 263,050 | 5,000 | Nov 22, 2013, 05:41 PM |
LARET MARK R | Director | Nov 20, 2013 | Sale | $74.58 | 5,000 | 372,900 | 0 | Nov 22, 2013, 05:41 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Nov 15, 2013 | Option Exercise | $57.90 | 640 | 37,056 | 6,876 | Nov 19, 2013, 02:16 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Nov 15, 2013 | Sale | $75.00 | 640 | 48,000 | 6,236 | Nov 19, 2013, 02:16 PM |
FINNEY ELISHA W | Exec VP and CFO | Nov 14, 2013 | Option Exercise | $52.61 | 5,000 | 263,050 | 12,316 | Nov 15, 2013, 08:38 PM |
FINNEY ELISHA W | Exec VP and CFO | Nov 14, 2013 | Sale | $74.95 | 5,000 | 374,750 | 7,316 | Nov 15, 2013, 08:38 PM |
GUERTIN TIMOTHY E | Director | Nov 01, 2013 | Option Exercise | $37.17 | 25,000 | 929,250 | 68,834 | Nov 05, 2013, 11:44 AM |
GUERTIN TIMOTHY E | Director | Nov 01, 2013 | Sale | $72.25 | 2,000 | 144,506 | 61,332 | Nov 05, 2013, 11:44 AM |
GUERTIN TIMOTHY E | Director | Nov 01, 2013 | Sale | $72.27 | 25,000 | 1,806,668 | 43,834 | Nov 05, 2013, 11:44 AM |
FINNEY ELISHA W | Exec VP and CFO | Nov 01, 2013 | Option Exercise | $52.61 | 5,000 | 263,050 | 12,108 | Nov 05, 2013, 11:41 AM |
FINNEY ELISHA W | Exec VP and CFO | Nov 01, 2013 | Sale | $72.27 | 5,000 | 361,358 | 7,108 | Nov 05, 2013, 11:41 AM |
LEVY RICHARD M | Director | Nov 01, 2013 | Option Exercise | $39.85 | 20,000 | 797,000 | 20,000 | Nov 05, 2013, 11:39 AM |
LEVY RICHARD M | Director | Nov 01, 2013 | Sale | $72.27 | 20,000 | 1,445,330 | 0 | Nov 05, 2013, 11:39 AM |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | Oct 14, 2013 | Option Exercise | $57.90 | 13,889 | 804,173 | 44,010 | Oct 15, 2013, 02:15 PM |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | Oct 14, 2013 | Sale | $78.00 | 13,889 | 1,083,342 | 30,121 | Oct 15, 2013, 02:15 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Oct 11, 2013 | Option Exercise | $57.90 | 641 | 37,114 | 6,877 | Oct 15, 2013, 02:10 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Oct 11, 2013 | Sale | $77.13 | 641 | 49,442 | 6,236 | Oct 15, 2013, 02:10 PM |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | Oct 10, 2013 | Option Exercise | $52.83 | 13,871 | 732,805 | 43,992 | Oct 10, 2013, 05:23 PM |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | Oct 10, 2013 | Sale | $77.00 | 13,871 | 1,068,067 | 30,121 | Oct 10, 2013, 05:23 PM |
FINNEY ELISHA W | Exec VP and CFO | Oct 01, 2013 | Option Exercise | $49.88 | 10,000 | 498,800 | 12,108 | Oct 02, 2013, 08:59 PM |
FINNEY ELISHA W | Exec VP and CFO | Oct 01, 2013 | Sale | $75.09 | 10,000 | 750,921 | 7,108 | Oct 02, 2013, 08:59 PM |
LEVY RICHARD M | Director | Oct 01, 2013 | Option Exercise | $39.85 | 20,000 | 797,000 | 20,000 | Oct 02, 2013, 08:56 PM |
LEVY RICHARD M | Director | Oct 01, 2013 | Sale | $75.23 | 20,000 | 1,504,694 | 0 | Oct 02, 2013, 08:56 PM |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | Sep 20, 2013 | Option Exercise | $52.83 | 13,870 | 732,752 | 43,991 | Sep 23, 2013, 06:36 PM |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | Sep 20, 2013 | Sale | $76.00 | 13,870 | 1,054,120 | 30,121 | Sep 23, 2013, 06:36 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Sep 20, 2013 | Sale | $76.00 | 1,247 | 94,772 | 6,236 | Sep 23, 2013, 06:28 PM |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | Sep 16, 2013 | Option Exercise | $52.83 | 13,870 | 732,752 | 43,991 | Sep 17, 2013, 06:02 PM |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | Sep 16, 2013 | Sale | $75.00 | 13,870 | 1,040,250 | 30,121 | Sep 17, 2013, 06:02 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Sep 16, 2013 | Option Exercise | $57.90 | 2,562 | 148,340 | 10,045 | Sep 17, 2013, 05:59 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Sep 16, 2013 | Sale | $75.00 | 2,562 | 192,150 | 7,483 | Sep 17, 2013, 05:59 PM |
FINNEY ELISHA W | Exec VP and CFO | Sep 16, 2013 | Option Exercise | $49.88 | 16,334 | 814,740 | 23,442 | Sep 17, 2013, 05:56 PM |
FINNEY ELISHA W | Exec VP and CFO | Sep 16, 2013 | Sale | $74.95 | 16,334 | 1,224,233 | 7,108 | Sep 17, 2013, 05:56 PM |
FINNEY ELISHA W | Exec VP and CFO | Sep 11, 2013 | Option Exercise | $49.88 | 23,666 | 1,180,460 | 30,774 | Sep 12, 2013, 09:36 PM |
FINNEY ELISHA W | Exec VP and CFO | Sep 11, 2013 | Sale | $74.95 | 23,666 | 1,773,767 | 7,108 | Sep 12, 2013, 09:36 PM |
LEVY RICHARD M | Director | Sep 03, 2013 | Option Exercise | $39.85 | 20,000 | 797,000 | 20,000 | Sep 04, 2013, 08:26 PM |
LEVY RICHARD M | Director | Sep 03, 2013 | Sale | $70.95 | 20,000 | 1,418,983 | 4,000 | Sep 04, 2013, 08:26 PM |
FINNEY ELISHA W | Exec VP and CFO | Sep 03, 2013 | Option Exercise | $49.88 | 5,000 | 249,400 | 12,108 | Sep 04, 2013, 08:11 PM |
FINNEY ELISHA W | Exec VP and CFO | Sep 03, 2013 | Sale | $70.95 | 5,000 | 354,773 | 8,108 | Sep 04, 2013, 08:11 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Aug 08, 2013 | Sale | $73.50 | 2,400 | 176,400 | 7,483 | Aug 09, 2013, 05:37 PM |
ECKERT R ANDREW | Director | Aug 01, 2013 | Sale | $72.93 | 1,375 | 100,274 | 6,796 | Aug 02, 2013, 08:37 PM |
FINNEY ELISHA W | Exec VP and CFO | Aug 01, 2013 | Option Exercise | $49.88 | 5,000 | 249,400 | 12,108 | Aug 02, 2013, 07:58 PM |
FINNEY ELISHA W | Exec VP and CFO | Aug 01, 2013 | Sale | $72.81 | 5,000 | 364,074 | 7,108 | Aug 02, 2013, 07:58 PM |
GUERTIN TIMOTHY E | Director | Aug 01, 2013 | Option Exercise | $37.17 | 25,000 | 929,250 | 68,834 | Aug 02, 2013, 07:55 PM |
GUERTIN TIMOTHY E | Director | Aug 01, 2013 | Sale | $72.78 | 2,000 | 145,560 | 63,332 | Aug 02, 2013, 07:55 PM |
GUERTIN TIMOTHY E | Director | Aug 01, 2013 | Sale | $72.82 | 25,000 | 1,820,495 | 43,834 | Aug 02, 2013, 07:55 PM |
LEVY RICHARD M | Director | Aug 01, 2013 | Option Exercise | $39.85 | 20,000 | 797,000 | 20,000 | Aug 02, 2013, 07:50 PM |
LEVY RICHARD M | Director | Aug 01, 2013 | Sale | $72.82 | 20,000 | 1,456,350 | 0 | Aug 02, 2013, 07:50 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Jul 19, 2013 | Sale | $72.00 | 2,027 | 145,944 | 9,883 | Jul 22, 2013, 09:25 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jul 19, 2013 | Option Exercise | $57.90 | 1,817 | 105,204 | 12,947 | Jul 22, 2013, 09:21 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jul 19, 2013 | Sale | $72.00 | 1,817 | 130,824 | 11,130 | Jul 22, 2013, 09:21 PM |
LEVY RICHARD M | Director | Jul 17, 2013 | Option Exercise | $39.85 | 20,000 | 797,000 | 20,000 | Jul 18, 2013, 04:25 PM |
LEVY RICHARD M | Director | Jul 17, 2013 | Sale | $70.00 | 20,000 | 1,400,000 | 0 | Jul 18, 2013, 04:25 PM |
FINNEY ELISHA W | Exec VP and CFO | Jul 16, 2013 | Option Exercise | $49.88 | 5,000 | 249,400 | 12,108 | Jul 18, 2013, 04:22 PM |
FINNEY ELISHA W | Exec VP and CFO | Jul 16, 2013 | Sale | $69.95 | 5,000 | 349,750 | 7,108 | Jul 18, 2013, 04:22 PM |
LEVY RICHARD M | Director | Jun 17, 2013 | Option Exercise | $39.85 | 20,000 | 797,000 | 20,000 | Jun 18, 2013, 06:38 PM |
LEVY RICHARD M | Director | Jun 17, 2013 | Sale | $70.00 | 20,000 | 1,400,000 | 0 | Jun 18, 2013, 06:38 PM |
FINNEY ELISHA W | Exec VP and CFO | Jun 17, 2013 | Option Exercise | $49.88 | 5,000 | 249,400 | 12,108 | Jun 18, 2013, 06:35 PM |
FINNEY ELISHA W | Exec VP and CFO | Jun 17, 2013 | Sale | $69.95 | 5,000 | 349,750 | 7,108 | Jun 18, 2013, 06:35 PM |
GUERTIN TIMOTHY E | Director | Jun 10, 2013 | Option Exercise | $37.17 | 25,000 | 929,250 | 68,834 | Jun 11, 2013, 07:31 PM |
GUERTIN TIMOTHY E | Director | Jun 10, 2013 | Sale | $68.80 | 2,000 | 137,608 | 65,332 | Jun 11, 2013, 07:31 PM |
GUERTIN TIMOTHY E | Director | Jun 10, 2013 | Sale | $68.81 | 25,000 | 1,720,150 | 45,707 | Jun 11, 2013, 07:31 PM |
WILSON DOW R | President and CEO | May 20, 2013 | Option Exercise | $69.45 | 2,178 | 151,262 | 44,696 | May 21, 2013, 07:47 PM |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | May 20, 2013 | Option Exercise | $69.45 | 501 | 34,794 | 1,804 | May 21, 2013, 07:44 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | May 20, 2013 | Option Exercise | $69.45 | 835 | 57,991 | 11,130 | May 21, 2013, 07:41 PM |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | May 20, 2013 | Option Exercise | $69.45 | 1,794 | 124,593 | 30,121 | May 21, 2013, 07:38 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | May 20, 2013 | Option Exercise | $69.45 | 717 | 49,796 | 11,910 | May 21, 2013, 07:36 PM |
GUERTIN TIMOTHY E | Director | May 20, 2013 | Option Exercise | $69.45 | 5,798 | 402,671 | 43,834 | May 21, 2013, 07:33 PM |
FINNEY ELISHA W | Exec VP and CFO | May 20, 2013 | Option Exercise | $69.45 | 1,391 | 96,605 | 9,421 | May 21, 2013, 07:25 PM |
FINNEY ELISHA W | Exec VP and CFO | May 21, 2013 | Sale | $69.86 | 2,313 | 161,576 | 7,108 | May 21, 2013, 07:25 PM |
LEVY RICHARD M | Director | May 14, 2013 | Option Exercise | $39.85 | 20,000 | 797,000 | 20,000 | May 15, 2013, 03:26 PM |
LEVY RICHARD M | Director | May 14, 2013 | Sale | $70.00 | 20,000 | 1,400,000 | 0 | May 15, 2013, 03:26 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | May 14, 2013 | Option Exercise | $52.83 | 954 | 50,400 | 11,673 | May 15, 2013, 03:24 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | May 14, 2013 | Sale | $70.09 | 954 | 66,870 | 11,473 | May 15, 2013, 03:24 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | May 14, 2013 | Option Exercise | $52.83 | 1,112 | 58,747 | 10,854 | May 15, 2013, 03:15 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | May 14, 2013 | Sale | $70.00 | 1,112 | 77,840 | 9,742 | May 15, 2013, 03:15 PM |
FINNEY ELISHA W | Exec VP and CFO | May 14, 2013 | Option Exercise | $49.88 | 5,000 | 249,400 | 12,108 | May 15, 2013, 03:13 PM |
FINNEY ELISHA W | Exec VP and CFO | May 14, 2013 | Sale | $69.95 | 5,000 | 349,750 | 7,108 | May 15, 2013, 03:13 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | May 13, 2013 | Option Exercise | $57.90 | 640 | 37,056 | 11,359 | May 14, 2013, 04:59 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | May 13, 2013 | Sale | $69.05 | 640 | 44,190 | 11,059 | May 14, 2013, 04:59 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Apr 15, 2013 | Option Exercise | $52.83 | 954 | 50,400 | 11,673 | Apr 16, 2013, 07:56 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Apr 15, 2013 | Sale | $69.47 | 954 | 66,270 | 10,719 | Apr 16, 2013, 07:56 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Apr 15, 2013 | Option Exercise | $52.83 | 1,111 | 58,694 | 10,479 | Apr 16, 2013, 07:53 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Apr 15, 2013 | Sale | $70.00 | 1,111 | 77,770 | 9,368 | Apr 16, 2013, 07:53 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Apr 11, 2013 | Option Exercise | $57.90 | 606 | 35,087 | 9,974 | Apr 12, 2013, 06:46 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Apr 11, 2013 | Sale | $72.00 | 606 | 43,632 | 9,368 | Apr 12, 2013, 06:46 PM |
LEVY RICHARD M | Director | Apr 01, 2013 | Option Exercise | $39.85 | 20,000 | 797,000 | 20,000 | Apr 02, 2013, 05:29 PM |
LEVY RICHARD M | Director | Apr 01, 2013 | Sale | $71.61 | 20,000 | 1,432,134 | 0 | Apr 02, 2013, 05:29 PM |
FINNEY ELISHA W | Exec VP and CFO | Apr 01, 2013 | Option Exercise | $49.88 | 5,000 | 249,400 | 11,899 | Apr 02, 2013, 05:19 PM |
FINNEY ELISHA W | Exec VP and CFO | Apr 01, 2013 | Sale | $71.60 | 5,000 | 358,024 | 6,899 | Apr 02, 2013, 05:19 PM |
GUERTIN TIMOTHY E | Director | Mar 26, 2013 | Option Exercise | $50.66 | 100,000 | 5,066,000 | 138,520 | Mar 28, 2013, 01:06 PM |
GUERTIN TIMOTHY E | Director | Mar 26, 2013 | Sale | $71.76 | 100,000 | 7,176,070 | 38,520 | Mar 28, 2013, 01:06 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Mar 14, 2013 | Option Exercise | $52.83 | 1,111 | 58,694 | 10,479 | Mar 15, 2013, 07:31 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Mar 14, 2013 | Sale | $73.86 | 1,111 | 82,058 | 9,368 | Mar 15, 2013, 07:31 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Mar 14, 2013 | Option Exercise | $52.83 | 954 | 50,400 | 11,673 | Mar 15, 2013, 07:27 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Mar 14, 2013 | Sale | $73.86 | 954 | 70,460 | 10,719 | Mar 15, 2013, 07:27 PM |
LEVY RICHARD M | Director | Mar 14, 2013 | Option Exercise | $39.85 | 20,000 | 797,000 | 20,000 | Mar 15, 2013, 07:24 PM |
LEVY RICHARD M | Director | Mar 14, 2013 | Sale | $73.86 | 20,000 | 1,477,168 | 0 | Mar 15, 2013, 07:24 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Mar 11, 2013 | Option Exercise | $57.90 | 605 | 35,030 | 9,973 | Mar 12, 2013, 07:20 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Mar 11, 2013 | Sale | $73.43 | 605 | 44,425 | 9,368 | Mar 12, 2013, 07:20 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Mar 11, 2013 | Option Exercise | $57.90 | 641 | 37,114 | 11,360 | Mar 12, 2013, 07:14 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Mar 11, 2013 | Sale | $73.43 | 641 | 47,071 | 10,719 | Mar 12, 2013, 07:14 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Mar 05, 2013 | Option Exercise | $57.90 | 606 | 35,087 | 9,974 | Mar 06, 2013, 08:06 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Mar 05, 2013 | Sale | $72.00 | 606 | 43,632 | 9,368 | Mar 06, 2013, 08:06 PM |
FINNEY ELISHA W | Exec VP and CFO | Mar 01, 2013 | Option Exercise | $49.88 | 5,000 | 249,400 | 11,899 | Mar 04, 2013, 05:43 PM |
FINNEY ELISHA W | Exec VP and CFO | Mar 01, 2013 | Sale | $69.98 | 5,000 | 349,913 | 6,899 | Mar 04, 2013, 05:43 PM |
LARET MARK R | Director | Feb 22, 2013 | Sale | $70.05 | 2,102 | 147,245 | 0 | Feb 25, 2013, 09:30 PM |
THYAGARAJAN VENKATRAMAN | Director | Feb 19, 2013 | Option Exercise | $47.58 | 5,000 | 237,900 | 8,594 | Feb 19, 2013, 09:55 PM |
THYAGARAJAN VENKATRAMAN | Director | Feb 19, 2013 | Sale | $70.73 | 5,000 | 353,658 | 3,594 | Feb 19, 2013, 09:55 PM |
NAUMANN-ETIENNE RUEDIGER | Director | Feb 19, 2013 | Sale | $70.15 | 2,102 | 147,456 | 0 | Feb 19, 2013, 09:53 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Feb 14, 2013 | Option Exercise | $52.83 | 1,111 | 58,694 | 10,479 | Feb 15, 2013, 06:11 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Feb 14, 2013 | Sale | $71.05 | 1,111 | 78,942 | 9,368 | Feb 15, 2013, 06:11 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Feb 14, 2013 | Option Exercise | $52.83 | 953 | 50,347 | 11,672 | Feb 15, 2013, 06:08 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Feb 14, 2013 | Sale | $71.06 | 953 | 67,716 | 10,719 | Feb 15, 2013, 06:08 PM |
THYAGARAJAN VENKATRAMAN | Director | Feb 12, 2013 | Option Exercise | $71.36 | 392 | 27,973 | 3,594 | Feb 13, 2013, 07:16 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Feb 11, 2013 | Option Exercise | $57.90 | 640 | 37,056 | 11,359 | Feb 12, 2013, 04:12 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Feb 11, 2013 | Sale | $70.98 | 640 | 45,425 | 10,719 | Feb 12, 2013, 04:12 PM |
FINNEY ELISHA W | Exec VP and CFO | Feb 01, 2013 | Option Exercise | $49.88 | 5,000 | 249,400 | 11,899 | Feb 04, 2013, 09:55 PM |
FINNEY ELISHA W | Exec VP and CFO | Feb 01, 2013 | Sale | $71.20 | 5,000 | 355,985 | 6,899 | Feb 04, 2013, 09:55 PM |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | Jan 29, 2013 | Sale | $71.80 | 748 | 53,706 | 0 | Jan 30, 2013, 04:44 PM |
NAUMANN-ETIENNE RUEDIGER | Director | Jan 28, 2013 | Option Exercise | $60.32 | 5,000 | 301,600 | 5,000 | Jan 29, 2013, 09:07 PM |
NAUMANN-ETIENNE RUEDIGER | Director | Jan 28, 2013 | Sale | $72.34 | 5,000 | 361,679 | 0 | Jan 29, 2013, 09:07 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jan 11, 2013 | Option Exercise | $57.90 | 605 | 35,030 | 9,973 | Jan 14, 2013, 08:03 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jan 14, 2013 | Option Exercise | $52.83 | 1,111 | 58,694 | 10,479 | Jan 14, 2013, 08:03 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jan 14, 2013 | Sale | $73.79 | 1,111 | 81,981 | 9,368 | Jan 14, 2013, 08:03 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Jan 11, 2013 | Sale | $74.50 | 605 | 45,073 | 9,368 | Jan 14, 2013, 08:03 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Jan 14, 2013 | Option Exercise | $52.83 | 954 | 50,400 | 11,673 | Jan 14, 2013, 07:57 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Jan 11, 2013 | Option Exercise | $57.90 | 641 | 37,114 | 11,360 | Jan 14, 2013, 07:57 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Jan 14, 2013 | Sale | $73.77 | 954 | 70,372 | 10,719 | Jan 14, 2013, 07:57 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Jan 11, 2013 | Sale | $74.50 | 641 | 47,757 | 10,719 | Jan 14, 2013, 07:57 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Jan 07, 2013 | Sale | $74.00 | 1,208 | 89,392 | 10,719 | Jan 08, 2013, 05:39 PM |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | Jan 07, 2013 | Option Exercise | $42.95 | 52,834 | 2,269,210 | 61,545 | Jan 08, 2013, 05:36 PM |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | Jan 07, 2013 | Sale | $74.37 | 52,834 | 3,929,216 | 28,211 | Jan 08, 2013, 05:36 PM |
FINNEY ELISHA W | Exec VP and CFO | Jan 07, 2013 | Option Exercise | $49.88 | 5,000 | 249,400 | 11,899 | Jan 08, 2013, 05:31 PM |
FINNEY ELISHA W | Exec VP and CFO | Jan 07, 2013 | Sale | $74.95 | 5,000 | 374,750 | 6,899 | Jan 08, 2013, 05:31 PM |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | Jan 03, 2013 | Option Exercise | $40.28 | 43,333 | 1,745,588 | 71,544 | Jan 04, 2013, 05:55 PM |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | Jan 03, 2013 | Sale | $73.00 | 43,333 | 3,163,309 | 28,211 | Jan 04, 2013, 05:55 PM |
FINNEY ELISHA W | Exec VP and CFO | Jan 02, 2013 | Option Exercise | $49.88 | 5,000 | 249,400 | 11,899 | Jan 03, 2013, 08:17 PM |
FINNEY ELISHA W | Exec VP and CFO | Jan 02, 2013 | Sale | $71.57 | 5,000 | 357,849 | 6,899 | Jan 03, 2013, 08:17 PM |
GUERTIN TIMOTHY E | Director | Dec 26, 2012 | Option Exercise | $50.66 | 100,000 | 5,066,000 | 138,520 | Dec 26, 2012, 09:12 PM |
GUERTIN TIMOTHY E | Director | Dec 26, 2012 | Sale | $69.85 | 100,000 | 6,985,103 | 65,115 | Dec 26, 2012, 09:12 PM |
FINNEY ELISHA W | Exec VP and CFO | Dec 20, 2012 | Sale | $71.50 | 7,524 | 537,939 | 11,623 | Dec 21, 2012, 02:25 PM |
GUERTIN TIMOTHY E | Director | Dec 20, 2012 | Sale | $71.52 | 16,000 | 1,144,331 | 82,032 | Dec 21, 2012, 02:22 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Dec 14, 2012 | Sale | $71.23 | 1,111 | 79,134 | 9,368 | Dec 17, 2012, 04:47 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Dec 14, 2012 | Sale | $71.32 | 954 | 68,041 | 11,927 | Dec 17, 2012, 04:46 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Dec 11, 2012 | Sale | $72.00 | 7,872 | 566,784 | 9,368 | Dec 12, 2012, 04:50 PM |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | Dec 11, 2012 | Sale | $72.00 | 40,500 | 2,916,000 | 28,211 | Dec 12, 2012, 04:48 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Dec 11, 2012 | Sale | $72.01 | 640 | 46,088 | 11,927 | Dec 12, 2012, 04:47 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Dec 07, 2012 | Sale | $70.00 | 1,111 | 77,770 | 9,368 | Dec 10, 2012, 05:23 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Dec 06, 2012 | Sale | $69.37 | 12,223 | 847,911 | 9,368 | Dec 07, 2012, 12:21 PM |
KUO JOHN W | SVP, Gen Counsel and Secretary | Nov 21, 2012 | Option Exercise | $68.86 | 872 | 60,046 | 9,368 | Nov 26, 2012, 04:48 PM |
WILSON DOW R | President and CEO | Nov 21, 2012 | Option Exercise | $68.86 | 2,522 | 173,665 | 40,702 | Nov 26, 2012, 04:28 PM |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | Nov 21, 2012 | Option Exercise | $68.86 | 432 | 29,748 | 1,453 | Nov 26, 2012, 04:26 PM |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | Nov 21, 2012 | Option Exercise | $68.86 | 1,232 | 84,836 | 28,211 | Nov 26, 2012, 04:20 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Nov 21, 2012 | Option Exercise | $68.86 | 1,090 | 75,057 | 11,927 | Nov 26, 2012, 04:17 PM |
GUERTIN TIMOTHY E | Director | Nov 21, 2012 | Option Exercise | $68.86 | 4,732 | 325,846 | 38,520 | Nov 26, 2012, 04:14 PM |
FINNEY ELISHA W | Exec VP and CFO | Nov 21, 2012 | Option Exercise | $68.86 | 1,577 | 108,592 | 14,423 | Nov 26, 2012, 04:10 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Nov 14, 2012 | Option Exercise | $52.83 | 954 | 50,400 | 11,634 | Nov 15, 2012, 06:52 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Nov 14, 2012 | Sale | $68.04 | 954 | 64,911 | 10,680 | Nov 15, 2012, 06:52 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Nov 12, 2012 | Option Exercise | $57.90 | 7,685 | 444,962 | 18,365 | Nov 13, 2012, 05:17 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Nov 12, 2012 | Sale | $68.51 | 7,685 | 526,464 | 10,680 | Nov 13, 2012, 05:17 PM |
BOSTROM SUSAN L | Director | Nov 05, 2012 | Option Exercise | $57.35 | 13,000 | 745,610 | 18,342 | Nov 06, 2012, 03:41 PM |
BOSTROM SUSAN L | Director | Nov 05, 2012 | Sale | $70.33 | 15,691 | 1,103,548 | 2,651 | Nov 06, 2012, 03:41 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Nov 05, 2012 | Sale | $71.00 | 1,153 | 81,863 | 10,680 | Nov 06, 2012, 03:38 PM |
WILSON DOW R | President and CEO | Nov 02, 2012 | Option Exercise | $49.88 | 26,000 | 1,296,880 | 63,821 | Nov 06, 2012, 03:36 PM |
WILSON DOW R | President and CEO | Nov 02, 2012 | Sale | $70.00 | 26,000 | 1,820,000 | 37,821 | Nov 06, 2012, 03:36 PM |
FINNEY ELISHA W | Exec VP and CFO | Nov 02, 2012 | Sale | $69.95 | 8,000 | 559,600 | 14,435 | Nov 06, 2012, 03:33 PM |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | Nov 01, 2012 | Sale | $68.65 | 1,992 | 136,756 | 0 | Nov 02, 2012, 03:58 PM |
LARET MARK R | Director | Nov 01, 2012 | Option Exercise | $49.74 | 16,000 | 795,840 | 16,000 | Nov 02, 2012, 03:55 PM |
LARET MARK R | Director | Nov 01, 2012 | Sale | $67.04 | 16,000 | 1,072,573 | 0 | Nov 02, 2012, 03:55 PM |
WILSON DOW R | President and CEO | Nov 01, 2012 | Option Exercise | $39.05 | 10,000 | 390,523 | 47,821 | Nov 02, 2012, 03:45 PM |
WILSON DOW R | President and CEO | Nov 01, 2012 | Sale | $67.02 | 10,000 | 670,170 | 37,821 | Nov 02, 2012, 03:45 PM |
NAUMANN-ETIENNE RUEDIGER | Director | Oct 31, 2012 | Option Exercise | $52.61 | 5,000 | 263,050 | 6,000 | Nov 02, 2012, 03:39 PM |
NAUMANN-ETIENNE RUEDIGER | Director | Oct 31, 2012 | Sale | $67.35 | 6,000 | 404,105 | 1,000 | Nov 02, 2012, 03:39 PM |
ECKERT R ANDREW | Director | Oct 31, 2012 | Sale | $66.72 | 2,691 | 179,553 | 6,146 | Nov 02, 2012, 03:34 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Nov 01, 2012 | Option Exercise | $52.83 | 27,657 | 1,461,119 | 39,490 | Nov 02, 2012, 03:27 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Oct 31, 2012 | Option Exercise | $43.17 | 9,009 | 388,920 | 21,602 | Nov 02, 2012, 03:27 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Nov 01, 2012 | Sale | $67.02 | 27,657 | 1,853,489 | 11,833 | Nov 02, 2012, 03:27 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Oct 31, 2012 | Sale | $66.70 | 9,769 | 651,618 | 11,833 | Nov 02, 2012, 03:27 PM |
FINNEY ELISHA W | Exec VP and CFO | Nov 01, 2012 | Option Exercise | $37.17 | 8,000 | 297,360 | 31,435 | Nov 02, 2012, 03:18 PM |
FINNEY ELISHA W | Exec VP and CFO | Oct 31, 2012 | Option Exercise | $37.17 | 22,667 | 842,532 | 55,795 | Nov 02, 2012, 03:18 PM |
FINNEY ELISHA W | Exec VP and CFO | Oct 31, 2012 | Sale | $66.70 | 32,360 | 2,158,496 | 23,435 | Nov 02, 2012, 03:18 PM |
FINNEY ELISHA W | Exec VP and CFO | Nov 01, 2012 | Sale | $68.35 | 9,000 | 615,120 | 30,335 | Nov 02, 2012, 03:18 PM |
GUERTIN TIMOTHY E | Director | Oct 31, 2012 | Option Exercise | $50.66 | 100,000 | 5,066,000 | 133,114 | Nov 02, 2012, 03:12 PM |
GUERTIN TIMOTHY E | Director | Oct 31, 2012 | Sale | $66.71 | 100,000 | 6,670,630 | 33,114 | Nov 02, 2012, 03:12 PM |
FINNEY ELISHA W | Exec VP and CFO | Oct 01, 2012 | Option Exercise | $37.17 | 4,000 | 148,680 | 36,921 | Oct 02, 2012, 06:50 PM |
FINNEY ELISHA W | Exec VP and CFO | Oct 01, 2012 | Sale | $60.81 | 4,000 | 243,242 | 32,921 | Oct 02, 2012, 06:50 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Sep 04, 2012 | Option Exercise | $37.17 | 1,900 | 70,623 | 14,493 | Sep 05, 2012, 06:03 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Sep 04, 2012 | Sale | $64.00 | 1,900 | 121,600 | 12,593 | Sep 05, 2012, 06:03 PM |
FINNEY ELISHA W | Exec VP and CFO | Sep 04, 2012 | Option Exercise | $38.51 | 4,000 | 154,040 | 36,921 | Sep 05, 2012, 05:59 PM |
FINNEY ELISHA W | Exec VP and CFO | Sep 04, 2012 | Sale | $60.82 | 4,000 | 243,280 | 32,921 | Sep 05, 2012, 05:59 PM |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | Aug 23, 2012 | Sale | $58.92 | 1,719 | 101,285 | 1,992 | Aug 27, 2012, 01:57 PM |
BROWN JOHN SEELY | Director | Aug 21, 2012 | Option Exercise | $42.23 | 41,866 | 1,768,047 | 53,458 | Aug 22, 2012, 05:02 PM |
BROWN JOHN SEELY | Director | Aug 21, 2012 | Sale | $59.99 | 41,866 | 2,511,377 | 23,820 | Aug 22, 2012, 05:02 PM |
FINNEY ELISHA W | Exec VP and CFO | Aug 20, 2012 | Option Exercise | $39.85 | 4,000 | 159,400 | 36,921 | Aug 22, 2012, 04:21 PM |
FINNEY ELISHA W | Exec VP and CFO | Aug 20, 2012 | Sale | $59.95 | 4,000 | 239,800 | 32,921 | Aug 22, 2012, 04:21 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | Aug 10, 2012 | Option Exercise | $56.85 | 1,760 | 100,056 | 8,000 | Aug 10, 2012, 08:59 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Aug 10, 2012 | Option Exercise | $56.85 | 1,186 | 67,424 | 26,064 | Aug 10, 2012, 08:54 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Aug 10, 2012 | Option Exercise | $56.85 | 1,173 | 66,685 | 12,593 | Aug 10, 2012, 08:52 PM |
FINNEY ELISHA W | Exec VP and CFO | Aug 10, 2012 | Option Exercise | $56.85 | 4,107 | 233,483 | 32,921 | Aug 10, 2012, 08:50 PM |
CHEN TAI-YUN | SVP and Corporate Controller | Aug 10, 2012 | Option Exercise | $56.85 | 1,555 | 88,402 | 4,037 | Aug 10, 2012, 08:47 PM |
FINNEY ELISHA W | Exec VP and CFO | Jul 02, 2012 | Option Exercise | $39.85 | 4,000 | 159,400 | 41,028 | Jul 03, 2012, 06:16 PM |
FINNEY ELISHA W | Exec VP and CFO | Jul 02, 2012 | Sale | $60.06 | 4,000 | 240,252 | 37,028 | Jul 03, 2012, 06:16 PM |
FINNEY ELISHA W | Exec VP and CFO | Jun 07, 2012 | Option Exercise | $39.85 | 4,000 | 159,400 | 41,028 | Jun 08, 2012, 06:29 PM |
FINNEY ELISHA W | Exec VP and CFO | Jun 07, 2012 | Sale | $60.00 | 4,000 | 240,000 | 37,028 | Jun 08, 2012, 06:29 PM |
WILSON DOW R | EVP and COO | May 18, 2012 | Option Exercise | $61.29 | 2,125 | 130,241 | 37,820 | May 21, 2012, 08:28 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | May 18, 2012 | Option Exercise | $61.29 | 815 | 49,951 | 9,760 | May 21, 2012, 08:26 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | May 18, 2012 | Option Exercise | $61.29 | 1,220 | 74,774 | 27,250 | May 21, 2012, 08:24 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | May 18, 2012 | Option Exercise | $61.29 | 699 | 42,842 | 13,766 | May 21, 2012, 08:22 PM |
GUERTIN TIMOTHY E | President and CEO | May 18, 2012 | Option Exercise | $61.29 | 5,186 | 317,850 | 33,025 | May 21, 2012, 08:19 PM |
FINNEY ELISHA W | Exec VP and CFO | May 18, 2012 | Option Exercise | $61.29 | 1,729 | 105,970 | 37,028 | May 21, 2012, 08:16 PM |
CHEN TAI-YUN | SVP and Corporate Controller | May 18, 2012 | Option Exercise | $61.29 | 543 | 33,280 | 5,592 | May 21, 2012, 08:13 PM |
FINNEY ELISHA W | Exec VP and CFO | May 02, 2012 | Option Exercise | $37.17 | 5,000 | 185,850 | 41,053 | May 03, 2012, 08:09 PM |
FINNEY ELISHA W | Exec VP and CFO | May 02, 2012 | Sale | $64.95 | 6,000 | 389,700 | 35,053 | May 03, 2012, 08:09 PM |
FINNEY ELISHA W | Exec VP and CFO | May 01, 2012 | Option Exercise | $39.85 | 4,000 | 159,400 | 40,053 | May 02, 2012, 03:39 PM |
FINNEY ELISHA W | Exec VP and CFO | May 01, 2012 | Sale | $64.32 | 4,000 | 257,292 | 39,053 | May 02, 2012, 03:39 PM |
FINNEY ELISHA W | Exec VP and CFO | Apr 02, 2012 | Option Exercise | $38.36 | 9,000 | 345,250 | 45,832 | Apr 03, 2012, 07:06 PM |
FINNEY ELISHA W | Exec VP and CFO | Apr 02, 2012 | Sale | $69.08 | 10,000 | 690,837 | 35,832 | Apr 03, 2012, 07:06 PM |
GUERTIN TIMOTHY E | President and CEO | Mar 26, 2012 | Option Exercise | $49.88 | 50,000 | 2,494,000 | 77,006 | Mar 27, 2012, 04:28 PM |
GUERTIN TIMOTHY E | President and CEO | Mar 26, 2012 | Sale | $69.43 | 50,000 | 3,471,405 | 27,006 | Mar 27, 2012, 04:28 PM |
WILSON DOW R | EVP and COO | Mar 26, 2012 | Option Exercise | $37.17 | 10,000 | 371,700 | 43,724 | Mar 27, 2012, 04:26 PM |
WILSON DOW R | EVP and COO | Mar 26, 2012 | Sale | $69.42 | 10,000 | 694,229 | 33,724 | Mar 27, 2012, 04:26 PM |
FINNEY ELISHA W | Exec VP and CFO | Mar 14, 2012 | Sale | $69.95 | 2,000 | 139,900 | 36,832 | Mar 14, 2012, 07:15 PM |
FINNEY ELISHA W | Exec VP and CFO | Mar 01, 2012 | Option Exercise | $38.36 | 9,000 | 345,250 | 48,832 | Mar 02, 2012, 04:29 PM |
FINNEY ELISHA W | Exec VP and CFO | Mar 01, 2012 | Sale | $65.59 | 10,000 | 655,857 | 38,832 | Mar 02, 2012, 04:29 PM |
LARET MARK R | Director | Feb 21, 2012 | Sale | $66.12 | 2,691 | 177,917 | 0 | Feb 22, 2012, 07:23 PM |
WILSON DOW R | EVP and COO | Feb 15, 2012 | Option Exercise | $66.13 | 1,698 | 112,289 | 33,724 | Feb 16, 2012, 07:00 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | Feb 15, 2012 | Option Exercise | $66.13 | 815 | 53,896 | 7,959 | Feb 16, 2012, 06:58 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Feb 15, 2012 | Option Exercise | $66.13 | 1,236 | 81,737 | 24,766 | Feb 16, 2012, 06:56 PM |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | Feb 15, 2012 | Option Exercise | $66.13 | 699 | 46,225 | 12,557 | Feb 16, 2012, 06:54 PM |
GUERTIN TIMOTHY E | President and CEO | Feb 15, 2012 | Option Exercise | $66.13 | 4,075 | 269,480 | 27,006 | Feb 16, 2012, 06:51 PM |
FINNEY ELISHA W | Exec VP and CFO | Feb 15, 2012 | Option Exercise | $66.13 | 1,358 | 89,805 | 39,832 | Feb 16, 2012, 06:47 PM |
CHEN TAI-YUN | VP and Corporate Controller | Feb 15, 2012 | Option Exercise | $66.13 | 543 | 35,909 | 4,339 | Feb 16, 2012, 06:45 PM |
NAUMANN-ETIENNE RUEDIGER | Director | Feb 14, 2012 | Sale | $65.61 | 2,691 | 176,569 | 1,000 | Feb 14, 2012, 03:03 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | Feb 13, 2012 | Option Exercise | $37.17 | 1,112 | 41,333 | 9,886 | Feb 14, 2012, 01:58 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | Feb 13, 2012 | Sale | $65.40 | 1,112 | 72,727 | 8,774 | Feb 14, 2012, 01:58 PM |
THYAGARAJAN VENKATRAMAN | Director | Feb 13, 2012 | Option Exercise | $65.12 | 807 | 52,552 | 1,884 | Feb 13, 2012, 09:27 PM |
ECKERT R ANDREW | Director | Feb 03, 2012 | Option Exercise | $47.58 | 5,000 | 237,900 | 12,936 | Feb 06, 2012, 07:56 PM |
ECKERT R ANDREW | Director | Feb 03, 2012 | Sale | $67.82 | 6,790 | 460,494 | 6,146 | Feb 06, 2012, 07:56 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Feb 01, 2012 | Option Exercise | $38.36 | 9,000 | 345,250 | 51,190 | Feb 02, 2012, 04:55 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Feb 01, 2012 | Sale | $66.42 | 10,000 | 664,183 | 41,190 | Feb 02, 2012, 04:55 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | Jan 13, 2012 | Option Exercise | $37.17 | 1,111 | 41,296 | 9,885 | Jan 13, 2012, 05:53 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | Jan 13, 2012 | Sale | $70.36 | 1,111 | 78,168 | 8,774 | Jan 13, 2012, 05:53 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Jan 12, 2012 | Sale | $69.95 | 2,000 | 139,900 | 42,190 | Jan 13, 2012, 05:48 PM |
CHEN TAI-YUN | VP and Corporate Controller | Jan 12, 2012 | Option Exercise | $52.83 | 13,333 | 704,382 | 22,959 | Jan 13, 2012, 05:41 PM |
CHEN TAI-YUN | VP and Corporate Controller | Jan 12, 2012 | Sale | $71.00 | 18,077 | 1,283,467 | 9,626 | Jan 13, 2012, 05:41 PM |
CHEN TAI-YUN | VP and Corporate Controller | Jan 03, 2012 | Option Exercise | $54.15 | 37,450 | 2,028,070 | 47,076 | Jan 04, 2012, 05:51 PM |
CHEN TAI-YUN | VP and Corporate Controller | Jan 03, 2012 | Sale | $68.80 | 37,450 | 2,576,525 | 32,076 | Jan 04, 2012, 05:51 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | Jan 03, 2012 | Option Exercise | $52.83 | 6,666 | 352,165 | 15,440 | Jan 04, 2012, 05:46 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | Jan 03, 2012 | Sale | $68.00 | 6,666 | 453,288 | 8,774 | Jan 04, 2012, 05:46 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Jan 03, 2012 | Option Exercise | $38.36 | 9,000 | 345,250 | 54,190 | Jan 04, 2012, 05:43 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Jan 03, 2012 | Sale | $69.30 | 10,000 | 693,046 | 53,184 | Jan 04, 2012, 05:43 PM |
CHEN TAI-YUN | VP and Corporate Controller | Dec 30, 2011 | Option Exercise | $37.17 | 14,074 | 523,131 | 23,700 | Jan 03, 2012, 06:41 PM |
CHEN TAI-YUN | VP and Corporate Controller | Dec 30, 2011 | Sale | $67.17 | 14,074 | 945,351 | 9,626 | Jan 03, 2012, 06:41 PM |
GUERTIN TIMOTHY E | President and CEO | Dec 30, 2011 | Option Exercise | $49.88 | 100,000 | 4,988,000 | 131,081 | Jan 03, 2012, 06:37 PM |
GUERTIN TIMOTHY E | President and CEO | Dec 30, 2011 | Sale | $67.00 | 100,000 | 6,700,000 | 31,081 | Jan 03, 2012, 06:37 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | Dec 27, 2011 | Option Exercise | $52.61 | 11,249 | 591,810 | 20,023 | Dec 28, 2011, 03:32 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | Dec 27, 2011 | Sale | $66.50 | 11,249 | 748,059 | 8,774 | Dec 28, 2011, 03:32 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | Dec 22, 2011 | Option Exercise | $49.86 | 57,778 | 2,880,608 | 66,552 | Dec 23, 2011, 04:32 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | Dec 22, 2011 | Sale | $65.56 | 57,778 | 3,788,064 | 18,774 | Dec 23, 2011, 04:32 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Dec 20, 2011 | Option Exercise | $37.17 | 5,000 | 185,850 | 51,190 | Dec 21, 2011, 05:41 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Dec 20, 2011 | Sale | $64.95 | 6,000 | 389,700 | 46,190 | Dec 21, 2011, 05:41 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Dec 14, 2011 | Option Exercise | $39.85 | 4,000 | 159,400 | 50,190 | Dec 15, 2011, 07:28 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Dec 14, 2011 | Sale | $63.38 | 4,000 | 253,526 | 46,190 | Dec 15, 2011, 07:28 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Dec 13, 2011 | Sale | $65.00 | 15,483 | 1,006,395 | 26,002 | Dec 14, 2011, 07:44 PM |
NAUMANN-ETIENNE RUEDIGER | Director | Nov 15, 2011 | Sale | $60.75 | 1,901 | 115,490 | 1,000 | Nov 16, 2011, 08:29 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Nov 07, 2011 | Option Exercise | $39.85 | 5,000 | 199,250 | 42,995 | Nov 08, 2011, 08:19 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Nov 07, 2011 | Sale | $58.00 | 5,000 | 290,000 | 37,995 | Nov 08, 2011, 08:19 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Nov 04, 2011 | Option Exercise | $39.85 | 10,000 | 398,500 | 47,995 | Nov 08, 2011, 08:11 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Nov 04, 2011 | Sale | $58.00 | 10,000 | 580,000 | 37,995 | Nov 07, 2011, 06:39 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | Aug 10, 2011 | Option Exercise | $51.68 | 753 | 38,915 | 8,420 | Aug 11, 2011, 07:04 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Aug 10, 2011 | Option Exercise | $51.68 | 579 | 29,923 | 41,485 | Aug 11, 2011, 07:01 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Aug 10, 2011 | Option Exercise | $51.68 | 1,540 | 79,587 | 37,785 | Aug 11, 2011, 06:39 PM |
CHEN TAI-YUN | VP and Corporate Controller | Aug 10, 2011 | Option Exercise | $51.68 | 467 | 24,135 | 9,328 | Aug 11, 2011, 06:34 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Aug 05, 2011 | Option Exercise | $39.85 | 5,000 | 199,250 | 44,325 | Aug 08, 2011, 03:39 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Aug 05, 2011 | Sale | $58.00 | 5,000 | 290,000 | 39,325 | Aug 08, 2011, 03:39 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Jul 05, 2011 | Option Exercise | $39.85 | 10,000 | 398,500 | 49,325 | Jul 06, 2011, 07:46 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Jul 05, 2011 | Sale | $70.61 | 10,000 | 706,085 | 39,325 | Jul 06, 2011, 07:46 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | Jul 01, 2011 | Option Exercise | $48.40 | 23,750 | 1,149,498 | 40,123 | Jul 05, 2011, 04:52 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | Jul 01, 2011 | Sale | $70.57 | 30,950 | 2,184,003 | 15,188 | Jul 05, 2011, 04:52 PM |
GUERTIN TIMOTHY E | President and CEO | Jun 27, 2011 | Option Exercise | $49.88 | 50,000 | 2,494,000 | 80,991 | Jun 28, 2011, 04:43 PM |
GUERTIN TIMOTHY E | President and CEO | Jun 27, 2011 | Sale | $68.32 | 50,000 | 3,415,889 | 59,500 | Jun 28, 2011, 04:43 PM |
WILSON DOW R | EVP and Pres. Oncology Sys. | Jun 13, 2011 | Option Exercise | $37.17 | 2,315 | 86,049 | 37,548 | Jun 14, 2011, 06:59 PM |
WILSON DOW R | EVP and Pres. Oncology Sys. | Jun 13, 2011 | Sale | $66.16 | 2,315 | 153,153 | 35,233 | Jun 14, 2011, 06:59 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Jun 06, 2011 | Option Exercise | $39.85 | 10,000 | 398,500 | 49,325 | Jun 07, 2011, 04:45 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Jun 06, 2011 | Sale | $65.42 | 10,000 | 654,174 | 39,325 | Jun 07, 2011, 04:45 PM |
WILSON DOW R | EVP and Pres. Oncology Sys. | May 18, 2011 | Option Exercise | $68.71 | 2,608 | 179,196 | 38,421 | May 19, 2011, 07:39 PM |
WILSON DOW R | EVP and Pres. Oncology Sys. | May 19, 2011 | Sale | $68.78 | 3,188 | 219,265 | 35,233 | May 19, 2011, 07:39 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | May 18, 2011 | Option Exercise | $68.71 | 815 | 55,999 | 16,373 | May 19, 2011, 06:06 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | May 18, 2011 | Option Exercise | $68.71 | 1,590 | 109,249 | 42,064 | May 19, 2011, 06:02 PM |
GUERTIN TIMOTHY E | President and CEO | May 18, 2011 | Option Exercise | $68.71 | 5,186 | 356,330 | 30,991 | May 19, 2011, 05:59 PM |
FINNEY ELISHA W | SVP, Finance and CFO | May 18, 2011 | Option Exercise | $68.71 | 1,729 | 118,800 | 39,325 | May 19, 2011, 05:53 PM |
CHEN TAI-YUN | VP and Corporate Controller | May 18, 2011 | Option Exercise | $68.71 | 543 | 37,310 | 9,795 | May 19, 2011, 05:48 PM |
WILSON DOW R | EVP and Pres. Oncology Sys. | May 13, 2011 | Option Exercise | $37.17 | 2,315 | 86,049 | 37,548 | May 16, 2011, 07:02 PM |
WILSON DOW R | EVP and Pres. Oncology Sys. | May 13, 2011 | Sale | $69.36 | 2,315 | 160,560 | 35,833 | May 16, 2011, 07:02 PM |
ECKERT R ANDREW | Director | May 06, 2011 | Option Exercise | $49.74 | 8,000 | 397,920 | 15,936 | May 06, 2011, 06:33 PM |
ECKERT R ANDREW | Director | May 06, 2011 | Sale | $70.46 | 8,000 | 563,668 | 7,936 | May 06, 2011, 06:33 PM |
LARET MARK R | Director | May 05, 2011 | Sale | $69.96 | 1,901 | 132,990 | 397 | May 06, 2011, 06:28 PM |
FINNEY ELISHA W | SVP, Finance and CFO | May 05, 2011 | Option Exercise | $39.85 | 10,000 | 398,500 | 47,150 | May 06, 2011, 06:23 PM |
FINNEY ELISHA W | SVP, Finance and CFO | May 05, 2011 | Sale | $69.63 | 10,000 | 696,270 | 37,150 | May 06, 2011, 06:23 PM |
GUERTIN TIMOTHY E | President and CEO | May 02, 2011 | Option Exercise | $39.85 | 40,000 | 1,594,000 | 65,066 | May 03, 2011, 07:44 PM |
GUERTIN TIMOTHY E | President and CEO | May 02, 2011 | Sale | $70.44 | 40,000 | 2,817,724 | 25,066 | May 03, 2011, 07:44 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Apr 20, 2011 | Option Exercise | $52.61 | 30,000 | 1,578,300 | 69,950 | Apr 21, 2011, 04:41 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Apr 20, 2011 | Sale | $70.00 | 30,000 | 2,100,000 | 39,950 | Apr 21, 2011, 04:41 PM |
WILSON DOW R | EVP and Pres. Oncology Sys. | Apr 13, 2011 | Option Exercise | $37.17 | 2,315 | 86,049 | 36,964 | Apr 14, 2011, 01:14 PM |
WILSON DOW R | EVP and Pres. Oncology Sys. | Apr 13, 2011 | Sale | $69.17 | 2,315 | 160,139 | 34,649 | Apr 14, 2011, 01:14 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Apr 05, 2011 | Option Exercise | $33.65 | 10,000 | 336,460 | 47,150 | Apr 06, 2011, 05:10 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Apr 05, 2011 | Sale | $68.92 | 10,000 | 689,155 | 37,150 | Apr 06, 2011, 05:10 PM |
LEVY RICHARD M | Director | Mar 21, 2011 | Option Exercise | $32.10 | 15,000 | 481,425 | 15,000 | Mar 22, 2011, 08:46 PM |
LEVY RICHARD M | Director | Mar 21, 2011 | Sale | $66.00 | 15,000 | 990,000 | 0 | Mar 22, 2011, 08:46 PM |
WILSON DOW R | EVP and Pres. Oncology Sys. | Mar 14, 2011 | Option Exercise | $37.17 | 2,315 | 86,049 | 36,964 | Mar 15, 2011, 04:44 PM |
WILSON DOW R | EVP and Pres. Oncology Sys. | Mar 14, 2011 | Sale | $66.31 | 2,315 | 153,506 | 34,649 | Mar 15, 2011, 04:44 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Mar 07, 2011 | Option Exercise | $32.10 | 10,000 | 320,950 | 47,150 | Mar 08, 2011, 04:50 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Mar 07, 2011 | Sale | $69.90 | 10,000 | 699,022 | 40,028 | Mar 08, 2011, 04:50 PM |
LEVY RICHARD M | Director | Mar 07, 2011 | Option Exercise | $32.10 | 15,000 | 481,425 | 15,000 | Mar 08, 2011, 04:45 PM |
LEVY RICHARD M | Director | Mar 07, 2011 | Sale | $69.90 | 15,000 | 1,048,531 | 3,000 | Mar 08, 2011, 04:45 PM |
LEVY RICHARD M | Director | Feb 22, 2011 | Option Exercise | $32.10 | 15,000 | 481,425 | 15,000 | Feb 23, 2011, 02:15 PM |
LEVY RICHARD M | Director | Feb 22, 2011 | Sale | $68.75 | 15,000 | 1,031,274 | 14,700 | Feb 23, 2011, 02:15 PM |
WILSON DOW R | EVP and Pres. Oncology Sys. | Feb 16, 2011 | Sale | $70.83 | 5,044 | 357,259 | 34,649 | Feb 17, 2011, 07:09 PM |
NAUMANN-ETIENNE RUEDIGER | Director | Feb 16, 2011 | Option Exercise | $48.91 | 13,000 | 635,820 | 15,901 | Feb 16, 2011, 08:42 PM |
NAUMANN-ETIENNE RUEDIGER | Director | Feb 16, 2011 | Sale | $70.68 | 13,000 | 918,853 | 3,701 | Feb 16, 2011, 08:42 PM |
CHEN TAI-YUN | VP and Corporate Controller | Feb 15, 2011 | Option Exercise | $70.75 | 991 | 70,113 | 8,573 | Feb 16, 2011, 06:17 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | Feb 15, 2011 | Option Exercise | $70.75 | 1,451 | 102,658 | 14,616 | Feb 16, 2011, 06:15 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Feb 15, 2011 | Option Exercise | $70.75 | 2,592 | 183,384 | 37,150 | Feb 16, 2011, 06:14 PM |
GUERTIN TIMOTHY E | President and CEO | Feb 15, 2011 | Option Exercise | $70.75 | 9,076 | 642,127 | 24,981 | Feb 16, 2011, 06:12 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Feb 15, 2011 | Option Exercise | $70.75 | 4,668 | 330,261 | 39,950 | Feb 16, 2011, 06:11 PM |
WILSON DOW R | EVP and Pres. Oncology Sys. | Feb 15, 2011 | Option Exercise | $70.75 | 2,920 | 206,590 | 39,693 | Feb 16, 2011, 06:08 PM |
WILSON DOW R | EVP and Pres. Oncology Sys. | Feb 14, 2011 | Option Exercise | $37.17 | 2,314 | 86,011 | 44,927 | Feb 15, 2011, 03:01 PM |
WILSON DOW R | EVP and Pres. Oncology Sys. | Feb 14, 2011 | Sale | $70.56 | 2,314 | 163,282 | 44,427 | Feb 15, 2011, 03:01 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Feb 08, 2011 | Option Exercise | $50.66 | 20,000 | 1,013,200 | 64,618 | Feb 08, 2011, 08:01 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Feb 07, 2011 | Option Exercise | $50.51 | 49,875 | 2,518,965 | 94,493 | Feb 08, 2011, 08:01 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Feb 07, 2011 | Sale | $67.70 | 49,875 | 3,376,682 | 44,618 | Feb 08, 2011, 08:01 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Feb 08, 2011 | Sale | $68.00 | 20,000 | 1,360,000 | 44,618 | Feb 08, 2011, 08:01 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Feb 07, 2011 | Option Exercise | $32.10 | 10,000 | 320,950 | 49,742 | Feb 08, 2011, 07:55 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Feb 07, 2011 | Sale | $67.70 | 10,000 | 677,047 | 39,742 | Feb 08, 2011, 07:55 PM |
LEVY RICHARD M | Director | Feb 07, 2011 | Option Exercise | $32.10 | 15,000 | 481,425 | 15,000 | Feb 08, 2011, 07:51 PM |
LEVY RICHARD M | Director | Feb 07, 2011 | Sale | $67.71 | 15,000 | 1,015,586 | 0 | Feb 08, 2011, 07:51 PM |
GUERTIN TIMOTHY E | President and CEO | Jan 31, 2011 | Option Exercise | $39.85 | 45,000 | 1,793,250 | 79,057 | Feb 01, 2011, 07:17 PM |
GUERTIN TIMOTHY E | President and CEO | Jan 31, 2011 | Sale | $68.40 | 45,000 | 3,077,862 | 61,376 | Feb 01, 2011, 07:17 PM |
LEVY RICHARD M | Director | Jan 31, 2011 | Option Exercise | $32.10 | 15,000 | 481,425 | 15,000 | Feb 01, 2011, 07:14 PM |
LEVY RICHARD M | Director | Jan 31, 2011 | Sale | $68.40 | 15,000 | 1,025,931 | 10,000 | Feb 01, 2011, 07:14 PM |
WILSON DOW R | EVP and Pres. Oncology Sys. | Jan 13, 2011 | Option Exercise | $37.17 | 2,315 | 86,049 | 44,928 | Jan 14, 2011, 04:08 PM |
WILSON DOW R | EVP and Pres. Oncology Sys. | Jan 13, 2011 | Sale | $69.81 | 2,315 | 161,618 | 42,613 | Jan 14, 2011, 04:08 PM |
LEVY RICHARD M | Director | Jan 10, 2011 | Option Exercise | $32.10 | 15,000 | 481,425 | 15,000 | Jan 11, 2011, 02:38 PM |
LEVY RICHARD M | Director | Jan 10, 2011 | Sale | $68.27 | 15,000 | 1,024,082 | 11,400 | Jan 11, 2011, 02:38 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Jan 05, 2011 | Option Exercise | $32.10 | 10,000 | 320,950 | 49,742 | Jan 06, 2011, 04:54 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Jan 05, 2011 | Sale | $69.52 | 10,000 | 695,213 | 39,742 | Jan 06, 2011, 04:54 PM |
LEVY RICHARD M | Director | Dec 27, 2010 | Option Exercise | $32.10 | 15,000 | 481,425 | 15,000 | Dec 28, 2010, 05:21 PM |
LEVY RICHARD M | Director | Dec 27, 2010 | Sale | $70.59 | 15,000 | 1,058,877 | 0 | Dec 28, 2010, 05:21 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | Dec 28, 2010 | Option Exercise | $50.66 | 17,318 | 877,330 | 33,385 | Dec 28, 2010, 05:18 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | Dec 27, 2010 | Option Exercise | $48.10 | 56,015 | 2,694,108 | 72,082 | Dec 28, 2010, 05:18 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | Dec 28, 2010 | Sale | $70.66 | 17,318 | 1,223,690 | 16,067 | Dec 28, 2010, 05:18 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | Dec 27, 2010 | Sale | $70.60 | 56,015 | 3,954,772 | 23,749 | Dec 28, 2010, 05:18 PM |
CHEN TAI-YUN | VP and Corporate Controller | Dec 16, 2010 | Option Exercise | $60.32 | 7,500 | 452,400 | 17,064 | Dec 17, 2010, 05:30 PM |
CHEN TAI-YUN | VP and Corporate Controller | Dec 16, 2010 | Sale | $69.32 | 7,500 | 519,900 | 9,564 | Dec 17, 2010, 05:30 PM |
WILSON DOW R | EVP and Pres. Oncology Sys. | Dec 13, 2010 | Option Exercise | $37.17 | 20,926 | 777,819 | 63,539 | Dec 14, 2010, 07:19 PM |
WILSON DOW R | EVP and Pres. Oncology Sys. | Dec 13, 2010 | Sale | $67.83 | 20,926 | 1,419,486 | 42,613 | Dec 14, 2010, 07:19 PM |
LEVY RICHARD M | Director | Dec 13, 2010 | Option Exercise | $32.10 | 15,000 | 481,425 | 15,000 | Dec 14, 2010, 07:13 PM |
LEVY RICHARD M | Director | Dec 13, 2010 | Sale | $67.83 | 15,000 | 1,017,461 | 0 | Dec 14, 2010, 07:13 PM |
WILSON DOW R | EVP and Pres. Oncology Sys. | Dec 06, 2010 | Option Exercise | $40.57 | 28,073 | 1,138,922 | 70,686 | Dec 07, 2010, 06:50 PM |
WILSON DOW R | EVP and Pres. Oncology Sys. | Dec 06, 2010 | Sale | $69.05 | 28,073 | 1,938,314 | 42,613 | Dec 07, 2010, 06:50 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | Dec 06, 2010 | Sale | $69.05 | 10,061 | 694,696 | 16,067 | Dec 07, 2010, 06:46 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Dec 06, 2010 | Option Exercise | $32.10 | 10,000 | 320,950 | 49,742 | Dec 07, 2010, 06:41 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Dec 06, 2010 | Sale | $69.05 | 10,000 | 690,520 | 39,742 | Dec 07, 2010, 06:41 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Dec 02, 2010 | Option Exercise | $49.88 | 20,000 | 997,600 | 64,618 | Dec 03, 2010, 06:22 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Dec 02, 2010 | Sale | $68.00 | 20,000 | 1,360,000 | 44,618 | Dec 03, 2010, 06:22 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Nov 30, 2010 | Option Exercise | $49.88 | 20,000 | 997,600 | 64,618 | Dec 01, 2010, 05:11 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Nov 30, 2010 | Sale | $66.00 | 20,000 | 1,320,000 | 44,618 | Dec 01, 2010, 05:11 PM |
LEVY RICHARD M | Director | Nov 29, 2010 | Option Exercise | $32.10 | 15,000 | 481,425 | 15,000 | Nov 30, 2010, 03:25 PM |
LEVY RICHARD M | Director | Nov 29, 2010 | Sale | $65.41 | 15,000 | 981,156 | 0 | Nov 30, 2010, 03:25 PM |
BROWN JOHN SEELY | Director | Nov 23, 2010 | Option Exercise | $41.56 | 23,370 | 971,257 | 30,370 | Nov 23, 2010, 07:50 PM |
BROWN JOHN SEELY | Director | Nov 23, 2010 | Sale | $64.27 | 23,370 | 1,502,053 | 7,000 | Nov 23, 2010, 07:50 PM |
LARET MARK R | Director | Nov 23, 2010 | Sale | $64.31 | 2,500 | 160,773 | 0 | Nov 23, 2010, 07:33 PM |
ECKERT R ANDREW | Director | Nov 19, 2010 | Option Exercise | $37.17 | 5,000 | 185,850 | 12,000 | Nov 22, 2010, 07:24 PM |
ECKERT R ANDREW | Director | Nov 19, 2010 | Sale | $64.95 | 5,000 | 324,737 | 7,000 | Nov 22, 2010, 07:24 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Nov 19, 2010 | Option Exercise | $49.88 | 7,738 | 385,971 | 52,356 | Nov 22, 2010, 02:57 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Nov 19, 2010 | Sale | $65.00 | 7,738 | 502,970 | 44,618 | Nov 22, 2010, 02:57 PM |
THYAGARAJAN VENKATRAMAN | Director | Nov 18, 2010 | Option Exercise | $37.17 | 5,000 | 185,850 | 5,000 | Nov 19, 2010, 02:35 PM |
THYAGARAJAN VENKATRAMAN | Director | Nov 18, 2010 | Sale | $63.99 | 5,000 | 319,928 | 0 | Nov 19, 2010, 02:35 PM |
LEVY RICHARD M | Director | Nov 15, 2010 | Option Exercise | $32.10 | 15,000 | 481,425 | 15,000 | Nov 16, 2010, 02:49 PM |
LEVY RICHARD M | Director | Nov 15, 2010 | Sale | $64.27 | 15,000 | 964,011 | 0 | Nov 16, 2010, 02:49 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Nov 08, 2010 | Option Exercise | $45.46 | 40,000 | 1,818,542 | 84,618 | Nov 09, 2010, 02:53 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Nov 08, 2010 | Sale | $64.63 | 40,000 | 2,585,048 | 44,618 | Nov 09, 2010, 02:53 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | Nov 05, 2010 | Option Exercise | $49.88 | 10,000 | 498,800 | 36,128 | Nov 08, 2010, 05:11 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | Nov 05, 2010 | Sale | $65.00 | 10,000 | 650,000 | 26,128 | Nov 08, 2010, 05:11 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Nov 05, 2010 | Option Exercise | $39.85 | 32,262 | 1,285,641 | 76,880 | Nov 08, 2010, 05:05 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Nov 05, 2010 | Sale | $65.00 | 32,262 | 2,097,030 | 44,618 | Nov 08, 2010, 05:05 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Nov 05, 2010 | Option Exercise | $32.10 | 10,000 | 320,950 | 49,742 | Nov 08, 2010, 05:00 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Nov 05, 2010 | Sale | $64.79 | 10,000 | 647,860 | 39,742 | Nov 08, 2010, 05:00 PM |
CHEN TAI-YUN | VP and Corporate Controller | Nov 03, 2010 | Option Exercise | $49.88 | 7,712 | 384,675 | 17,276 | Nov 04, 2010, 06:17 PM |
CHEN TAI-YUN | VP and Corporate Controller | Nov 03, 2010 | Sale | $62.88 | 7,712 | 484,931 | 9,564 | Nov 04, 2010, 06:17 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Nov 03, 2010 | Sale | $63.00 | 31,603 | 1,990,989 | 44,618 | Nov 04, 2010, 06:09 PM |
CHEN TAI-YUN | VP and Corporate Controller | Nov 02, 2010 | Option Exercise | $49.88 | 4,288 | 213,885 | 16,148 | Nov 03, 2010, 07:45 PM |
CHEN TAI-YUN | VP and Corporate Controller | Nov 02, 2010 | Sale | $62.76 | 6,584 | 413,213 | 11,860 | Nov 03, 2010, 07:45 PM |
NAUMANN-ETIENNE RUEDIGER | Director | Nov 02, 2010 | Option Exercise | $41.56 | 20,000 | 831,200 | 21,000 | Nov 03, 2010, 07:35 PM |
NAUMANN-ETIENNE RUEDIGER | Director | Nov 02, 2010 | Sale | $62.48 | 20,000 | 1,249,606 | 1,000 | Nov 03, 2010, 07:35 PM |
GUERTIN TIMOTHY E | President and CEO | Nov 02, 2010 | Option Exercise | $39.85 | 45,000 | 1,793,250 | 98,225 | Nov 03, 2010, 07:29 PM |
GUERTIN TIMOTHY E | President and CEO | Nov 02, 2010 | Sale | $62.44 | 45,000 | 2,809,737 | 53,225 | Nov 03, 2010, 07:29 PM |
LEVY RICHARD M | Director | Nov 02, 2010 | Option Exercise | $32.10 | 15,000 | 481,425 | 15,000 | Nov 03, 2010, 07:19 PM |
LEVY RICHARD M | Director | Nov 02, 2010 | Sale | $62.44 | 15,000 | 936,591 | 0 | Nov 03, 2010, 07:19 PM |
LEVY RICHARD M | Director | Oct 18, 2010 | Option Exercise | $32.10 | 15,000 | 481,425 | 15,000 | Oct 19, 2010, 07:23 PM |
LEVY RICHARD M | Director | Oct 18, 2010 | Sale | $62.20 | 15,000 | 933,052 | 0 | Oct 19, 2010, 07:23 PM |
CHEN TAI-YUN | VP and Corporate Controller | Oct 05, 2010 | Option Exercise | $37.17 | 10,370 | 385,453 | 22,230 | Oct 06, 2010, 06:37 PM |
CHEN TAI-YUN | VP and Corporate Controller | Oct 05, 2010 | Sale | $61.75 | 10,370 | 640,348 | 11,860 | Oct 06, 2010, 06:37 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | Oct 05, 2010 | Option Exercise | $37.17 | 5,000 | 185,850 | 31,128 | Oct 06, 2010, 06:33 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | Oct 05, 2010 | Sale | $62.00 | 5,000 | 310,000 | 26,128 | Oct 06, 2010, 06:33 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Oct 05, 2010 | Option Exercise | $32.10 | 10,000 | 320,950 | 49,742 | Oct 06, 2010, 06:29 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Oct 05, 2010 | Sale | $61.68 | 10,000 | 616,833 | 39,742 | Oct 06, 2010, 06:29 PM |
LEVY RICHARD M | Director | Oct 04, 2010 | Option Exercise | $32.10 | 15,000 | 481,425 | 15,000 | Oct 05, 2010, 06:47 PM |
LEVY RICHARD M | Director | Oct 04, 2010 | Sale | $60.45 | 15,000 | 906,751 | 0 | Oct 05, 2010, 06:47 PM |
GUERTIN TIMOTHY E | President and CEO | Sep 27, 2010 | Option Exercise | $39.85 | 45,000 | 1,793,250 | 98,225 | Sep 28, 2010, 05:43 PM |
GUERTIN TIMOTHY E | President and CEO | Sep 27, 2010 | Sale | $59.59 | 45,000 | 2,681,434 | 75,305 | Sep 28, 2010, 05:43 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | Sep 21, 2010 | Option Exercise | $38.57 | 10,500 | 405,025 | 36,628 | Sep 22, 2010, 05:17 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | Sep 21, 2010 | Sale | $60.00 | 10,500 | 630,000 | 31,628 | Sep 22, 2010, 05:17 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Sep 21, 2010 | Option Exercise | $39.85 | 20,000 | 797,000 | 96,221 | Sep 22, 2010, 05:11 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Sep 21, 2010 | Sale | $60.00 | 20,000 | 1,200,000 | 76,221 | Sep 22, 2010, 05:11 PM |
LEVY RICHARD M | Director | Sep 20, 2010 | Option Exercise | $32.10 | 15,000 | 481,425 | 15,000 | Sep 21, 2010, 01:09 PM |
LEVY RICHARD M | Director | Sep 20, 2010 | Sale | $59.68 | 15,000 | 895,212 | 0 | Sep 21, 2010, 01:09 PM |
LEVY RICHARD M | Director | Sep 13, 2010 | Option Exercise | $31.50 | 130,000 | 4,095,150 | 130,000 | Sep 14, 2010, 06:08 PM |
LEVY RICHARD M | Director | Sep 13, 2010 | Sale | $59.00 | 130,000 | 7,670,000 | 0 | Sep 14, 2010, 06:08 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Sep 07, 2010 | Option Exercise | $32.10 | 10,000 | 320,950 | 49,742 | Sep 08, 2010, 07:37 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Sep 07, 2010 | Sale | $56.02 | 10,000 | 560,156 | 39,742 | Sep 08, 2010, 07:37 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Aug 10, 2010 | Option Exercise | $56.59 | 559 | 31,634 | 76,221 | Aug 11, 2010, 06:22 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Aug 10, 2010 | Option Exercise | $36.02 | 20,000 | 720,419 | 96,780 | Aug 11, 2010, 06:22 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Aug 10, 2010 | Sale | $57.00 | 20,000 | 1,140,000 | 76,780 | Aug 11, 2010, 06:22 PM |
KUO JOHN W | VP, Gen Counsel and Secretary | Aug 10, 2010 | Option Exercise | $56.59 | 840 | 47,536 | 26,128 | Aug 11, 2010, 06:16 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Aug 10, 2010 | Option Exercise | $56.59 | 1,540 | 87,149 | 39,742 | Aug 11, 2010, 06:11 PM |
CHEN TAI-YUN | VP and Corporate Controller | Aug 10, 2010 | Option Exercise | $56.59 | 467 | 26,428 | 11,860 | Aug 11, 2010, 06:07 PM |
WILSON DOW R | EVP and Pres. Oncology Sys. | Aug 10, 2010 | Option Exercise | $37.17 | 19,200 | 713,664 | 61,813 | Aug 11, 2010, 06:02 PM |
WILSON DOW R | EVP and Pres. Oncology Sys. | Aug 10, 2010 | Sale | $57.00 | 19,200 | 1,094,400 | 42,613 | Aug 11, 2010, 06:02 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Aug 06, 2010 | Option Exercise | $32.10 | 20,000 | 641,900 | 96,780 | Aug 09, 2010, 08:45 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Aug 06, 2010 | Sale | $55.14 | 20,000 | 1,102,792 | 81,280 | Aug 09, 2010, 08:45 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Aug 05, 2010 | Option Exercise | $32.10 | 10,000 | 320,950 | 51,282 | Aug 06, 2010, 05:30 PM |
FINNEY ELISHA W | SVP, Finance and CFO | Aug 05, 2010 | Sale | $56.33 | 10,000 | 563,259 | 41,282 | Aug 06, 2010, 05:30 PM |
WILSON DOW R | EVP and Pres. Oncology Sys. | Aug 04, 2010 | Option Exercise | $37.17 | 10,800 | 401,436 | 53,413 | Aug 05, 2010, 09:25 PM |
WILSON DOW R | EVP and Pres. Oncology Sys. | Aug 04, 2010 | Sale | $57.00 | 10,800 | 615,600 | 42,613 | Aug 05, 2010, 09:25 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Aug 04, 2010 | Option Exercise | $32.10 | 20,000 | 641,900 | 96,780 | Aug 05, 2010, 09:21 PM |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | Aug 04, 2010 | Sale | $57.00 | 20,000 | 1,140,000 | 76,780 | Aug 05, 2010, 09:21 PM |
GUERTIN TIMOTHY E | President and CEO | Aug 02, 2010 | Option Exercise | $32.10 | 34,000 | 1,091,230 | 87,225 | Aug 03, 2010, 07:44 PM |
GUERTIN TIMOTHY E | President and CEO | Aug 02, 2010 | Sale | $55.19 | 34,000 | 1,876,459 | 60,225 | Aug 03, 2010, 07:44 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Bruff Jesse Michael | SVP Finance, CFO | 03/01/2021 | 1,142,563 |
Bruff Jesse Michael | SVP Finance, CFO | 02/16/2021 | 83,847 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 02/16/2021 | 196,936 |
BUTEL JEAN LUC | Director | 02/16/2021 | 64,647 |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | 02/16/2021 | 60,243 |
Toth Christopher A. | SVP and Pres. Oncology Systems | 02/16/2021 | 149,375 |
O'Reilly Kevin | SVP, President of Oncology Sys | 02/16/2021 | 149,375 |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | 12/10/2020 | 366,652 |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | 12/10/2020 | 782,551 |
WILSON DOW R | President and CEO | 12/08/2020 | 17,357,358 |
WILSON DOW R | President and CEO | 12/08/2020 | 27,764,769 |
WILSON DOW R | President and CEO | 12/07/2020 | 15,197,911 |
WILSON DOW R | President and CEO | 12/07/2020 | 27,463,047 |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | 12/04/2020 | 1,071,602 |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | 12/04/2020 | 2,775,625 |
Toth Christopher A. | SVP and Pres. Oncology Systems | 12/01/2020 | 6,341,039 |
Toth Christopher A. | SVP and Pres. Oncology Systems | 12/01/2020 | 4,485,512 |
Bruff Jesse Michael | SVP Finance, CFO | 12/01/2020 | 4,621,435 |
Bruff Jesse Michael | SVP Finance, CFO | 12/01/2020 | 3,847,176 |
Hutchinson Michael Damon | SVP,Chief Legal Officer, Secy | 12/01/2020 | 944,981 |
O'Reilly Kevin | SVP, President of Oncology Sys | 11/23/2020 | 71,135 |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | 11/23/2020 | 51,530 |
Toth Christopher A. | SVP and Pres. Oncology Systems | 11/23/2020 | 115,725 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 11/23/2020 | 733,038 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 11/24/2020 | 746,759 |
WILSON DOW R | President and CEO | 11/23/2020 | 1,631,074 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 11/16/2020 | 52,708 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 11/16/2020 | 69,481 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 11/09/2020 | 61,261 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 11/09/2020 | 94,370 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 10/14/2020 | 52,708 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 10/14/2020 | 68,805 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 10/08/2020 | 61,261 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 10/08/2020 | 93,347 |
WILSON DOW R | President and CEO | 09/21/2020 | 2,611,438 |
WILSON DOW R | President and CEO | 09/21/2020 | 6,708,734 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 09/14/2020 | 52,708 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 09/14/2020 | 69,392 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 09/08/2020 | 61,261 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 09/08/2020 | 94,266 |
WILSON DOW R | President and CEO | 08/21/2020 | 2,611,438 |
WILSON DOW R | President and CEO | 08/21/2020 | 6,716,321 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 08/14/2020 | 52,708 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 08/14/2020 | 69,271 |
Bruff Jesse Michael | SVP Finance, CFO | 08/10/2020 | 96,718 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 08/10/2020 | 957,429 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 08/10/2020 | 1,272,769 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 07/29/2020 | 306,419 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 07/29/2020 | 366,660 |
Bruff Jesse Michael | SVP Finance, CFO | 05/07/2020 | 24,031 |
Toth Christopher A. | SVP and Pres. Oncology Systems | 04/13/2020 | 178,325 |
WILSON DOW R | President and CEO | 03/17/2020 | 2,611,572 |
WILSON DOW R | President and CEO | 03/17/2020 | 4,279,990 |
BUTEL JEAN LUC | Director | 03/02/2020 | 70,995 |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | 02/19/2020 | 160,439 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 02/19/2020 | 390,503 |
Bruff Jesse Michael | SVP Finance, CFO | 02/18/2020 | 36,329 |
WILSON DOW R | President and CEO | 02/18/2020 | 236,212 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 02/18/2020 | 194,631 |
Toth Christopher A. | SVP and Pres. Oncology Systems | 02/18/2020 | 127,371 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 02/18/2020 | 129,997 |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | 02/18/2020 | 93,084 |
BUTEL JEAN LUC | Director | 02/13/2020 | 54,651 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 02/10/2020 | 117,541 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 02/10/2020 | 176,111 |
ECKERT R ANDREW | Director | 02/04/2020 | 350,249 |
ECKERT R ANDREW | Director | 02/04/2020 | 804,759 |
ILLINGWORTH DAVID J | Director | 02/03/2020 | 350,249 |
ILLINGWORTH DAVID J | Director | 02/03/2020 | 798,091 |
WILSON DOW R | President and CEO | 01/10/2020 | 433,262 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 01/10/2020 | 56,200 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 01/08/2020 | 61,261 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 01/08/2020 | 182,214 |
Toth Christopher A. | SVP and Pres. Oncology Systems | 01/03/2020 | 180,174 |
Toth Christopher A. | SVP and Pres. Oncology Systems | 01/03/2020 | 231,565 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 01/02/2020 | 117,574 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 01/02/2020 | 874,869 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 12/16/2019 | 76,760 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 12/16/2019 | 115,566 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 12/12/2019 | 275,619 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 12/12/2019 | 346,906 |
Toth Christopher A. | SVP and Pres. Oncology Systems | 12/06/2019 | 78,366 |
WILSON DOW R | President and CEO | 11/21/2019 | 1,852,202 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 11/21/2019 | 384,321 |
Toth Christopher A. | SVP and Pres. Oncology Systems | 11/21/2019 | 93,448 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 11/21/2019 | 621,387 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 11/15/2019 | 469,924 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 11/15/2019 | 636,032 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 11/15/2019 | 37,386 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 11/15/2019 | 59,531 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 10/15/2019 | 37,386 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 10/15/2019 | 52,932 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 09/16/2019 | 37,386 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 09/16/2019 | 54,080 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 08/19/2019 | 37,386 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 08/19/2019 | 51,378 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 07/15/2019 | 37,386 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 07/15/2019 | 62,879 |
GUERTIN TIMOTHY E | Director | 07/15/2019 | 350,249 |
GUERTIN TIMOTHY E | Director | 07/15/2019 | 946,456 |
GUERTIN TIMOTHY E | Director | 07/15/2019 | 764,117 |
BISCHOPING GARY E JR | SVP, Finance & CFO | 07/11/2019 | 5,429,104 |
BISCHOPING GARY E JR | SVP, Finance & CFO | 07/11/2019 | 7,454,176 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 07/10/2019 | 56,200 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 07/08/2019 | 61,261 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 07/10/2019 | 96,662 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 07/08/2019 | 74,722 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 06/17/2019 | 37,386 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 06/17/2019 | 61,103 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 06/10/2019 | 117,461 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 06/10/2019 | 163,332 |
BISCHOPING GARY E JR | SVP, Finance & CFO | 05/22/2019 | 108,109 |
BISCHOPING GARY E JR | SVP, Finance & CFO | 05/18/2019 | 127,117 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 05/15/2019 | 37,386 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 05/15/2019 | 60,502 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 05/10/2019 | 56,200 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 05/10/2019 | 92,880 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 05/08/2019 | 61,374 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 05/08/2019 | 73,164 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 04/16/2019 | 551,464 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 04/15/2019 | 481,642 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 04/15/2019 | 1,179,291 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 04/16/2019 | 694,096 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 04/10/2019 | 56,200 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 04/08/2019 | 61,261 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 04/10/2019 | 98,492 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 04/08/2019 | 76,552 |
WILSON DOW R | President and CEO | 03/29/2019 | 3,336,403 |
WILSON DOW R | President and CEO | 03/29/2019 | 6,378,211 |
Toth Christopher A. | SVP and Pres. Oncology Systems | 04/01/2019 | 157,948 |
Toth Christopher A. | SVP and Pres. Oncology Systems | 04/01/2019 | 199,500 |
Toth Christopher A. | SVP and Pres. Oncology Systems | 03/21/2019 | 97,364 |
Toth Christopher A. | SVP and Pres. Oncology Systems | 03/22/2019 | 157,948 |
Toth Christopher A. | SVP and Pres. Oncology Systems | 03/21/2019 | 166,513 |
Toth Christopher A. | SVP and Pres. Oncology Systems | 03/22/2019 | 196,000 |
Toth Christopher A. | SVP and Pres. Oncology Systems | 03/18/2019 | 250,722 |
Toth Christopher A. | SVP and Pres. Oncology Systems | 03/18/2019 | 624,633 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 03/08/2019 | 61,261 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 03/11/2019 | 56,280 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 03/08/2019 | 71,508 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 03/11/2019 | 93,761 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 02/15/2019 | 133,005 |
BISCHOPING GARY E JR | SVP, Finance & CFO | 02/15/2019 | 44,202 |
BISCHOPING GARY E JR | SVP, Finance & CFO | 02/15/2019 | 39,508 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 02/15/2019 | 271,321 |
KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | 02/19/2019 | 292,810 |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | 02/15/2019 | 100,617 |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | 02/19/2019 | 190,237 |
WILSON DOW R | President and CEO | 02/15/2019 | 415,609 |
Toth Christopher A. | SVP and Pres. Oncology Systems | 02/15/2019 | 161,412 |
BUTEL JEAN LUC | Director | 02/11/2019 | 56,631 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 02/12/2019 | 73,027 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 02/12/2019 | 144,233 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 02/11/2019 | 56,200 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 02/11/2019 | 91,886 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 02/08/2019 | 735,248 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 02/08/2019 | 847,848 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 01/28/2019 | 1,402,325 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 01/28/2019 | 2,554,738 |
ECKERT R ANDREW | Director | 01/28/2019 | 323,633 |
ECKERT R ANDREW | Director | 01/28/2019 | 735,478 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 01/11/2019 | 807,750 |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | 01/03/2019 | 207,368 |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | 01/03/2019 | 308,465 |
WILSON DOW R | President and CEO | 11/16/2018 | 2,100,983 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 11/16/2018 | 654,368 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 11/16/2018 | 559,003 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 11/15/2018 | 95,002 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 11/15/2018 | 152,923 |
BISCHOPING GARY E JR | SVP, Finance & CFO | 10/31/2018 | 101,603 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 10/29/2018 | 37,386 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 10/29/2018 | 52,073 |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | 10/29/2018 | 184,747 |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | 10/29/2018 | 301,639 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 10/15/2018 | 57,857 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 10/15/2018 | 90,737 |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | 10/04/2018 | 6,091 |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | 10/04/2018 | 11,021 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 09/17/2018 | 95,243 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 09/17/2018 | 147,167 |
GUERTIN TIMOTHY E | Director | 09/05/2018 | 1,108,360 |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | 09/04/2018 | 170,548 |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | 09/04/2018 | 312,696 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 08/16/2018 | 29,346 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 08/16/2018 | 40,150 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 08/15/2018 | 65,897 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 08/15/2018 | 104,707 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 07/16/2018 | 95,243 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 07/16/2018 | 152,974 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 06/15/2018 | 95,378 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 06/15/2018 | 162,871 |
BISCHOPING GARY E JR | SVP, Finance & CFO | 05/18/2018 | 115,322 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 05/15/2018 | 95,243 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 05/15/2018 | 155,460 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 05/10/2018 | 56,200 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 05/10/2018 | 82,624 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 04/16/2018 | 95,311 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 04/16/2018 | 161,935 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 04/10/2018 | 56,200 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 04/10/2018 | 84,113 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 03/15/2018 | 95,311 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 03/15/2018 | 166,672 |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | 03/12/2018 | 196,792 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 03/12/2018 | 56,200 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 03/12/2018 | 88,400 |
ILLINGWORTH DAVID J | Director | 03/06/2018 | 323,633 |
ILLINGWORTH DAVID J | Director | 03/06/2018 | 692,558 |
WILSON DOW R | President and CEO | 03/01/2018 | 1,777,440 |
WILSON DOW R | President and CEO | 03/01/2018 | 2,832,803 |
BOSTROM SUSAN L | Director | 02/22/2018 | 235,413 |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | 02/15/2018 | 106,514 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 02/15/2018 | 178,296 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 02/15/2018 | 506,476 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 02/15/2018 | 777,344 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 02/15/2018 | 213,394 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 02/16/2018 | 425,621 |
WILSON DOW R | President and CEO | 02/15/2018 | 962,651 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 02/12/2018 | 674,556 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 02/12/2018 | 977,162 |
WILSON DOW R | President and CEO | 02/01/2018 | 1,777,440 |
WILSON DOW R | President and CEO | 02/01/2018 | 3,041,464 |
LARET MARK R | Director | 02/01/2018 | 274,382 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 01/16/2018 | 57,925 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 01/16/2018 | 93,575 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 01/16/2018 | 76,478 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 01/16/2018 | 101,056 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 01/12/2018 | 73,094 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 01/12/2018 | 117,823 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 01/08/2018 | 590,944 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 01/08/2018 | 884,200 |
GUERTIN TIMOTHY E | Director | 01/02/2018 | 1,114,639 |
WILSON DOW R | President and CEO | 12/18/2017 | 5,406,737 |
WILSON DOW R | President and CEO | 12/18/2017 | 9,852,915 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 12/13/2017 | 76,314 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 12/12/2017 | 72,959 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 12/13/2017 | 105,210 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 12/12/2017 | 120,755 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 11/13/2017 | 149,505 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 11/13/2017 | 216,983 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 10/18/2017 | 76,314 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 10/18/2017 | 97,755 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 10/12/2017 | 73,027 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 10/12/2017 | 110,490 |
ECKERT R ANDREW | Director | 10/06/2017 | 354,544 |
ECKERT R ANDREW | Director | 10/06/2017 | 578,595 |
WILSON DOW R | President and CEO | 10/06/2017 | 771,473 |
WILSON DOW R | President and CEO | 10/06/2017 | 1,541,981 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 09/13/2017 | 76,478 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 09/12/2017 | 73,027 |
WILSON DOW R | President and CEO | 09/07/2017 | 771,473 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 09/13/2017 | 100,100 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 09/12/2017 | 116,777 |
WILSON DOW R | President and CEO | 09/07/2017 | 1,587,372 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 08/31/2017 | 76,314 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 08/31/2017 | 97,755 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 08/14/2017 | 73,027 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 08/14/2017 | 106,525 |
WILSON DOW R | President and CEO | 08/07/2017 | 771,473 |
WILSON DOW R | President and CEO | 08/07/2017 | 1,452,895 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 07/13/2017 | 60,166 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 07/12/2017 | 57,925 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 07/13/2017 | 76,614 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 07/12/2017 | 90,166 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 07/13/2017 | 76,478 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 07/12/2017 | 73,027 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 07/13/2017 | 97,965 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 07/12/2017 | 113,689 |
WILSON DOW R | President and CEO | 07/10/2017 | 771,524 |
WILSON DOW R | President and CEO | 07/10/2017 | 1,556,698 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 06/20/2017 | 2,138,761 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 06/20/2017 | 2,739,660 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 06/13/2017 | 60,166 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 06/13/2017 | 74,800 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 06/12/2017 | 57,925 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 06/12/2017 | 87,378 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 06/12/2017 | 72,959 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 06/12/2017 | 110,000 |
GUERTIN TIMOTHY E | Director | 06/09/2017 | 1,651,544 |
LARET MARK R | Director | 06/08/2017 | 147,761 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 06/01/2017 | 3,995,848 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 06/01/2017 | 5,643,894 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 05/31/2017 | 1,624,563 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 05/31/2017 | 1,975,360 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 05/12/2017 | 57,857 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 05/12/2017 | 83,084 |
BOSTROM SUSAN L | Director | 05/02/2017 | 326,902 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 04/12/2017 | 57,992 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 04/12/2017 | 77,533 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 03/17/2017 | 287,057 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 03/17/2017 | 355,623 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 03/13/2017 | 57,857 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 03/13/2017 | 75,758 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 03/01/2017 | 694,893 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 03/01/2017 | 878,038 |
LARET MARK R | Director | 02/22/2017 | 678,177 |
LARET MARK R | Director | 02/22/2017 | 944,408 |
MOMSEN MAGNUS | SVP, CAO, Corporate Controller | 02/15/2017 | 63,517 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 02/15/2017 | 148,450 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 02/15/2017 | 175,219 |
FINNEY ELISHA W | Exec VP and CFO | 02/15/2017 | 162,402 |
WILSON DOW R | President and CEO | 02/15/2017 | 743,708 |
WILSON DOW R | President and CEO | 01/10/2017 | 618,321 |
WILSON DOW R | President and CEO | 01/05/2017 | 704,435 |
WILSON DOW R | President and CEO | 01/05/2017 | 1,183,260 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 12/08/2016 | 114,451 |
WILSON DOW R | President and CEO | 12/05/2016 | 528,300 |
WILSON DOW R | President and CEO | 12/05/2016 | 900,311 |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | 11/21/2016 | 42,499 |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | 11/18/2016 | 22,680 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 11/18/2016 | 69,894 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 11/18/2016 | 93,810 |
FINNEY ELISHA W | Exec VP and CFO | 11/18/2016 | 126,374 |
WILSON DOW R | President and CEO | 11/18/2016 | 355,559 |
WILSON DOW R | President and CEO | 11/07/2016 | 528,300 |
WILSON DOW R | President and CEO | 11/07/2016 | 905,907 |
GUERTIN TIMOTHY E | Director | 10/31/2016 | 361,296 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 10/20/2016 | 1,779,964 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 10/20/2016 | 2,205,284 |
WILSON DOW R | President and CEO | 10/05/2016 | 528,300 |
WILSON DOW R | President and CEO | 10/05/2016 | 994,417 |
FINNEY ELISHA W | Exec VP and CFO | 10/03/2016 | 321,345 |
FINNEY ELISHA W | Exec VP and CFO | 10/03/2016 | 461,537 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 09/15/2016 | 280,385 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 09/15/2016 | 388,860 |
FINNEY ELISHA W | Exec VP and CFO | 09/07/2016 | 619,560 |
FINNEY ELISHA W | Exec VP and CFO | 09/07/2016 | 872,550 |
WILSON DOW R | President and CEO | 09/06/2016 | 528,300 |
WILSON DOW R | President and CEO | 09/06/2016 | 960,818 |
FINNEY ELISHA W | Exec VP and CFO | 09/01/2016 | 137,680 |
FINNEY ELISHA W | Exec VP and CFO | 09/01/2016 | 191,646 |
THYAGARAJAN VENKATRAMAN | Director | 08/22/2016 | 67,797 |
WILSON DOW R | President and CEO | 08/05/2016 | 528,300 |
WILSON DOW R | President and CEO | 08/05/2016 | 951,425 |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | 08/01/2016 | 378,900 |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | 08/01/2016 | 899,756 |
GUERTIN TIMOTHY E | Director | 08/01/2016 | 379,519 |
FINNEY ELISHA W | Exec VP and CFO | 08/01/2016 | 1,619,999 |
FINNEY ELISHA W | Exec VP and CFO | 08/01/2016 | 2,404,095 |
WILSON DOW R | President and CEO | 07/05/2016 | 528,300 |
WILSON DOW R | President and CEO | 07/05/2016 | 820,806 |
WILSON DOW R | President and CEO | 06/27/2016 | 528,300 |
WILSON DOW R | President and CEO | 06/27/2016 | 782,741 |
NAUMANN-ETIENNE RUEDIGER | Director | 06/08/2016 | 84,831 |
LARET MARK R | Director | 06/03/2016 | 128,969 |
GUERTIN TIMOTHY E | Director | 05/02/2016 | 326,210 |
FINNEY ELISHA W | Exec VP and CFO | 04/20/2016 | 231,600 |
FINNEY ELISHA W | Exec VP and CFO | 04/20/2016 | 343,800 |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | 04/18/2016 | 126,300 |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | 04/18/2016 | 212,500 |
WILSON DOW R | President and CEO | 03/23/2016 | 2,684,980 |
WILSON DOW R | President and CEO | 03/23/2016 | 3,599,968 |
NAUMANN-ETIENNE RUEDIGER | Director | 03/10/2016 | 33,378 |
GUERTIN TIMOTHY E | Director | 03/07/2016 | 317,894 |
SANYAL SUNNY | SVP and President, ICB | 02/16/2016 | 93,402 |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | 02/16/2016 | 35,348 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 02/16/2016 | 99,956 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 02/16/2016 | 117,435 |
FINNEY ELISHA W | Exec VP and CFO | 02/16/2016 | 114,626 |
FINNEY ELISHA W | Exec VP and CFO | 02/17/2016 | 192,868 |
WILSON DOW R | President and CEO | 02/16/2016 | 357,533 |
THYAGARAJAN VENKATRAMAN | Director | 02/16/2016 | 20,834 |
REINHARDT ERICH R | Director | 02/16/2016 | 17,791 |
WILSON DOW R | President and CEO | 12/07/2015 | 455,940 |
WILSON DOW R | President and CEO | 12/07/2015 | 720,000 |
ECKERT R ANDREW | Director | 12/02/2015 | 180,960 |
ECKERT R ANDREW | Director | 12/02/2015 | 245,010 |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | 11/23/2015 | 57,860 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 11/23/2015 | 58,749 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 11/23/2015 | 78,386 |
FINNEY ELISHA W | Exec VP and CFO | 11/23/2015 | 115,639 |
FINNEY ELISHA W | Exec VP and CFO | 11/23/2015 | 82,799 |
FINNEY ELISHA W | Exec VP and CFO | 11/24/2015 | 106,026 |
WILSON DOW R | President and CEO | 11/23/2015 | 306,270 |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | 11/20/2015 | 15,157 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 11/20/2015 | 45,550 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 11/20/2015 | 60,787 |
FINNEY ELISHA W | Exec VP and CFO | 11/20/2015 | 89,730 |
WILSON DOW R | President and CEO | 11/20/2015 | 237,668 |
WILSON DOW R | President and CEO | 11/06/2015 | 455,940 |
WILSON DOW R | President and CEO | 11/05/2015 | 455,940 |
WILSON DOW R | President and CEO | 11/06/2015 | 724,603 |
WILSON DOW R | President and CEO | 11/05/2015 | 720,000 |
WILSON DOW R | President and CEO | 09/08/2015 | 455,940 |
WILSON DOW R | President and CEO | 09/08/2015 | 720,450 |
WILSON DOW R | President and CEO | 08/06/2015 | 455,940 |
WILSON DOW R | President and CEO | 08/06/2015 | 780,013 |
FINNEY ELISHA W | Exec VP and CFO | 08/03/2015 | 115,800 |
FINNEY ELISHA W | Exec VP and CFO | 08/03/2015 | 171,914 |
GUERTIN TIMOTHY E | Director | 08/03/2015 | 342,281 |
WILSON DOW R | President and CEO | 07/06/2015 | 455,940 |
WILSON DOW R | President and CEO | 07/06/2015 | 772,227 |
FINNEY ELISHA W | Exec VP and CFO | 07/02/2015 | 115,800 |
FINNEY ELISHA W | Exec VP and CFO | 07/02/2015 | 171,900 |
GUERTIN TIMOTHY E | Director | 07/01/2015 | 1,447,500 |
GUERTIN TIMOTHY E | Director | 07/01/2015 | 2,104,946 |
WILSON DOW R | President and CEO | 06/05/2015 | 455,940 |
WILSON DOW R | President and CEO | 06/05/2015 | 776,646 |
FINNEY ELISHA W | Exec VP and CFO | 06/01/2015 | 115,800 |
FINNEY ELISHA W | Exec VP and CFO | 06/01/2015 | 171,986 |
GUERTIN TIMOTHY E | Director | 06/01/2015 | 1,447,500 |
GUERTIN TIMOTHY E | Director | 06/01/2015 | 2,151,927 |
NAUMANN-ETIENNE RUEDIGER | Director | 05/29/2015 | 134,596 |
WILSON DOW R | President and CEO | 05/06/2015 | 455,940 |
WILSON DOW R | President and CEO | 05/06/2015 | 779,756 |
FINNEY ELISHA W | Exec VP and CFO | 05/04/2015 | 115,800 |
FINNEY ELISHA W | Exec VP and CFO | 05/04/2015 | 176,682 |
GUERTIN TIMOTHY E | Director | 05/04/2015 | 1,447,500 |
GUERTIN TIMOTHY E | Director | 05/04/2015 | 2,208,355 |
GUERTIN TIMOTHY E | Director | 05/04/2015 | 353,364 |
WILSON DOW R | President and CEO | 04/17/2015 | 935,749 |
WILSON DOW R | President and CEO | 04/17/2015 | 1,756,444 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 04/16/2015 | 53,420 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 04/16/2015 | 61,655 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 04/09/2015 | 39,996 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 04/09/2015 | 54,594 |
FINNEY ELISHA W | Exec VP and CFO | 04/01/2015 | 289,500 |
FINNEY ELISHA W | Exec VP and CFO | 04/01/2015 | 463,780 |
GUERTIN TIMOTHY E | Director | 04/01/2015 | 1,447,500 |
GUERTIN TIMOTHY E | Director | 04/01/2015 | 2,318,989 |
WILSON DOW R | President and CEO | 03/20/2015 | 935,699 |
WILSON DOW R | President and CEO | 03/20/2015 | 1,771,577 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 03/16/2015 | 160,191 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 03/16/2015 | 187,340 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 03/09/2015 | 40,065 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 03/09/2015 | 54,509 |
GUERTIN TIMOTHY E | Director | 03/06/2015 | 374,012 |
FINNEY ELISHA W | Exec VP and CFO | 03/02/2015 | 289,500 |
FINNEY ELISHA W | Exec VP and CFO | 03/02/2015 | 467,215 |
GUERTIN TIMOTHY E | Director | 03/02/2015 | 2,641,500 |
GUERTIN TIMOTHY E | Director | 03/02/2015 | 4,674,140 |
FINNEY ELISHA W | Exec VP and CFO | 02/23/2015 | 123,279 |
SANYAL SUNNY | SVP and President, ICB | 02/17/2015 | 59,895 |
KENNEDY KOLLEEN T | EVP and Pres. Oncology Sys. | 02/17/2015 | 75,774 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 02/17/2015 | 62,402 |
FINNEY ELISHA W | Exec VP and CFO | 02/17/2015 | 74,102 |
WILSON DOW R | President and CEO | 02/17/2015 | 289,352 |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | 02/17/2015 | 21,544 |
THYAGARAJAN VENKATRAMAN | Director | 02/10/2015 | 27,574 |
LARET MARK R | Director | 02/10/2015 | 423,750 |
LARET MARK R | Director | 02/10/2015 | 923,156 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 02/09/2015 | 40,065 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 02/09/2015 | 54,008 |
THYAGARAJAN VENKATRAMAN | Director | 02/03/2015 | 704,800 |
THYAGARAJAN VENKATRAMAN | Director | 02/03/2015 | 927,118 |
NAUMANN-ETIENNE RUEDIGER | Director | 02/02/2015 | 704,800 |
NAUMANN-ETIENNE RUEDIGER | Director | 02/02/2015 | 918,734 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 02/02/2015 | 240,252 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 02/02/2015 | 321,218 |
WILSON DOW R | President and CEO | 02/02/2015 | 2,992,800 |
WILSON DOW R | President and CEO | 02/02/2015 | 5,506,736 |
GUERTIN TIMOTHY E | Director | 02/02/2015 | 2,641,500 |
GUERTIN TIMOTHY E | Director | 02/02/2015 | 4,588,843 |
FINNEY ELISHA W | Exec VP and CFO | 02/02/2015 | 352,218 |
FINNEY ELISHA W | Exec VP and CFO | 02/02/2015 | 611,963 |
WILSON DOW R | President and CEO | 01/12/2015 | 534,913 |
GUERTIN TIMOTHY E | Director | 01/05/2015 | 2,641,500 |
GUERTIN TIMOTHY E | Director | 01/05/2015 | 4,313,344 |
FINNEY ELISHA W | Exec VP and CFO | 01/02/2015 | 792,450 |
FINNEY ELISHA W | Exec VP and CFO | 01/02/2015 | 1,305,823 |
GUERTIN TIMOTHY E | Director | 12/11/2014 | 5,535,050 |
GUERTIN TIMOTHY E | Director | 12/11/2014 | 9,100,360 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 12/09/2014 | 53,351 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 12/09/2014 | 63,807 |
FINNEY ELISHA W | Exec VP and CFO | 12/01/2014 | 1,085,560 |
FINNEY ELISHA W | Exec VP and CFO | 12/01/2014 | 1,863,130 |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | 11/21/2014 | 104,423 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 11/21/2014 | 150,228 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 11/21/2014 | 225,167 |
FINNEY ELISHA W | Exec VP and CFO | 11/21/2014 | 280,274 |
FINNEY ELISHA W | Exec VP and CFO | 11/24/2014 | 258,532 |
WILSON DOW R | President and CEO | 11/21/2014 | 579,852 |
GUERTIN TIMOTHY E | Director | 11/21/2014 | 464,198 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 11/14/2014 | 82,588 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 11/14/2014 | 87,405 |
GUERTIN TIMOTHY E | Director | 11/14/2014 | 526,356 |
FINNEY ELISHA W | Exec VP and CFO | 11/14/2014 | 175,423 |
FINNEY ELISHA W | Exec VP and CFO | 11/17/2014 | 161,123 |
WILSON DOW R | President and CEO | 11/14/2014 | 201,959 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 11/11/2014 | 35,087 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 11/11/2014 | 52,499 |
NAUMANN-ETIENNE RUEDIGER | Director | 11/10/2014 | 323,650 |
NAUMANN-ETIENNE RUEDIGER | Director | 11/10/2014 | 426,533 |
ECKERT R ANDREW | Director | 11/10/2014 | 263,050 |
ECKERT R ANDREW | Director | 11/10/2014 | 425,529 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 11/10/2014 | 53,420 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 11/11/2014 | 37,114 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 11/10/2014 | 60,360 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 11/11/2014 | 46,193 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 04/11/2013 | 37,056 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 04/11/2013 | 46,178 |
FINNEY ELISHA W | Exec VP and CFO | 11/03/2014 | 1,288,200 |
FINNEY ELISHA W | Exec VP and CFO | 11/03/2014 | 2,095,404 |
GUERTIN TIMOTHY E | Director | 11/03/2014 | 4,208,800 |
GUERTIN TIMOTHY E | Director | 11/03/2014 | 6,697,770 |
FINNEY ELISHA W | Exec VP and CFO | 10/29/2014 | 528,300 |
FINNEY ELISHA W | Exec VP and CFO | 10/29/2014 | 839,500 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 10/27/2014 | 90,407 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 10/27/2014 | 100,440 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 10/13/2014 | 35,087 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 10/13/2014 | 48,263 |
FINNEY ELISHA W | Exec VP and CFO | 10/01/2014 | 759,900 |
FINNEY ELISHA W | Exec VP and CFO | 10/01/2014 | 1,199,694 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 09/11/2014 | 35,030 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 09/11/2014 | 51,923 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 09/11/2014 | 37,114 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 09/09/2014 | 53,420 |
FINNEY ELISHA W | Exec VP and CFO | 09/02/2014 | 1,024,050 |
FINNEY ELISHA W | Exec VP and CFO | 09/02/2014 | 1,703,604 |
THYAGARAJAN VENKATRAMAN | Director | 08/20/2014 | 323,650 |
THYAGARAJAN VENKATRAMAN | Director | 08/20/2014 | 421,250 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 08/11/2014 | 90,476 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 08/11/2014 | 65,985 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 08/11/2014 | 35,087 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 08/11/2014 | 51,550 |
FINNEY ELISHA W | Exec VP and CFO | 08/07/2014 | 264,150 |
FINNEY ELISHA W | Exec VP and CFO | 08/07/2014 | 419,750 |
FINNEY ELISHA W | Exec VP and CFO | 08/01/2014 | 759,900 |
FINNEY ELISHA W | Exec VP and CFO | 08/01/2014 | 1,224,890 |
GUERTIN TIMOTHY E | Director | 08/01/2014 | 4,208,800 |
GUERTIN TIMOTHY E | Director | 08/01/2014 | 6,534,904 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 07/14/2014 | 37,114 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 07/14/2014 | 54,565 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 07/11/2014 | 35,030 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 07/11/2014 | 51,400 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 07/09/2014 | 40,065 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 07/09/2014 | 49,470 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 07/09/2014 | 53,351 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 07/09/2014 | 65,633 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 06/16/2014 | 90,476 |
FINNEY ELISHA W | Exec VP and CFO | 07/01/2014 | 1,024,050 |
FINNEY ELISHA W | Exec VP and CFO | 07/01/2014 | 1,677,222 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 06/23/2014 | 120,126 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 06/23/2014 | 148,325 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 06/16/2014 | 116,704 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 06/11/2014 | 35,087 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 06/11/2014 | 49,314 |
FINNEY ELISHA W | Exec VP and CFO | 06/02/2014 | 506,600 |
FINNEY ELISHA W | Exec VP and CFO | 06/02/2014 | 823,495 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 05/12/2014 | 35,030 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 05/12/2014 | 50,087 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 05/12/2014 | 37,114 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 05/09/2014 | 53,420 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 05/09/2014 | 63,056 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 05/12/2014 | 53,085 |
FINNEY ELISHA W | Exec VP and CFO | 05/01/2014 | 518,300 |
FINNEY ELISHA W | Exec VP and CFO | 05/01/2014 | 789,871 |
GUERTIN TIMOTHY E | Director | 05/01/2014 | 3,763,500 |
GUERTIN TIMOTHY E | Director | 05/01/2014 | 6,318,672 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 04/11/2014 | 35,087 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 04/11/2014 | 48,944 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 04/11/2014 | 37,056 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 04/11/2014 | 51,775 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 04/09/2014 | 53,351 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 04/09/2014 | 64,762 |
FINNEY ELISHA W | Exec VP and CFO | 04/01/2014 | 526,100 |
FINNEY ELISHA W | Exec VP and CFO | 04/01/2014 | 839,731 |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | 03/17/2014 | 96,562 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 03/11/2014 | 675,781 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 03/11/2014 | 842,447 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 03/11/2014 | 37,114 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 03/10/2014 | 53,420 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 03/11/2014 | 54,356 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 03/10/2014 | 65,229 |
GUERTIN TIMOTHY E | Director | 03/10/2014 | 2,973,600 |
GUERTIN TIMOTHY E | Director | 03/10/2014 | 6,723,835 |
FINNEY ELISHA W | Exec VP and CFO | 03/03/2014 | 526,100 |
FINNEY ELISHA W | Exec VP and CFO | 03/03/2014 | 834,066 |
NAUMANN-ETIENNE RUEDIGER | Director | 02/21/2014 | 180,960 |
NAUMANN-ETIENNE RUEDIGER | Director | 02/21/2014 | 370,468 |
LARET MARK R | Director | 02/21/2014 | 118,609 |
THYAGARAJAN VENKATRAMAN | Director | 02/18/2014 | 21,792 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 02/11/2014 | 35,030 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 02/11/2014 | 48,776 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 02/11/2014 | 37,056 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 02/10/2014 | 53,420 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 02/11/2014 | 51,632 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 02/10/2014 | 62,481 |
ECKERT R ANDREW | Director | 02/10/2014 | 301,600 |
ECKERT R ANDREW | Director | 02/10/2014 | 474,007 |
GUERTIN TIMOTHY E | Director | 02/03/2014 | 929,250 |
GUERTIN TIMOTHY E | Director | 02/03/2014 | 158,773 |
GUERTIN TIMOTHY E | Director | 02/03/2014 | 1,983,495 |
LEVY RICHARD M | Director | 02/03/2014 | 797,000 |
LEVY RICHARD M | Director | 02/03/2014 | 1,586,916 |
FINNEY ELISHA W | Exec VP and CFO | 02/03/2014 | 526,100 |
FINNEY ELISHA W | Exec VP and CFO | 02/03/2014 | 793,420 |
BOSTROM SUSAN L | Director | 01/31/2014 | 1,028,450 |
BOSTROM SUSAN L | Director | 01/31/2014 | 1,540,350 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 01/13/2014 | 35,087 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 01/13/2014 | 48,658 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 01/13/2014 | 37,056 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 01/13/2014 | 51,384 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 01/09/2014 | 53,351 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 01/09/2014 | 62,614 |
FINNEY ELISHA W | Exec VP and CFO | 01/02/2014 | 1,052,200 |
FINNEY ELISHA W | Exec VP and CFO | 01/02/2014 | 1,889,455 |
LEVY RICHARD M | Director | 01/02/2014 | 797,000 |
LEVY RICHARD M | Director | 01/02/2014 | 1,553,696 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 12/30/2013 | 175,263 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 12/30/2013 | 233,330 |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | 12/23/2013 | 98,744 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 12/11/2013 | 37,114 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 12/11/2013 | 49,804 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 12/09/2013 | 53,420 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 12/09/2013 | 61,403 |
WILSON DOW R | President and CEO | 12/09/2013 | 4,997,950 |
WILSON DOW R | President and CEO | 12/09/2013 | 7,513,616 |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | 12/04/2013 | 1,034,560 |
FINNEY ELISHA W | Exec VP and CFO | 12/02/2013 | 526,100 |
FINNEY ELISHA W | Exec VP and CFO | 12/02/2013 | 790,354 |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | 12/02/2013 | 680,759 |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | 12/02/2013 | 781,231 |
LEVY RICHARD M | Director | 12/02/2013 | 797,000 |
LEVY RICHARD M | Director | 12/02/2013 | 1,580,780 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 11/29/2013 | 640,694 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 11/29/2013 | 725,946 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 11/25/2013 | 224,360 |
WILSON DOW R | President and CEO | 11/21/2013 | 409,690 |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | 11/21/2013 | 223,043 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 11/21/2013 | 138,970 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 11/22/2013 | 7,500 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 11/21/2013 | 117,086 |
FINNEY ELISHA W | Exec VP and CFO | 11/21/2013 | 240,189 |
FINNEY ELISHA W | Exec VP and CFO | 11/22/2013 | 120,998 |
GUERTIN TIMOTHY E | Director | 11/21/2013 | 397,808 |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | 11/21/2013 | 51,512 |
LARET MARK R | Director | 11/20/2013 | 263,050 |
LARET MARK R | Director | 11/20/2013 | 372,900 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 11/15/2013 | 37,056 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 11/15/2013 | 48,000 |
FINNEY ELISHA W | Exec VP and CFO | 11/14/2013 | 263,050 |
FINNEY ELISHA W | Exec VP and CFO | 11/14/2013 | 374,750 |
GUERTIN TIMOTHY E | Director | 11/01/2013 | 929,250 |
GUERTIN TIMOTHY E | Director | 11/01/2013 | 144,506 |
GUERTIN TIMOTHY E | Director | 11/01/2013 | 1,806,668 |
FINNEY ELISHA W | Exec VP and CFO | 11/01/2013 | 263,050 |
FINNEY ELISHA W | Exec VP and CFO | 11/01/2013 | 361,358 |
LEVY RICHARD M | Director | 11/01/2013 | 797,000 |
LEVY RICHARD M | Director | 11/01/2013 | 1,445,330 |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | 10/14/2013 | 804,173 |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | 10/14/2013 | 1,083,342 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 10/11/2013 | 37,114 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 10/11/2013 | 49,442 |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | 10/10/2013 | 732,805 |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | 10/10/2013 | 1,068,067 |
FINNEY ELISHA W | Exec VP and CFO | 10/01/2013 | 498,800 |
FINNEY ELISHA W | Exec VP and CFO | 10/01/2013 | 750,921 |
LEVY RICHARD M | Director | 10/01/2013 | 797,000 |
LEVY RICHARD M | Director | 10/01/2013 | 1,504,694 |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | 09/20/2013 | 732,752 |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | 09/20/2013 | 1,054,120 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 09/20/2013 | 94,772 |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | 09/16/2013 | 732,752 |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | 09/16/2013 | 1,040,250 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 09/16/2013 | 148,340 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 09/16/2013 | 192,150 |
FINNEY ELISHA W | Exec VP and CFO | 09/16/2013 | 814,740 |
FINNEY ELISHA W | Exec VP and CFO | 09/16/2013 | 1,224,233 |
FINNEY ELISHA W | Exec VP and CFO | 09/11/2013 | 1,180,460 |
FINNEY ELISHA W | Exec VP and CFO | 09/11/2013 | 1,773,767 |
LEVY RICHARD M | Director | 09/03/2013 | 797,000 |
LEVY RICHARD M | Director | 09/03/2013 | 1,418,983 |
FINNEY ELISHA W | Exec VP and CFO | 09/03/2013 | 249,400 |
FINNEY ELISHA W | Exec VP and CFO | 09/03/2013 | 354,773 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 08/08/2013 | 176,400 |
ECKERT R ANDREW | Director | 08/01/2013 | 100,274 |
FINNEY ELISHA W | Exec VP and CFO | 08/01/2013 | 249,400 |
FINNEY ELISHA W | Exec VP and CFO | 08/01/2013 | 364,074 |
GUERTIN TIMOTHY E | Director | 08/01/2013 | 929,250 |
GUERTIN TIMOTHY E | Director | 08/01/2013 | 145,560 |
GUERTIN TIMOTHY E | Director | 08/01/2013 | 1,820,495 |
LEVY RICHARD M | Director | 08/01/2013 | 797,000 |
LEVY RICHARD M | Director | 08/01/2013 | 1,456,350 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 07/19/2013 | 145,944 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 07/19/2013 | 105,204 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 07/19/2013 | 130,824 |
LEVY RICHARD M | Director | 07/17/2013 | 797,000 |
LEVY RICHARD M | Director | 07/17/2013 | 1,400,000 |
FINNEY ELISHA W | Exec VP and CFO | 07/16/2013 | 249,400 |
FINNEY ELISHA W | Exec VP and CFO | 07/16/2013 | 349,750 |
LEVY RICHARD M | Director | 06/17/2013 | 797,000 |
LEVY RICHARD M | Director | 06/17/2013 | 1,400,000 |
FINNEY ELISHA W | Exec VP and CFO | 06/17/2013 | 249,400 |
FINNEY ELISHA W | Exec VP and CFO | 06/17/2013 | 349,750 |
GUERTIN TIMOTHY E | Director | 06/10/2013 | 929,250 |
GUERTIN TIMOTHY E | Director | 06/10/2013 | 137,608 |
GUERTIN TIMOTHY E | Director | 06/10/2013 | 1,720,150 |
WILSON DOW R | President and CEO | 05/20/2013 | 151,262 |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | 05/20/2013 | 34,794 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 05/20/2013 | 57,991 |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | 05/20/2013 | 124,593 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 05/20/2013 | 49,796 |
GUERTIN TIMOTHY E | Director | 05/20/2013 | 402,671 |
FINNEY ELISHA W | Exec VP and CFO | 05/20/2013 | 96,605 |
FINNEY ELISHA W | Exec VP and CFO | 05/21/2013 | 161,576 |
LEVY RICHARD M | Director | 05/14/2013 | 797,000 |
LEVY RICHARD M | Director | 05/14/2013 | 1,400,000 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 05/14/2013 | 50,400 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 05/14/2013 | 66,870 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 05/14/2013 | 58,747 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 05/14/2013 | 77,840 |
FINNEY ELISHA W | Exec VP and CFO | 05/14/2013 | 249,400 |
FINNEY ELISHA W | Exec VP and CFO | 05/14/2013 | 349,750 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 05/13/2013 | 37,056 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 05/13/2013 | 44,190 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 04/15/2013 | 50,400 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 04/15/2013 | 66,270 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 04/15/2013 | 58,694 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 04/15/2013 | 77,770 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 04/11/2013 | 35,087 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 04/11/2013 | 43,632 |
LEVY RICHARD M | Director | 04/01/2013 | 797,000 |
LEVY RICHARD M | Director | 04/01/2013 | 1,432,134 |
FINNEY ELISHA W | Exec VP and CFO | 04/01/2013 | 249,400 |
FINNEY ELISHA W | Exec VP and CFO | 04/01/2013 | 358,024 |
GUERTIN TIMOTHY E | Director | 03/26/2013 | 5,066,000 |
GUERTIN TIMOTHY E | Director | 03/26/2013 | 7,176,070 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 03/14/2013 | 58,694 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 03/14/2013 | 82,058 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 03/14/2013 | 50,400 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 03/14/2013 | 70,460 |
LEVY RICHARD M | Director | 03/14/2013 | 797,000 |
LEVY RICHARD M | Director | 03/14/2013 | 1,477,168 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 03/11/2013 | 35,030 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 03/11/2013 | 44,425 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 03/11/2013 | 37,114 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 03/11/2013 | 47,071 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 03/05/2013 | 35,087 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 03/05/2013 | 43,632 |
FINNEY ELISHA W | Exec VP and CFO | 03/01/2013 | 249,400 |
FINNEY ELISHA W | Exec VP and CFO | 03/01/2013 | 349,913 |
LARET MARK R | Director | 02/22/2013 | 147,245 |
THYAGARAJAN VENKATRAMAN | Director | 02/19/2013 | 237,900 |
THYAGARAJAN VENKATRAMAN | Director | 02/19/2013 | 353,658 |
NAUMANN-ETIENNE RUEDIGER | Director | 02/19/2013 | 147,456 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 02/14/2013 | 58,694 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 02/14/2013 | 78,942 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 02/14/2013 | 50,347 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 02/14/2013 | 67,716 |
THYAGARAJAN VENKATRAMAN | Director | 02/12/2013 | 27,973 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 02/11/2013 | 37,056 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 02/11/2013 | 45,425 |
FINNEY ELISHA W | Exec VP and CFO | 02/01/2013 | 249,400 |
FINNEY ELISHA W | Exec VP and CFO | 02/01/2013 | 355,985 |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | 01/29/2013 | 53,706 |
NAUMANN-ETIENNE RUEDIGER | Director | 01/28/2013 | 301,600 |
NAUMANN-ETIENNE RUEDIGER | Director | 01/28/2013 | 361,679 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 01/11/2013 | 35,030 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 01/14/2013 | 58,694 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 01/14/2013 | 81,981 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 01/11/2013 | 45,073 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 01/14/2013 | 50,400 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 01/11/2013 | 37,114 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 01/14/2013 | 70,372 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 01/11/2013 | 47,757 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 01/07/2013 | 89,392 |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | 01/07/2013 | 2,269,210 |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | 01/07/2013 | 3,929,216 |
FINNEY ELISHA W | Exec VP and CFO | 01/07/2013 | 249,400 |
FINNEY ELISHA W | Exec VP and CFO | 01/07/2013 | 374,750 |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | 01/03/2013 | 1,745,588 |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | 01/03/2013 | 3,163,309 |
FINNEY ELISHA W | Exec VP and CFO | 01/02/2013 | 249,400 |
FINNEY ELISHA W | Exec VP and CFO | 01/02/2013 | 357,849 |
GUERTIN TIMOTHY E | Director | 12/26/2012 | 5,066,000 |
GUERTIN TIMOTHY E | Director | 12/26/2012 | 6,985,103 |
FINNEY ELISHA W | Exec VP and CFO | 12/20/2012 | 537,939 |
GUERTIN TIMOTHY E | Director | 12/20/2012 | 1,144,331 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 12/14/2012 | 79,134 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 12/14/2012 | 68,041 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 12/11/2012 | 566,784 |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | 12/11/2012 | 2,916,000 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 12/11/2012 | 46,088 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 12/07/2012 | 77,770 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 12/06/2012 | 847,911 |
KUO JOHN W | SVP, Gen Counsel and Secretary | 11/21/2012 | 60,046 |
WILSON DOW R | President and CEO | 11/21/2012 | 173,665 |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | 11/21/2012 | 29,748 |
KLUGE ROBERT H | Corp SVP; Pres. X-Ray Products | 11/21/2012 | 84,836 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 11/21/2012 | 75,057 |
GUERTIN TIMOTHY E | Director | 11/21/2012 | 325,846 |
FINNEY ELISHA W | Exec VP and CFO | 11/21/2012 | 108,592 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 11/14/2012 | 50,400 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 11/14/2012 | 64,911 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 11/12/2012 | 444,962 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 11/12/2012 | 526,464 |
BOSTROM SUSAN L | Director | 11/05/2012 | 745,610 |
BOSTROM SUSAN L | Director | 11/05/2012 | 1,103,548 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 11/05/2012 | 81,863 |
WILSON DOW R | President and CEO | 11/02/2012 | 1,296,880 |
WILSON DOW R | President and CEO | 11/02/2012 | 1,820,000 |
FINNEY ELISHA W | Exec VP and CFO | 11/02/2012 | 559,600 |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | 11/01/2012 | 136,756 |
LARET MARK R | Director | 11/01/2012 | 795,840 |
LARET MARK R | Director | 11/01/2012 | 1,072,573 |
WILSON DOW R | President and CEO | 11/01/2012 | 390,523 |
WILSON DOW R | President and CEO | 11/01/2012 | 670,170 |
NAUMANN-ETIENNE RUEDIGER | Director | 10/31/2012 | 263,050 |
NAUMANN-ETIENNE RUEDIGER | Director | 10/31/2012 | 404,105 |
ECKERT R ANDREW | Director | 10/31/2012 | 179,553 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 11/01/2012 | 1,461,119 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 10/31/2012 | 388,920 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 11/01/2012 | 1,853,489 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 10/31/2012 | 651,618 |
FINNEY ELISHA W | Exec VP and CFO | 11/01/2012 | 297,360 |
FINNEY ELISHA W | Exec VP and CFO | 10/31/2012 | 842,532 |
FINNEY ELISHA W | Exec VP and CFO | 10/31/2012 | 2,158,496 |
FINNEY ELISHA W | Exec VP and CFO | 11/01/2012 | 615,120 |
GUERTIN TIMOTHY E | Director | 10/31/2012 | 5,066,000 |
GUERTIN TIMOTHY E | Director | 10/31/2012 | 6,670,630 |
FINNEY ELISHA W | Exec VP and CFO | 10/01/2012 | 148,680 |
FINNEY ELISHA W | Exec VP and CFO | 10/01/2012 | 243,242 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 09/04/2012 | 70,623 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 09/04/2012 | 121,600 |
FINNEY ELISHA W | Exec VP and CFO | 09/04/2012 | 154,040 |
FINNEY ELISHA W | Exec VP and CFO | 09/04/2012 | 243,280 |
VERHOEF CLARENCE R | SVP, Finance, Corp Controller | 08/23/2012 | 101,285 |
BROWN JOHN SEELY | Director | 08/21/2012 | 1,768,047 |
BROWN JOHN SEELY | Director | 08/21/2012 | 2,511,377 |
FINNEY ELISHA W | Exec VP and CFO | 08/20/2012 | 159,400 |
FINNEY ELISHA W | Exec VP and CFO | 08/20/2012 | 239,800 |
KUO JOHN W | VP, Gen Counsel and Secretary | 08/10/2012 | 100,056 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 08/10/2012 | 67,424 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 08/10/2012 | 66,685 |
FINNEY ELISHA W | Exec VP and CFO | 08/10/2012 | 233,483 |
CHEN TAI-YUN | SVP and Corporate Controller | 08/10/2012 | 88,402 |
FINNEY ELISHA W | Exec VP and CFO | 07/02/2012 | 159,400 |
FINNEY ELISHA W | Exec VP and CFO | 07/02/2012 | 240,252 |
FINNEY ELISHA W | Exec VP and CFO | 06/07/2012 | 159,400 |
FINNEY ELISHA W | Exec VP and CFO | 06/07/2012 | 240,000 |
WILSON DOW R | EVP and COO | 05/18/2012 | 130,241 |
KUO JOHN W | VP, Gen Counsel and Secretary | 05/18/2012 | 49,951 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 05/18/2012 | 74,774 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 05/18/2012 | 42,842 |
GUERTIN TIMOTHY E | President and CEO | 05/18/2012 | 317,850 |
FINNEY ELISHA W | Exec VP and CFO | 05/18/2012 | 105,970 |
CHEN TAI-YUN | SVP and Corporate Controller | 05/18/2012 | 33,280 |
FINNEY ELISHA W | Exec VP and CFO | 05/02/2012 | 185,850 |
FINNEY ELISHA W | Exec VP and CFO | 05/02/2012 | 389,700 |
FINNEY ELISHA W | Exec VP and CFO | 05/01/2012 | 159,400 |
FINNEY ELISHA W | Exec VP and CFO | 05/01/2012 | 257,292 |
FINNEY ELISHA W | Exec VP and CFO | 04/02/2012 | 345,250 |
FINNEY ELISHA W | Exec VP and CFO | 04/02/2012 | 690,837 |
GUERTIN TIMOTHY E | President and CEO | 03/26/2012 | 2,494,000 |
GUERTIN TIMOTHY E | President and CEO | 03/26/2012 | 3,471,405 |
WILSON DOW R | EVP and COO | 03/26/2012 | 371,700 |
WILSON DOW R | EVP and COO | 03/26/2012 | 694,229 |
FINNEY ELISHA W | Exec VP and CFO | 03/14/2012 | 139,900 |
FINNEY ELISHA W | Exec VP and CFO | 03/01/2012 | 345,250 |
FINNEY ELISHA W | Exec VP and CFO | 03/01/2012 | 655,857 |
LARET MARK R | Director | 02/21/2012 | 177,917 |
WILSON DOW R | EVP and COO | 02/15/2012 | 112,289 |
KUO JOHN W | VP, Gen Counsel and Secretary | 02/15/2012 | 53,896 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 02/15/2012 | 81,737 |
KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 02/15/2012 | 46,225 |
GUERTIN TIMOTHY E | President and CEO | 02/15/2012 | 269,480 |
FINNEY ELISHA W | Exec VP and CFO | 02/15/2012 | 89,805 |
CHEN TAI-YUN | VP and Corporate Controller | 02/15/2012 | 35,909 |
NAUMANN-ETIENNE RUEDIGER | Director | 02/14/2012 | 176,569 |
KUO JOHN W | VP, Gen Counsel and Secretary | 02/13/2012 | 41,333 |
KUO JOHN W | VP, Gen Counsel and Secretary | 02/13/2012 | 72,727 |
THYAGARAJAN VENKATRAMAN | Director | 02/13/2012 | 52,552 |
ECKERT R ANDREW | Director | 02/03/2012 | 237,900 |
ECKERT R ANDREW | Director | 02/03/2012 | 460,494 |
FINNEY ELISHA W | SVP, Finance and CFO | 02/01/2012 | 345,250 |
FINNEY ELISHA W | SVP, Finance and CFO | 02/01/2012 | 664,183 |
KUO JOHN W | VP, Gen Counsel and Secretary | 01/13/2012 | 41,296 |
KUO JOHN W | VP, Gen Counsel and Secretary | 01/13/2012 | 78,168 |
FINNEY ELISHA W | SVP, Finance and CFO | 01/12/2012 | 139,900 |
CHEN TAI-YUN | VP and Corporate Controller | 01/12/2012 | 704,382 |
CHEN TAI-YUN | VP and Corporate Controller | 01/12/2012 | 1,283,467 |
CHEN TAI-YUN | VP and Corporate Controller | 01/03/2012 | 2,028,070 |
CHEN TAI-YUN | VP and Corporate Controller | 01/03/2012 | 2,576,525 |
KUO JOHN W | VP, Gen Counsel and Secretary | 01/03/2012 | 352,165 |
KUO JOHN W | VP, Gen Counsel and Secretary | 01/03/2012 | 453,288 |
FINNEY ELISHA W | SVP, Finance and CFO | 01/03/2012 | 345,250 |
FINNEY ELISHA W | SVP, Finance and CFO | 01/03/2012 | 693,046 |
CHEN TAI-YUN | VP and Corporate Controller | 12/30/2011 | 523,131 |
CHEN TAI-YUN | VP and Corporate Controller | 12/30/2011 | 945,351 |
GUERTIN TIMOTHY E | President and CEO | 12/30/2011 | 4,988,000 |
GUERTIN TIMOTHY E | President and CEO | 12/30/2011 | 6,700,000 |
KUO JOHN W | VP, Gen Counsel and Secretary | 12/27/2011 | 591,810 |
KUO JOHN W | VP, Gen Counsel and Secretary | 12/27/2011 | 748,059 |
KUO JOHN W | VP, Gen Counsel and Secretary | 12/22/2011 | 2,880,608 |
KUO JOHN W | VP, Gen Counsel and Secretary | 12/22/2011 | 3,788,064 |
FINNEY ELISHA W | SVP, Finance and CFO | 12/20/2011 | 185,850 |
FINNEY ELISHA W | SVP, Finance and CFO | 12/20/2011 | 389,700 |
FINNEY ELISHA W | SVP, Finance and CFO | 12/14/2011 | 159,400 |
FINNEY ELISHA W | SVP, Finance and CFO | 12/14/2011 | 253,526 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 12/13/2011 | 1,006,395 |
NAUMANN-ETIENNE RUEDIGER | Director | 11/15/2011 | 115,490 |
FINNEY ELISHA W | SVP, Finance and CFO | 11/07/2011 | 199,250 |
FINNEY ELISHA W | SVP, Finance and CFO | 11/07/2011 | 290,000 |
FINNEY ELISHA W | SVP, Finance and CFO | 11/04/2011 | 398,500 |
FINNEY ELISHA W | SVP, Finance and CFO | 11/04/2011 | 580,000 |
KUO JOHN W | VP, Gen Counsel and Secretary | 08/10/2011 | 38,915 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 08/10/2011 | 29,923 |
FINNEY ELISHA W | SVP, Finance and CFO | 08/10/2011 | 79,587 |
CHEN TAI-YUN | VP and Corporate Controller | 08/10/2011 | 24,135 |
FINNEY ELISHA W | SVP, Finance and CFO | 08/05/2011 | 199,250 |
FINNEY ELISHA W | SVP, Finance and CFO | 08/05/2011 | 290,000 |
FINNEY ELISHA W | SVP, Finance and CFO | 07/05/2011 | 398,500 |
FINNEY ELISHA W | SVP, Finance and CFO | 07/05/2011 | 706,085 |
KUO JOHN W | VP, Gen Counsel and Secretary | 07/01/2011 | 1,149,498 |
KUO JOHN W | VP, Gen Counsel and Secretary | 07/01/2011 | 2,184,003 |
GUERTIN TIMOTHY E | President and CEO | 06/27/2011 | 2,494,000 |
GUERTIN TIMOTHY E | President and CEO | 06/27/2011 | 3,415,889 |
WILSON DOW R | EVP and Pres. Oncology Sys. | 06/13/2011 | 86,049 |
WILSON DOW R | EVP and Pres. Oncology Sys. | 06/13/2011 | 153,153 |
FINNEY ELISHA W | SVP, Finance and CFO | 06/06/2011 | 398,500 |
FINNEY ELISHA W | SVP, Finance and CFO | 06/06/2011 | 654,174 |
WILSON DOW R | EVP and Pres. Oncology Sys. | 05/18/2011 | 179,196 |
WILSON DOW R | EVP and Pres. Oncology Sys. | 05/19/2011 | 219,265 |
KUO JOHN W | VP, Gen Counsel and Secretary | 05/18/2011 | 55,999 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 05/18/2011 | 109,249 |
GUERTIN TIMOTHY E | President and CEO | 05/18/2011 | 356,330 |
FINNEY ELISHA W | SVP, Finance and CFO | 05/18/2011 | 118,800 |
CHEN TAI-YUN | VP and Corporate Controller | 05/18/2011 | 37,310 |
WILSON DOW R | EVP and Pres. Oncology Sys. | 05/13/2011 | 86,049 |
WILSON DOW R | EVP and Pres. Oncology Sys. | 05/13/2011 | 160,560 |
ECKERT R ANDREW | Director | 05/06/2011 | 397,920 |
ECKERT R ANDREW | Director | 05/06/2011 | 563,668 |
LARET MARK R | Director | 05/05/2011 | 132,990 |
FINNEY ELISHA W | SVP, Finance and CFO | 05/05/2011 | 398,500 |
FINNEY ELISHA W | SVP, Finance and CFO | 05/05/2011 | 696,270 |
GUERTIN TIMOTHY E | President and CEO | 05/02/2011 | 1,594,000 |
GUERTIN TIMOTHY E | President and CEO | 05/02/2011 | 2,817,724 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 04/20/2011 | 1,578,300 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 04/20/2011 | 2,100,000 |
WILSON DOW R | EVP and Pres. Oncology Sys. | 04/13/2011 | 86,049 |
WILSON DOW R | EVP and Pres. Oncology Sys. | 04/13/2011 | 160,139 |
FINNEY ELISHA W | SVP, Finance and CFO | 04/05/2011 | 336,460 |
FINNEY ELISHA W | SVP, Finance and CFO | 04/05/2011 | 689,155 |
LEVY RICHARD M | Director | 03/21/2011 | 481,425 |
LEVY RICHARD M | Director | 03/21/2011 | 990,000 |
WILSON DOW R | EVP and Pres. Oncology Sys. | 03/14/2011 | 86,049 |
WILSON DOW R | EVP and Pres. Oncology Sys. | 03/14/2011 | 153,506 |
FINNEY ELISHA W | SVP, Finance and CFO | 03/07/2011 | 320,950 |
FINNEY ELISHA W | SVP, Finance and CFO | 03/07/2011 | 699,022 |
LEVY RICHARD M | Director | 03/07/2011 | 481,425 |
LEVY RICHARD M | Director | 03/07/2011 | 1,048,531 |
LEVY RICHARD M | Director | 02/22/2011 | 481,425 |
LEVY RICHARD M | Director | 02/22/2011 | 1,031,274 |
WILSON DOW R | EVP and Pres. Oncology Sys. | 02/16/2011 | 357,259 |
NAUMANN-ETIENNE RUEDIGER | Director | 02/16/2011 | 635,820 |
NAUMANN-ETIENNE RUEDIGER | Director | 02/16/2011 | 918,853 |
CHEN TAI-YUN | VP and Corporate Controller | 02/15/2011 | 70,113 |
KUO JOHN W | VP, Gen Counsel and Secretary | 02/15/2011 | 102,658 |
FINNEY ELISHA W | SVP, Finance and CFO | 02/15/2011 | 183,384 |
GUERTIN TIMOTHY E | President and CEO | 02/15/2011 | 642,127 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 02/15/2011 | 330,261 |
WILSON DOW R | EVP and Pres. Oncology Sys. | 02/15/2011 | 206,590 |
WILSON DOW R | EVP and Pres. Oncology Sys. | 02/14/2011 | 86,011 |
WILSON DOW R | EVP and Pres. Oncology Sys. | 02/14/2011 | 163,282 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 02/08/2011 | 1,013,200 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 02/07/2011 | 2,518,965 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 02/07/2011 | 3,376,682 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 02/08/2011 | 1,360,000 |
FINNEY ELISHA W | SVP, Finance and CFO | 02/07/2011 | 320,950 |
FINNEY ELISHA W | SVP, Finance and CFO | 02/07/2011 | 677,047 |
LEVY RICHARD M | Director | 02/07/2011 | 481,425 |
LEVY RICHARD M | Director | 02/07/2011 | 1,015,586 |
GUERTIN TIMOTHY E | President and CEO | 01/31/2011 | 1,793,250 |
GUERTIN TIMOTHY E | President and CEO | 01/31/2011 | 3,077,862 |
LEVY RICHARD M | Director | 01/31/2011 | 481,425 |
LEVY RICHARD M | Director | 01/31/2011 | 1,025,931 |
WILSON DOW R | EVP and Pres. Oncology Sys. | 01/13/2011 | 86,049 |
WILSON DOW R | EVP and Pres. Oncology Sys. | 01/13/2011 | 161,618 |
LEVY RICHARD M | Director | 01/10/2011 | 481,425 |
LEVY RICHARD M | Director | 01/10/2011 | 1,024,082 |
FINNEY ELISHA W | SVP, Finance and CFO | 01/05/2011 | 320,950 |
FINNEY ELISHA W | SVP, Finance and CFO | 01/05/2011 | 695,213 |
LEVY RICHARD M | Director | 12/27/2010 | 481,425 |
LEVY RICHARD M | Director | 12/27/2010 | 1,058,877 |
KUO JOHN W | VP, Gen Counsel and Secretary | 12/28/2010 | 877,330 |
KUO JOHN W | VP, Gen Counsel and Secretary | 12/27/2010 | 2,694,108 |
KUO JOHN W | VP, Gen Counsel and Secretary | 12/28/2010 | 1,223,690 |
KUO JOHN W | VP, Gen Counsel and Secretary | 12/27/2010 | 3,954,772 |
CHEN TAI-YUN | VP and Corporate Controller | 12/16/2010 | 452,400 |
CHEN TAI-YUN | VP and Corporate Controller | 12/16/2010 | 519,900 |
WILSON DOW R | EVP and Pres. Oncology Sys. | 12/13/2010 | 777,819 |
WILSON DOW R | EVP and Pres. Oncology Sys. | 12/13/2010 | 1,419,486 |
LEVY RICHARD M | Director | 12/13/2010 | 481,425 |
LEVY RICHARD M | Director | 12/13/2010 | 1,017,461 |
WILSON DOW R | EVP and Pres. Oncology Sys. | 12/06/2010 | 1,138,922 |
WILSON DOW R | EVP and Pres. Oncology Sys. | 12/06/2010 | 1,938,314 |
KUO JOHN W | VP, Gen Counsel and Secretary | 12/06/2010 | 694,696 |
FINNEY ELISHA W | SVP, Finance and CFO | 12/06/2010 | 320,950 |
FINNEY ELISHA W | SVP, Finance and CFO | 12/06/2010 | 690,520 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 12/02/2010 | 997,600 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 12/02/2010 | 1,360,000 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 11/30/2010 | 997,600 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 11/30/2010 | 1,320,000 |
LEVY RICHARD M | Director | 11/29/2010 | 481,425 |
LEVY RICHARD M | Director | 11/29/2010 | 981,156 |
BROWN JOHN SEELY | Director | 11/23/2010 | 971,257 |
BROWN JOHN SEELY | Director | 11/23/2010 | 1,502,053 |
LARET MARK R | Director | 11/23/2010 | 160,773 |
ECKERT R ANDREW | Director | 11/19/2010 | 185,850 |
ECKERT R ANDREW | Director | 11/19/2010 | 324,737 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 11/19/2010 | 385,971 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 11/19/2010 | 502,970 |
THYAGARAJAN VENKATRAMAN | Director | 11/18/2010 | 185,850 |
THYAGARAJAN VENKATRAMAN | Director | 11/18/2010 | 319,928 |
LEVY RICHARD M | Director | 11/15/2010 | 481,425 |
LEVY RICHARD M | Director | 11/15/2010 | 964,011 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 11/08/2010 | 1,818,542 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 11/08/2010 | 2,585,048 |
KUO JOHN W | VP, Gen Counsel and Secretary | 11/05/2010 | 498,800 |
KUO JOHN W | VP, Gen Counsel and Secretary | 11/05/2010 | 650,000 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 11/05/2010 | 1,285,641 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 11/05/2010 | 2,097,030 |
FINNEY ELISHA W | SVP, Finance and CFO | 11/05/2010 | 320,950 |
FINNEY ELISHA W | SVP, Finance and CFO | 11/05/2010 | 647,860 |
CHEN TAI-YUN | VP and Corporate Controller | 11/03/2010 | 384,675 |
CHEN TAI-YUN | VP and Corporate Controller | 11/03/2010 | 484,931 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 11/03/2010 | 1,990,989 |
CHEN TAI-YUN | VP and Corporate Controller | 11/02/2010 | 213,885 |
CHEN TAI-YUN | VP and Corporate Controller | 11/02/2010 | 413,213 |
NAUMANN-ETIENNE RUEDIGER | Director | 11/02/2010 | 831,200 |
NAUMANN-ETIENNE RUEDIGER | Director | 11/02/2010 | 1,249,606 |
GUERTIN TIMOTHY E | President and CEO | 11/02/2010 | 1,793,250 |
GUERTIN TIMOTHY E | President and CEO | 11/02/2010 | 2,809,737 |
LEVY RICHARD M | Director | 11/02/2010 | 481,425 |
LEVY RICHARD M | Director | 11/02/2010 | 936,591 |
LEVY RICHARD M | Director | 10/18/2010 | 481,425 |
LEVY RICHARD M | Director | 10/18/2010 | 933,052 |
CHEN TAI-YUN | VP and Corporate Controller | 10/05/2010 | 385,453 |
CHEN TAI-YUN | VP and Corporate Controller | 10/05/2010 | 640,348 |
KUO JOHN W | VP, Gen Counsel and Secretary | 10/05/2010 | 185,850 |
KUO JOHN W | VP, Gen Counsel and Secretary | 10/05/2010 | 310,000 |
FINNEY ELISHA W | SVP, Finance and CFO | 10/05/2010 | 320,950 |
FINNEY ELISHA W | SVP, Finance and CFO | 10/05/2010 | 616,833 |
LEVY RICHARD M | Director | 10/04/2010 | 481,425 |
LEVY RICHARD M | Director | 10/04/2010 | 906,751 |
GUERTIN TIMOTHY E | President and CEO | 09/27/2010 | 1,793,250 |
GUERTIN TIMOTHY E | President and CEO | 09/27/2010 | 2,681,434 |
KUO JOHN W | VP, Gen Counsel and Secretary | 09/21/2010 | 405,025 |
KUO JOHN W | VP, Gen Counsel and Secretary | 09/21/2010 | 630,000 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 09/21/2010 | 797,000 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 09/21/2010 | 1,200,000 |
LEVY RICHARD M | Director | 09/20/2010 | 481,425 |
LEVY RICHARD M | Director | 09/20/2010 | 895,212 |
LEVY RICHARD M | Director | 09/13/2010 | 4,095,150 |
LEVY RICHARD M | Director | 09/13/2010 | 7,670,000 |
FINNEY ELISHA W | SVP, Finance and CFO | 09/07/2010 | 320,950 |
FINNEY ELISHA W | SVP, Finance and CFO | 09/07/2010 | 560,156 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 08/10/2010 | 31,634 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 08/10/2010 | 720,419 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 08/10/2010 | 1,140,000 |
KUO JOHN W | VP, Gen Counsel and Secretary | 08/10/2010 | 47,536 |
FINNEY ELISHA W | SVP, Finance and CFO | 08/10/2010 | 87,149 |
CHEN TAI-YUN | VP and Corporate Controller | 08/10/2010 | 26,428 |
WILSON DOW R | EVP and Pres. Oncology Sys. | 08/10/2010 | 713,664 |
WILSON DOW R | EVP and Pres. Oncology Sys. | 08/10/2010 | 1,094,400 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 08/06/2010 | 641,900 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 08/06/2010 | 1,102,792 |
FINNEY ELISHA W | SVP, Finance and CFO | 08/05/2010 | 320,950 |
FINNEY ELISHA W | SVP, Finance and CFO | 08/05/2010 | 563,259 |
WILSON DOW R | EVP and Pres. Oncology Sys. | 08/04/2010 | 401,436 |
WILSON DOW R | EVP and Pres. Oncology Sys. | 08/04/2010 | 615,600 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 08/04/2010 | 641,900 |
KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 08/04/2010 | 1,140,000 |
GUERTIN TIMOTHY E | President and CEO | 08/02/2010 | 1,091,230 |
GUERTIN TIMOTHY E | President and CEO | 08/02/2010 | 1,876,459 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR VARIAN MEDICAL SYSTEMS, INC.
LOADING...